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Abstract
The work presented in this thesis is intended to contribute towards the under-
standing of the cerebral vascular behaviour in response to changes in neuronal
activation. The blood oxygenation-level dependent (BOLD) functional mag-
netic resonance imaging (fMRI) signal provides an indirect measure of neuronal
activation, arising from a combination of metabolic and vascular (blood flow
and blood volume) changes local to the activation. Therefore the BOLD signal
is dependent on local vascular properties as well as on the neuronal activation,
leading to a variability of the BOLD signal, based on the underlying vascular
structure. It has become an important goal to improve understanding of the
mechanisms underlying the BOLD signal in order to separate out this vascular
variability from the underlying correspondence with the neuronal activation.
The effect of field strength on the temporal characteristics of the BOLD haemo-
dynamic response function is investigated. An earlier BOLD response onset
has been measured with increasing static magnetic field strength, consistent
with an earlier microvascular (compared with macrovascular) signal response.
This result can be used to improve haemodynamic models of the BOLD signal.
Hypercapnia, a vasodilator, has been used both to assess the relationship be-
tween transverse relaxation and blood oxygenation at 3 and 7 Tesla and to
identify vascular heterogeneity between two equivalent brain regions. A tight,
linear relationship was found between the level of hypercapnia and transverse
relaxation at both 3 and 7 Tesla, whilst the change in transverse relaxation
due to hypercapnia increased 2.1 ± 0.5 fold from 3 to 7 Tesla, indicating an
approximately linear relationship across field strength. In a separate experi-
vi
ment, a vascular asymmetry was found between the left and right precentral
gyri using hypercapnia. This result highlights the need to account for the vas-
cular contribution to the BOLD signal before using this BOLD signal to make
comparisons of neuronal activity across brain regions.
Finally, an improved model for calibrated BOLD has been proposed and im-
plemented, which requires fewer assumptions than existing approaches. This
uses the BOLD response to some task, repeated both at normoxia and hyper-
oxia. To assess the validity of this model, the effects of paramagnetic oxygen
molecules are considered, both dissolved in blood plasma and in airspaces ad-
jacent to the brain. These effects were found to be small, except for in the
frontal cortex.
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Chapter 1
Introduction
Blood oxygenation-level dependent (BOLD) functional magnetic resonance
imaging (fMRI) is a very promising tool for studying brain function. Since
the first implementation of the BOLD signal to detect changes in neuronal ac-
tivation in response to visual and motor stimuli [1, 2], this technique has been
widely adopted for psychology and neuroscience research. However some of its
limitations are restricting its use in a clinical environment. BOLD fMRI mea-
sures the local vascular response to neuronal activity (typically within several
mm of the neuronal activity [3]). This vascular response acts as a filter to blur
the detected signal change both spatially and temporally compared with the
underlying neuronal activity. Also, comparison of the neuronal activity across
subjects and across brain regions using BOLD is confounded by the ampli-
tude of the BOLD response depending on local vascular properties as well
as the underlying neuronal activity. This is of particular importance for pa-
tient groups who have compromised cerebrovascular or cardiovascular function.
Also, some drugs (for example caffeine) will influence the basal cerebrovascular
state, leading to an altered BOLD signal in response to neuronal activation.
This work aims to develop techniques for improving the understanding of the
BOLD signal response to changes in brain function.
1
1.1 Thesis outline
Chapter 2 introduces the physics behind NMR, the concepts underlying MRI
and the physics and physiology which provide contrast in fMRI. This chap-
ter introduces a range of MRI pulse sequences, of use for fMRI experiments.
Various fMRI acquisition techniques are introduced, along with some of the
current limitations of fMRI, which aim to be addressed in subsequent chapters.
Chapter 3 describes the theory behind modulating a subject’s blood gas levels
of oxygen and carbon dioxide. These can be used to provide a global perturba-
tion to the cerebral vasculature, which can be used to investigate the vascular
dependence of the BOLD signal. A system is described for modulating blood
gas levels of oxygen and carbon dioxide, which is used in the subsequent chap-
ters. Details of the application of this method to an MRI experiment are also
provided.
Chapter 4 presents results from a study which investigated the dependence
of the BOLD temporal characteristics on field strength. The relative con-
tributions to the BOLD signal of different sources (such as from large and
small blood vessels, or from blood and the surrounding tissue) depends on
field strength. Therefore this work aimed to investigate temporal differences
in the BOLD signal from these different sources through the perturbation of
field strength.
Chapter 5 is concerned with how hypercapnia perturbs cerebral vasculature
and how this can be used to investigate the BOLD signal mechanism. This
chapter presents results from two experiments. The first used hypercapnia to
investigate the relationship between transverse relaxation rate and the blood
gas level of carbon dioxide at 3 Tesla and 7 Tesla. This is of use for improving
the application of a technique for calibrating the BOLD signal at these field
strengths. The second experiment used the BOLD response to hypercapnia
to demonstrate a difference in the underlying vascular response between two
equivalent brain regions, the left and right precentral gyrus.
2
Chapter 6 considers the effect of hyperoxia on both vascular and magnetic
properties, to assess the viability of hyperoxia as a tool to investigate the
BOLD signal mechanism. Results are presented from an experiment to deter-
mine whether a field inhomogeneity created by increased oxygen in the nasal
cavity and frontal sinuses will cause a significant effect on the MRI signal,
which would confound BOLD analysis. A new approach for calibration of the
BOLD response to a task repeated both an normoxia and hyperoxia was pro-
posed and results presented for an experiment demonstrating implementation
of this approach.
Chapter 7 summarises the work presented in this thesis.
3
Chapter 2
Theory
2.1 Introduction
This chapter aims to introduce the major concepts of a magnetic resonance
imaging (MRI) experiment. The basic theory behind nuclear magnetic res-
onance NMR is described, leading to a description of the behaviour of an
ensemble of hydrogen nuclei in the presence of time-varying magnetic fields.
Basic principles of magnetic resonance imaging MRI are discussed, including
a brief introduction to the hardware used for MRI acquisition in this thesis.
Finally a description of the principles of using MRI to study brain function is
presented, highlighting some of the issues that will be addressed in the follow-
ing chapters of this thesis.
2.2 Nuclear Magnetic Resonance
Nuclear magnetic resonance NMR arises from spin angular momentum, which
is an intrinsic property of nuclei. This section introduces some basic principles
of the behaviour of nuclear spin angular momentum in the presence of a static
magnetic field. The magnetic properties of an ensemble of many hydrogen nu-
clei is considered at thermal equilibrium, in perturbed states and the recovery
from a perturbed state back to thermal equilibrium.
4
2.2.1 Spin angular momentum
Spin angular momentum is an intrinsic quantum mechanical property of a
particle, without a classical macroscopic analogue. Unlike conventional angular
momentum, spin angular momentum does not relate to rotation. Spin angular
momentum (Ls) of a particle is described by:
Ls = h¯
√
S(S + 1), (2.1)
where h¯ = 1.054×10−34 Js is Planck’s constant divided by 2pi and S is the spin
quantum number. S can either take a integer or half-integer value and is either
positive or zero. A particle with spin quantum number S has 2S + 1 energy
level states, associated with another quantum number ms. Here, ms takes a
range of values, from -S to +S, in integer steps. The separation between these
ms states depends on the magnetic field experienced by the particle. In the
absence of a magnetic field, these states are degenerate (all having the same
energy). The splitting of these levels in a magnetic field is known as the Zee-
man effect [4].
Spin angular momentum is associated with a magnetic moment, such that
magnetic moment is proportional to spin angular momentum. The constant
of proportionality is known as the gyromagnetic ratio γ. Magnetic moment
is parallel to spin angular momentum when γ > 0 and is anti-parallel to spin
angular momentum when γ < 0. In the absence of a magnetic field the spin
angular momentum vector and hence the magnetic moment vector can be
oriented in any direction. When a magnetic field is applied the spin angular
momentum vector precesses about the field, at a constant angle with respect
to the field. This precession is due to the magnetic field exerting a torque
on the magnetic moment, such that torque is the cross product of magnetic
moment and field. The frequency of this precession is known as the Larmor
frequency ω0:
ω0 = −γB0, (2.2)
where γ is the gyromagnetic ratio and B0 is the magnetic field experienced by
the particle. The precession direction is dependent on the sign of γ, as shown
5
Figure 2.1: Diagram showing the precession of the spin angular momentum vector about
a magnetic field B0, for the cases of positive and negative gyromagnetic ratios γ.
in figure 2.1.
For the specific case of nuclear spin, the convention is to replace S and ms
with I and mI . The nuclear spin quantum number depends on the number of
protons and neutrons in the nucleus. If the number of protons and neutrons
are both even, then the nucleus will have I = 0, whereas if the nucleus has
odd numbers of both protons and neutrons, then I will be a positive integer
[4]. If there are an odd number of either protons or neutrons and an even
number of the other nucleon, then I will have a half-integer value. Examples
of biologically interesting nuclei with I = 1/2 are 13C, 19F and 31P.
This thesis will only deal with NMR of hydrogen nuclei, specifically the 1H iso-
tope. NMR of hydrogen (1H) atoms is widely used to study organic tissue, due
to a high concentration of hydrogen atoms in tissue and a high natural abun-
dance (∼ 100% [4]) of 1H. The majority of hydrogen atoms in tissue are con-
tained in water (H2O) molecules.
1H nuclei have I = 1/2, so mI = −1/2, 1/2,
through Zeeman splitting. The gyromagnetic ratio of hydrogen nuclei γ1H
is 267.522 × 106 rad s−1 T−1 [4]. The separation between mI = 1/2 and
mI = −1/2 spin states is ∆E = h¯ · γ1H · B0, where mI = 1/2 is the lower
energy state, since the associated magnetic moment is parallel to the applied
magnetic field.
6
2.2.2 Ensemble of 1H nuclear spins at thermal equilib-
rium
An ensemble of many 1H nuclear spins will have a distribution of spin angular
momentum vectors, with the spin state of each being a superposition of the
mI = 1/2 and mI = −1/2 spin states. For this many spin, I = 1/2 system,
a spin density operator ρˆ can be used to describe the quantum state of the
whole spin ensemble [4].
ρˆ =
[
ρ 1
2
, 1
2
ρ 1
2
,− 1
2
ρ
−
1
2
, 1
2
ρ
−
1
2
,− 1
2
]
(2.3)
This spin density operator contains terms for the fractional populations of
both spin states (ρ 1
2
, 1
2
,ρ
−
1
2
,− 1
2
) and the coherence between both spin states
(ρ 1
2
,− 1
2
,ρ
−
1
2
, 1
2
). The population terms are fractions of the total spin ensemble,
such that ρ 1
2
, 1
2
+ ρ
−
1
2
,− 1
2
= 1. They can be used to determine the net magneti-
sation of the spin ensemble in the direction of the applied magnetic field (the
longitudinal direction). Non-zero coherence terms indicate some net magneti-
sation in the plane perpendicular to the applied magnetic field (the transverse
plane). This transverse component of net magnetisation arises from phase co-
herence in the precession of the spin ensemble.
In the absence of an applied magnetic field, the spin angular momentum vec-
tors will have an isotropic distribution, so will have no net magnetic mo-
ment across the spin ensemble. In this case, the coherence terms of the
spin density operator will equal zero and both population terms will be equal
(ρ 1
2
, 1
2
= ρ
−
1
2
,− 1
2
= 0.5). If a magnetic field (amplitude B0) were then applied
to this system, spin precession would occur with a frequency ω0 (equation
2.2) and at a constant angle from the applied field (figure 2.1), determined
by the initial orientation to the applied field. This precession alone will not
change net magnetisation. However, random molecular motion causes micro-
scopic perturbations to the field experienced by the spins, causing a shift in
the axis about which precession occurs. This gradually changes the precession
angle about B0, leading to changes in the spin density operator population
terms and a change in net longitudinal magnetisation, until the spin ensemble
7
reaches thermal equilibrium for the new B0. At thermal equilibrium, the spin
density operator can be calculated as follows. There is no coherence between
states at thermal equilibrium, so ρ 1
2
,− 1
2
= ρ
−
1
2
, 1
2
= 0. The population terms
depend on magnetic field strength B0 and temperature (T (K)), following the
Boltzmann distribution:
ρ
±
1
2
,± 1
2
=
exp(
±
1
2
h¯·γ1H·B0
kBT
)
exp(
+ 1
2
h¯·γ1H·B0
kBT
) + exp(
−
1
2
h¯·γ1H·B0
kBT
)
, (2.4)
where kB = 1.38066×10
−23 JK−1 is the Boltzmann constant. At room temper-
ature (T = 298 K), the difference in populations is 5×10−6 at 1.5 T, 10×10−6
at 3 T and 24× 10−6 at 7 T, so the net magnetisation is of the order of 10−5
that of the total magnetisation if all magnetic moments aligned with B0. In
the limit where (1
2
h¯ ·γ1H ·B0) << kBT , equation 2.4 reduces to a linear depen-
dence of population difference on B0. At room temperature, this limit holds
for a B0 up to several orders of magnitude higher than 7 T. The rate at which
the spin ensemble reaches thermal equilibrium is the longitudinal relaxation
rate. In this case, from an isotropic distribution to thermal equilibrium at
the applied field B0, the net longitudinal magnetisation obeys an exponential
recovery curve, with time constant T1.
2.2.3 Excitation of the spin ensemble
The longitudinal nuclear spin magnetisation resulting from this population
difference cannot be directly detected during an NMR experiment, due to
large electron spin magnetisation in the longitudinal direction (several orders
of magnitude greater than nuclear spin magnetisation). Instead, the nuclear
spin magnetisation is measured in the transverse plane. This is achieved using
magnetic field perturbations, which oscillate in time at a frequency approxi-
mating ω ∼ ω0 [5, 6]. This field perturbation is known as the radio-frequency
pulse, since this frequency is on the order of radio waves in the electromagnetic
spectrum. The effect of the radio-frequency pulse is to convert the population
difference into coherence, so the net magnetisation vector gains a component
8
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Figure 2.2: Classical illustration showing examples of the effect of a radio-frequency
pulse, with various durations, on the net magnetisation vector. The vertical axis is the
direction of the static magnetic field B0. The transverse plane is collapsed down to the
horizontal dashed line in this plot.
in the transverse plane and the net longitudinal component is reduced.
The radio-frequency pulse can be separated into two circularly rotating mag-
netic field components, rotating in opposite directions, with angular frequency
ω and −ω. The first component rotates at approximately the same frequency
as spin precession, whereas the second component rotates at a frequency ap-
proximately 2ω0 from spin precession. In the limit that the amplitude of
the radio-frequency pulse (B1) is much less than the static magnetic field (so
B1 << B0) the second component has a negligible effect on the spin ensemble.
The first component causes the net magnetisation vector to rotate orthogo-
nally to the static magnetic field (as shown in figure 2.2), with the amount of
rotation depending on the duration of the radio-frequency pulse. The radio-
frequency pulse duration and amplitude product is typically described by the
angle of rotation it causes on the net magnetisation vector, relative to the
static magnetic field direction, called the flip angle.
The effect on the spin density operator is initially to decrease the difference
in population terms and create non-zero coherence terms. The population dif-
ference decreases and the coherence increases with increasing flip angle, until
the flip angle = 90◦, at which point the populations of both spin states are
equal and the coherence is at a maximum. Between 90◦ < flip angle < 180◦
the population difference increases again and coherence decreases, but with
the higher energy spin state (mI = −1/2) having a higher population. When
the flip angle = 180◦, the coherence equals zero and the spin state popula-
tions are inverted (so there is the same population difference as for before the
radio-frequency pulse). For 180◦ < flip angle < 360◦ the spin state populations
return to their initial values and coherence increases up to a maximum at flip
angle = 270◦ and then decreases to zero at flip angle = 360◦, in a mirror of
0◦ < flip angle < 180◦. Therefore the spin density operator is the same before
and after a 360◦ flip angle radio-frequency pulse.
The radio-frequency pulse perturbs the spin density operator such that the
spin ensemble will not be in a state of thermal equilibrium. After the radio-
frequency pulse, microscopic perturbations to the field caused by random
molecular motion causes both the population terms and coherence terms to re-
turn to thermal equilibrium values, through longitudinal relaxation and trans-
verse relaxation respectively. The rate at which the coherence terms reach
their thermal equilibrium values (zero) is known as the transverse relaxation
rate, described by a time constant T2.
As well as transverse and longitudinal relaxation, after the radio-frequency
pulse the net magnetisation vector rotates in the transverse plane, with the
same frequency as spin precession (ω0). The transverse component of the net
magnetisation vector can be detected through a receive coil, by the transverse
magnetic field caused by the magnetisation vector inducing a current in the
coil. This will be described in more detail in section 2.3.1.
2.2.4 Bloch equations
Felix Bloch proposed a set of empirical differential equations to describe the
relaxation of the net magnetisation vector to thermal equilibrium, known as
the Bloch equations [7]. Defining a Cartesian coordinate system (such that x-,
y- and z-axes are perpendicular to one another), where the static magnetic field
lies parallel to the z-axis and the x- and y-axes are parallel to the transverse
10
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Figure 2.3: A solution to the Bloch equations (equation 2.6) following a 90◦ radio-
frequency pulse. Note that the choice of ω0 (of 10/T2) is for illustration only. Typical
values of ω0 are of the order 10
6/T2.
plane, then:
dMz
dt
=
1
T1
(M0 −Mz)
dMy
dt
= −ω0Mx −
My
T2
dMx
dt
= ω0My −
Mx
T2
(2.5)
such that M0 is the longitudinal magnetisation at thermal equilibrium, Mx,
My andMz are the net magnetisation components in each respective direction.
One possible solution of the Bloch equations for a time t after a 90◦ radio-
frequency pulse is
Mz(t) =M0(1− e
−t/T1)
My(t) = −M0e
−t/T2sin(ω0t)
Mx(t) =M0e
−t/T2cos(ω0t).
(2.6)
An illustration of these equations is shown in figure 2.3. The sinusoidal oscil-
lation terms describe the rotation of the net magnetisation vector about the
static magnetic field, reflecting spin precession.
2.2.5 Transverse relaxation and spin echoes
So far, this description assumes a homogeneous background magnetic field,
which is not the case in reality. Macroscopic field inhomogeneities are generally
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present across any sample. These field inhomogeneities are of the order of a
millionth of the magnitude of the static magnetic field, but are sufficient to
increase the rate of transverse relaxation. The extra component of transverse
relaxation due to macroscopic field inhomogeneities is described by a time
constant T ′2. The total transverse relaxation is described by another time
constant T ∗2 , such that
1
T ∗2
=
1
T2
+
1
T ′2
. (2.7)
As an aside, it is worth noting that sometimes a rate constant is used instead
of a time constant, such that
R1 =
1
T1
, R2 =
1
T2
, R′2 =
1
T ′2
and R∗2 =
1
T ∗2
. (2.8)
For a spin ensemble in the presence of macroscopic field homogeneities the net
magnetisation can be calculated by replacing T2 with T
∗
2 in equations 2.5 and
2.6.
Therefore transverse relaxation is caused by a combination of microscopic field
fluctuations (T2 decay) that are rapidly varying and macroscopic field inho-
mogeneities (T ′2 decay) that are considered to be static over short time-scales.
Transverse relaxation due to T2 decay is considered unrecoverable due to the
random nature of molecular motion causing the microscopic field fluctuations.
However it is possible to reverse the relaxation due to macroscopic field inho-
mogeneities, through the application of a 180◦ radio-frequency pulse.
If a 180◦ radio-frequency pulse is applied at time TE/2 after the 90◦ radio-
frequency pulse, then the transverse relaxation due to macroscopic field inho-
mogeneities is refocussed. This is seen as an echo of transverse magnetisation,
centred on a time TE/2 after the 180◦ radio-frequency pulse (see figure 2.4).
This will be designated as a spin echo, centred at a time TE after the 90◦
radio-frequency pulse, where TE is the echo time. To consider the origins
of this spin echo, it is appropriate to move to a non-inertial reference frame,
rotating around the axis of the static magnetic field with frequency ω0. In
this reference frame, spin precession at ω0 can be neglected, so the transverse
component of the net magnetisation vector can be considered purely in terms
12
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Figure 2.4: Plot illustrating the effect on transverse magnetisation of a 90◦ radio-
frequency pulse, followed a time TE/2 later by a 180◦ radio-frequency pulse. The T ′2
decay is fully refocussed after a time TE after the initial 90◦ radio-frequency pulse,
causing a spin echo, however the amplitude of the spin echo is attenuated by the T2
decay. This plot is formed in a reference frame rotating in phase with spins precessing
with frequency ω0, so there is no oscillation at ω0, as there would be in the laboratory
reference frame.
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of relaxation.
The spin ensemble can be separated into groups of nuclei which experience
the same field, such that all nuclei in a group have a common spin density
operator. Each group is called an isochromat, which can be considered to have
its own net magnetisation vector. T ′2 decay can be illustrated by considering
the relative phase of the transverse component of each isochromat magneti-
sation vector (see figure 2.5, referring to stages A–E). Prior to the 90◦ radio-
frequency pulse (A), each isochromat has no net transverse magnetisation, as
the whole spin ensemble is at thermal equilibrium. The 90◦ radio-frequency
pulse (at t = 0) converts the net longitudinal magnetisation of each isochromat
into a transverse phase coherence, such that immediately after the 90◦ radio-
frequency pulse (B), the transverse component of the net magnetisation vector
of all isochromats precess in phase with one another. However, since each
isochromat experiences a different local field, their net magnetisation vectors
precess at different frequencies, such that faster precessing isochromats lead
slower precessing isochromats, causing T ′2 decay (C). The effect of the 180
◦
radio-frequency pulse (at t = TE/2) is to rotate the net magnetisation vector
of each isochromat by 180◦, both inverting the net longitudinal magnetisation
(as will be discussed in section 2.3) and net transverse magnetisation (see fig-
ure 2.5). Therefore, immediately after the 180◦ radio-frequency pulse slower
precessing isochromats lead faster precessing isochromats (D) and at time t
= TE the transverse magnetisation of all isochromats are in phase again (E).
This leads to a net transverse magnetisation of the whole spin ensemble at t
= TE which is only attenuated by T2 decay and not T
′
2 decay.
In summary, the time constants T1 and T2 characterise the return of longitu-
dinal and transverse magnetisation, respectively to thermal equilibrium of a
spin ensemble. These values will depend on molecular environment, temper-
ature and field strength, according to Bloembergen-Purcell-Pound theory [8].
According to this theory, both T1 and T2 should increase with field strength,
which is the case for T1, for example in human grey matter [9]. For T2 however,
a decrease is observed with increasing field strength when assessed on clini-
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Figure 2.5: Diagram illustrating the relative phases of isochromat magnetisation vectors
through a spin echo, as shown in figure 2.4. Each arrow represents the transverse
magnetisation vector of an isochromat, each precessing at slightly different frequencies
due to macroscopic field homogeneities. This diagram shows the transverse plane in a
reference frame rotating in phase with spins precessing with frequency ω0 and ignores
T2 decay, which would affect each isochromat equally.
cal scanners, for example in human grey matter [10]. This can be attributed
to increased effects of diffusion, as field inhomogeneities increase with field
strength. The effect of diffusion on measured T2 will be discussed in section
2.3.3. Increasing field inhomogeneities with field strength will also lead to a
decrease in T ′2 with field strength, whilst T
∗
2 decreases with field strength as a
combination of T2 and T
′
2.
2.3 Magnetic Resonance Imaging
The concepts required for performing magnetic resonance imaging MRI are
outlined in this section. A brief introduction to the hardware is presented,
followed by a description of spatial encoding and slice selection; some relevant
pulse sequences are introduced and the safety considerations associated with
an MRI experiment are addressed.
2.3.1 Hardware
The major components present in an MRI scanner are the static magnet, shim-
ming gradient sets, imaging gradient coils and radio-frequency transmit and
receive coils. Static magnetic fields of 1.5 T or greater are typically used for
MRI, to make use of a greater signal available from the higher net magnetisa-
tion at higher field strengths (equation 2.4). The large currents used to induce
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these magnetic fields require superconducting coils, to avoid the high power
dissipation that would result from passing the large currents through resistive
wires. Superconducting coils are less susceptible than their resistive equiva-
lents to external voltage and temperature fluctuations causing fluctuations in
the induced magnetic field. The static magnetic field B0 needs to be homo-
geneous over the imaging region, known as the magnet’s iso-centre. When
the magnet is positioned in the magnet hall, field inhomogeneities from the
local surroundings need to be corrected through a process known as shimming.
Shimming involves placing ferromagnetic material (usually iron) at locations
suitable to correct the inhomogeneities (passive shimming), followed by the
addition of shimming coil sets (active shimming), to refine the field homo-
geneity. Field inhomogeneities are also caused by the sample or subject to be
imaged, so additional corrective shimming gradient sets are also used on an
individual scan basis.
In this thesis, work is presented which uses three MRI systems, Philips Achieva
1.5 T, 3 T and 7 T whole body scanners. These are horizontal, cylindrical scan-
ners, such that the static magnet coils, shimming set and imaging gradient coils
surround a cylindrical bore of approximately 90 cm diameter. A bed can be
moved into and out of the bore, to manoeuvre the sample or subject into and
out of the magnet iso-centre.
Imaging gradient coils induce spatially linearly varying magnetic field gradients
and are used for spatial encoding, as will be shown in section 2.3.2. These
gradient coils are designed so that they can be rapidly switched during an
imaging experiment. Gradient sets (gradient coil and amplifier combinations)
are specified by the field gradient they can produce (maximum amplitude) and
the switching rate (maximum slew rate). Table 2.1 lists these specifications for
the three MRI systems used in this thesis. The 7 T gradient set was upgraded
in between projects, such that data from chapter 5 was acquired with the lower
values whilst other data at 7 T was acquired with the higher values.
Both transmit and receive coils are radio-frequency coils, which are tuned (us-
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Gradient parameter 1.5 T 3 T 7 T
Maximum amplitude (mT/m) 66 40 30 / 33
Maximum slew rate (mT/m/ms) 160 200 100 / 166
Table 2.1: Imaging gradient specifications. The two values at 7 T are before and after
an upgrade.
ing capacitors) to approximately ω0 of the nuclei of interest, which in this
case is 1H. Transmit coils are generally designed to generate a radio-frequency
pulse that is as spatially homogeneous as possible over the volume of interest.
Receive coils have sensitivity profiles that drop off with distance from the vol-
ume of interest, so are positioned as close as possible to the volume of interest.
For the case of performing MRI of the brain, typically receive coils are made
up of multiple coils, positioned around the head to maximise the sensitivity
to the whole brain. Smaller coils generally have a smaller region of sensitivity,
so there is a compromise between having many small channels, closely fitting
the shape of the head, and having large enough coils to be sensitive to medial
parts of the brain, furthest from the surface. Net transverse magnetisation of
the sample will induce a current in the receive coil, forming the measured sig-
nal from the sample. Each receive coil is attached to a different receive channel.
The signal detected by the receive coil is combined (multiplied) with a sinu-
soidal reference waveform which has a reference frequency approximately equal
to ω0. This removes the component of the signal that oscillates at exactly the
reference frequency (de-modulation), analogous to viewing the signal from a
reference frame which rotates at the reference frequency, in the direction of spin
precession. This highlights both transverse relaxation and any component of
the signal which oscillates at different frequencies from the reference frequency.
This approach cannot distinguish whether components are oscillating at higher
or lower frequencies than the reference frequency. Therefore the solution is to
produce two reference waveforms, both oscillating at the same reference fre-
quency, but separated by a pi/2 phase difference. When the detected signal is
compared with both of these reference waveforms, the two resulting compo-
nents can be used to determine whether components are oscillating at higher
17
or lower frequencies than the reference frequency. This technique is known as
quadrature detection.
2.3.2 Spatial encoding
The concept of using spatially varying magnetic field gradients to encode spa-
tial information about an object in the NMR signal was originally proposed
by Paul Lauterbur [11]. An outline of using linear spatial gradients for spatial
encoding in MRI is provided here. The effect of a magnetic field gradient that
varies linearly in one dimension on a spin ensemble is to create a spatial de-
pendence of the spin precession frequency.
For example, consider two spin isochromats positioned along a magnetic field
gradient such that the first experiences field B0 +∆B and the second experi-
ences field B0 −∆B. Therefore the two isochromats will precess at ω0 + ∆ω
and ω0−∆ω respectively (where ∆ω = γ0∆B). Where the gradient is applied
following a 90◦ radio-frequency pulse the measured signal would be related to a
summation of the transverse magnetisation from both isochromats, such that
the signal would include components with frequencies of ω0+∆ω and ω0−∆ω.
Therefore the positions of the isochromats can be measured with respect to
the magnetic field gradient.
Gradient echoes
Gradients are applied to encode spatial information, however these gradients
are field inhomogeneities that lead to additional transverse dephasing. This
can be recovered by applying a gradient of opposite sign, of equal duration
(τ) and amplitude (G) to the original gradient (figure 2.6). This will lead to
an echo (at TE = 2τ) in the net transverse relaxation, known as a gradient
echo, through a similar mechanism as for a spin echo as shown in figures 2.4
and 2.5, except that only dephasing due to the gradient field inhomogeneities
is refocussed. The transverse magnetisation (and therefore measured signal)
at time TE will be attenuated by T2 and T
′
2 decay, but not by the gradients.
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Figure 2.6: Gradients required to form a gradient echo
k-space
The linear gradients create a well-defined relationship between the precession
frequency (ω) and position (r). The same is also true for their reciprocal values
of time (t) and spatial frequency (k) [12]. To that end, spatial frequency k
can be defined as
k(t) = γ
∫ t
0
G(t′)dt′, (2.9)
where bold typeface denotes a three dimensional vector, G is the gradient am-
plitude (such that B(r) = B0 + ∆B(r) = B0 + G · r). The integral is over
time, from the start of the applied gradient, up to time t and this accounts for
phase accumulation due to the gradient. The effect of applying a linear gradi-
ent in a particular direction across an object is to sample the object’s spatial
frequency distribution across that direction. The range of spatial frequencies
sampled depends on both the gradient amplitude G and on the sampling time
t. Position and spatial frequency can be related (much like time and temporal
frequency) by a Fourier transform.
The spatial encoded quantity is defined as the spin density ρ(r), such that
ρ(r) is proportional to the concentration of 1H nuclei and the polarisation of
the system (so is dependant on B0 and temperature, see equation 2.4). The
constant of proportionality is determined by a scaling factor related to the re-
ceiver amplification and can also be weighted by T1, T2 or T
∗
2, depending on the
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method for generating net transverse magnetisation. The signal s(k) (where
k is related to t by equation 2.9) is a three dimensional Fourier transform of
ρ(r) [13, 14], such that
s(k) =
∫∫∫
ρ(r) · e−i2pik·rdr. (2.10)
Therefore an inverse Fourier transform can be used to calculate ρ(r) from the
measured signal s(k).
If a gradient is applied which varies in only one dimension, then this integral
can be evaluated in that dimension alone. Defining a Cartesian coordinate
system such that the z-axis is parallel to the longitudinal direction and the x-
and y-axes are in the transverse plane, then a gradient is applied which only
varies along the x-axis, such that the magnetic field in the longitudinal (z)
direction varies as a function of x (Bz(x)). In this case, the three dimensional
ρ(r) collapses down into a one-dimensional function ρ(x), where each point
along the x-dimension is formed by an integration of ρ(r) along the y- and
z-dimensions such that
ρ(x) =
∫∫
ρ(r)dydz. (2.11)
The inverse Fourier transform of the resulting signal will provide a projection
of the spin density ρ along the x-axis. An example of this is shown in figure
2.7.
The effect of a linear gradient is to sample part of the spatial frequency dis-
tribution. This spatial frequency distribution can be mapped in inverse space,
or k-space. Gradients can be applied which vary in space across any arbitrary
direction, across k-space trajectories. Where the component of Bz which varies
spatially in the x dimension is defined as Gx, Gy in the y dimension and Gz in
the z dimension, the effect on k-space trajectory due to various combinations
of Gx and Gy is shown in figure 2.8. This example is not particularly useful
as transverse magnetisation is not refocussed, however it demonstrates how
gradients in multiple dimensions can be used separately or simultaneously to
sweep across any k-space trajectory. Also, real gradients will have a trapez-
ium shape and not a perfect box-car shape, taking time to reach the desired
20
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Figure 2.7: Example of using a one dimensional linear gradient Bz(x) to perform spatial
encoding on the objects shown at the top of the plot. An inverse Fourier transform of
the measured signal would result in the projection of ρ(x) shown at the bottom of the
plot. Note that all information about the ρ(y) distribution is lost, as shown by the right
hand objects.
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Figure 2.8: Plot illustrating the effect of linear gradient (Gx, Gy) combinations in two
dimensions on k-space trajectory. Each stage is colour coded, such that the effect of
gradients (bottom) can be seen on the k-space trajectory (top).
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amplitude. The box-car shape is used here as it is easier to display and does
not have a significant impact on the subsequent theory.
Slice selection
The examples shown so far have involved mapping k-space in one or two di-
mensions. This effectively gives a two-dimensional projection of ρ, where each
point includes all associated points from the third dimension. It is often de-
sirable to only excite a finite volume of the sample, for example to select a
discrete slice and spatially encode across only two dimensions.
A slice of the sample can be selectively excited by applying a field gradient
Gslice at the same time as the radio-frequency pulse B1(t), which varies in a
direction perpendicular to the slice (referred to as the slice direction). The
gradient causes a spatial dependence of precession frequency in the slice direc-
tion. The radio-frequency pulse can be designed to only excite spins precessing
over a limited range of frequencies, selecting a specific slice of the sample. A
radio-frequency pulse taking the form of a sinc function in time will excite spins
with a well-defined range of precession frequencies ∆ω. The reason for this is
that the Fourier transform of a sinc function is a box-car (figure 2.9a), which
is non-zero over a distinct range of frequencies (∆ω). This range of selected
frequencies depends on the shape of the sinc function. The thickness of the
slice selected will therefore depend on both the gradient amplitude Gslice and
on ∆ω. Real radio-frequency pulses have a finite duration, so the sinc function
is truncated. The Fourier transform resulting from this truncated sinc function
has less well-defined edges, but is a good approximation of a box-car.
Figure 2.9b shows an example pulse sequence diagram of slice selection. The
radio-frequency pulse is centred halfway along the slice-selection gradient. Fol-
lowing the radio-frequency pulse the gradient will cause phase to accumulate
in the slice direction. This is corrected by a negative gradient lobe, half the
duration of the positive lobe.
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Figure 2.9: Demonstrating the principles of slice selection. (a) A sinc function has a
box-car Fourier transform, so is a good choice for the slice selective radio-frequency pulse
shape since it has a well defined frequency distribution. (b) Pulse sequence diagram of
slice selection. A radio-frequency pulse is applied, centred a time τ after the start of the
slice selective gradient. The gradient has a positive lobe for slice selection (duration 2τ)
and a negative lobe (duration τ) to refocus phase accumulated during slice selection.
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2.3.3 Pulse sequences
This section describes a selection of common pulse sequences. Although other
k-space trajectories may be used (such as radial and spiral trajectories), only
Cartesian k-space trajectories are used here. A Cartesian coordinate system is
defined, with three orthogonal dimensions of kslice, kread and kphase. The kslice
dimension is the slice selection dimension as defined in the previous section.
The kread dimension is the readout or frequency-encoded dimension and the
kphase dimension is the phase-encoded dimension.
T ∗2 -weighted sequences: Basic gradient echo
The frequency-encoded and phase-encoded dimensions are illustrated using
the example in figure 2.10. Following slice selection, gradients are applied
in both the frequency-encoded dimension (Gread) and phase-encoded dimen-
sion (Gphase), selecting a k-space coordinate (kread, kphase). Following these
gradients, a frequency-encoding gradient is applied of opposite amplitude and
twice the duration of the previous gradients. This subsequent gradient causes
transverse relaxation to refocus in a gradient echo (as described in the pre-
vious section), with a peak at the mid-point of the gradient lobe. Signal is
detected during this subsequent gradient, sampling k-space along the kread di-
rection, with a constant kphase. Therefore the phase-encoding gradient selects
the kphase value to be sampled. In a basic gradient echo pulse sequence, as
shown in figure 2.10, only one line of k-space (with one kphase value) is sampled
from each radio-frequency pulse. Multiple repeats are performed, each with
a different Gphase amplitude, to fully sample k-space. This takes a significant
length of time (∼ 5T2) as transverse magnetisation needs to return to ther-
mal equilibrium steady state (through T2 decay) in between radio-frequency
pulses. The time between the radio-frequency pulse and the mid-point of the
Gread lobe is defined as the TE.
25
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Figure 2.10: The k-space trajectories and pulse sequence diagram for a simple gradi-
ent echo imaging sequence. Multiple repeats (corresponding to different colours) are
required to sample k-space in both dimensions.
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Figure 2.11: Echo-planar imaging (EPI) k-space trajectory and pulse sequence diagram.
The blue gradient lobes select the initial k-space coordinates, whilst a train of Gread
lobes, alternating between positive and negative gradients, cause a series of gradient
echoes to form. Gphase lobes positioned between Gread lobes selects the kphase coordinate
to be sampled with each echo.
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T ∗2 -weighted sequences: Echo-planar imaging
There are a variety of sequences which sample more than one line of k-space
following a single radio-frequency pulse. The most extreme example is sin-
gle shot echo-planar imaging (EPI). This is where a series of gradient echoes
(an echo train) are formed following a single radio-frequency pulse, with each
echo sweeping kread at a different kphase coordinate. EPI is the most commonly
used pulse sequence in this thesis, so is described in detail here. It is possible
to acquire all (single shot) or part (interleaved) of k-space following a sin-
gle radio-frequency pulse. An example k-space trajectory and pulse sequence
diagram is shown in figure 2.11. Each gradient echo is formed by reversing
the Gread amplitude, alternating between positive and negative gradient lobes.
In between Gread (frequency encoding) lobes, short Gphase lobes sweep across
kphase for phase encoding. To save time, the initial gradients for selecting the
starting k-space position (blue in figure 2.11) overlap with the refocussing lobe
of the slice select gradient. The series of gradient echoes are represented by
a single TE, located at the center of k-space, so at the midpoint of the Gread
lobe where kphase = 0.
Short acquisition times make EPI a popular choice for studying dynamic
changes, however this technique has several problems associated with its fast
nature. The effect of acquiring a series of echoes within a single T ∗2 decay is
that each echo (and so different kphase coordinates) will have different ampli-
tudes. This will act as a filter causing spatial blurring.
Imperfections in the spatial encoding gradients lead to offsets in the gradient
echo position relative to the Gread lobes. The result of this is to introduce a
ghost image displaced from the original image by half of the field of view in
the phase-encoded direction, called a Nyquist ghost. This can be corrected for
prospectively by correcting for these imperfections in the sequence design.
Reversal of Gread amplitude between echoes means that this technique is sus-
ceptible to any imperfection which will have opposite effects on the positive
and negative spatial gradients (termed phase errors), resulting in offsets in
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adjacent lines of k-space that build up across echoes. This can be corrected
for by taking an initial reference image, which is identical to the EPI, except
in that it lacks phase-encoding gradients. This reference image can be used
to measure and remove these offsets due to switching the frequency encoding
direction in adjacent echoes.
The acquisition bandwidth for EPI is low and the sampling time is long in the
phase-encoded direction compared to a basic gradient echo. Macroscopic field
inhomogeneities will cause particularly large distortions for EPI due to this low
bandwidth. The effect of a field inhomogeneity is to cause a frequency shift
(equation 2.2), so spatial encoding will give a shifted position for regions ex-
periencing this inhomogeneity. The magnitude of this shift will depend on the
field inhomogeneity frequency shift as a fraction of the bandwidth. Therefore
the image will either be stretched or compressed due to the field inhomogene-
ity. These distortions can be corrected retrospectively by using maps of the
field inhomogeneities [15], or prospectively by applying shim gradients to par-
tially cancel with the inhomogeneities. Field inhomogeneities within a voxel (a
volume element, the volume equivalent to a pixel) will also cause intra-voxel
dephasing, which is where dephasing due to the field inhomogeneity is not
refocussed with the gradient echo, causing signal loss which is unrecoverable
without using a spin echo.
EPI is particularly affected by chemical shift of the signal from fat. Hydrogen
nuclei in fat molecules experience a different molecular environment from wa-
ter, so microscopic field variations due to their molecular environment lead to
a shift in their precession frequency. Therefore spatial encoding gradients will
cause the fat signal to appear slightly displaced from its actual location. This
displacement is cumulative across the phase-encoding gradients [14], leading to
large displacements of the fat signal along the phase-encoding direction, with
larger displacement from smaller amplitude gradients. The resulting fat signal
appears shifted with respect to the brain and can appear to overlap the brain.
Several methods exist to reduce the fat signal, such as selective saturation of
the fat signal.
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After the first EPI echo train, it is possible to apply another set of refocussing
gradients and sample k-space again, at a later TE (see figure 2.12). Repeated
samplings of k-space can be performed following a single radio-frequency pulse,
within the constraint of sufficient signal within the T ∗2 decay. This can be used
to form two or more images, each at a different TE (defined as the center of
k-space for each echo train, as for the single echo train). These are referred
to as a double echo EPI acquisition for the case of two images and multi-echo
for more than two echoes. The number of images that can be acquired dur-
ing a single T ∗2 decay depends on the duration of each echo train and on the
T ∗2 of the sample of interest. This type of sequence can be used to map T
∗
2 [16].
T ∗2 -weighted sequences: Ernst angle
Following the initial radio-frequency pulse, the recovery of longitudinal mag-
netisation to thermal equilibrium values obeys the Bloch equations (equations
2.5), taking several multiples of T1 to do so. Ideally, to maximise signal and
minimise T1-weighting of the resulting images, the repetition time (TR) be-
tween acquiring consecutive images should also be several multiples of T1. How-
ever, to measure dynamic changes, or to shorten the experiment time when
repeated measurements are required, it may be desirable to acquire images at
faster intervals, increasing temporal resolution. When the longitudinal mag-
netisation has not fully recovered between consecutive radio-frequency pulses,
following several such pulses the longitudinal magnetisation reaches a steady
state of less than the thermal equilibrium value. This is demonstrated for a
series of 90◦ radio-frequency pulse, each separated by a time TR equal to T1,
in figure 2.13.
For long TR experiments, where longitudinal magnetisation is almost at ther-
mal equilibrium values, 90◦ radio-frequency pulses give the maximum signal.
However, for shorter TR experiments, a smaller flip angle will preserve more
longitudinal magnetisation for the next radio-frequency pulses. Although a
smaller proportion of the total magnetisation is available in the transverse
30
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Figure 2.12: Double echo EPI k-space trajectory and pulse sequence diagram. The first
echo train (identical to figure 2.11) is followed by a set of refocussing gradients (red),
followed by an additional echo train, to sample k-space for a second time, at a later
TE (TE2). The echo times for both echo trains (TE1 and TE2) are the time from the
radio-frequency pulse to the center of k-space for each.
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Figure 2.13: Example of the effect of a series of radio-frequency pulses on longitudinal
magnetisation. In this case 90◦ radio-frequency pulses were used and TR = T1 = 1000
ms. Longitudinal magnetisation (immediately before the next radio-frequency pulse)
reaches a steady state after approximately 5 TRs in this case.
plane, more is preserved for later repeats, resulting in higher transverse mag-
netisation once a steady state is reached. There is a compromise between
a smaller flip angle preserving more longitudinal magnetisation when steady
state is reached and a larger flip angle leading to a larger fraction of longitudi-
nal magnetisation converted into transverse magnetisation for detection. The
optimum angle, providing the highest transverse magnetisation for a given TR
and T1 (once a steady state is reached) is known as the Ernst angle (θE), such
that
θE = cos
−1
(
e−TR/T1
)
(2.12)
θE (in degrees) is plotted as a function of the ratio TR to T1 in figure 2.14.
T ∗2 -weighted sequences: FLASH (Spoiled gradient echo)
When high spatial resolution images are required, EPI is not the best choice of
gradient echo acquisition, as the echo train length increases with finer spatial
resolution and compounds the above issues. An alternative is to use a series
of low flip angle radio-frequency pulses and a short TR to acquire multiple
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Figure 2.14: Dependence of θE (in degrees) on the ratio between TR and T1.
lines of k-space in a short space of time. This approach acquires a single line
of k-space following each radio-frequency pulse, so is far less susceptible to
distortions than an EPI acquisition. It is able to sample k-space in a short
amount of time compared to a basic gradient echo due to the short TR, so is
less susceptible to subject motion. The TR values can be so short that trans-
verse magnetisation has not decayed to zero between radio-frequency pulses.
Spoiler gradients can be applied to dephase transverse magnetisation before
the next radio-frequency pulse. The resulting image can be weighted by T1
and/or by T ∗2 , based on the TR and TE values chosen relative to the sample’s
T1 and T
∗
2 , respectively. Names for this low angle, short TR, spoilt sequence
include fast low angle shot imaging (FLASH) and spoiled gradient echo. The
pulse sequence is shown in figure 2.15.
T2-weighted sequences
A T2-weighted image can be formed by using a 90
◦ radio-frequency pulse, fol-
lowed by a 180◦ radio-frequency pulse a time TE/2 later. A spin echo will form
a time TE after the 90◦ radio-frequency pulse, as shown in figures 2.4 and 2.5.
The 90◦ radio-frequency pulse can be tailored for slice selection, with the as-
sociated gradients (figure 2.9). Spatial encoding gradients can be applied so
that a gradient echo forms at the same time as the spin echo, so the resulting
image will only depend on T2 and not T
∗
2 . A long TR is required, to prevent
T1-weighting. For the case of an ideal, static sample, T2 could be measured by
repeating this sequence for various TE values and fitting the resultant signal
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Figure 2.15: Example of a FLASH (spoiled gradient echo) pulse sequence. Due to the
short TR, spoiler gradients are required to dephase any remaining transverse magneti-
sation before the subsequent low angle radio-frequency pulse. These spoiler gradients
are shown in the phase-encoded direction, but may be applied in multiple dimensions.
to an exponential decay curve.
Water molecules undergo diffusion, so if there are any field inhomogeneities
across the sample, diffusing 1H spins will accumulate phase as they move across
the field homogeneity in a random walk. This phase will not be refocussed by
the 180◦ radio-frequency pulse, resulting in reduced net transverse magnetisa-
tion and an attenuation of the measured signal. This phase accumulation (and
hence signal attenuation) will be dependent on the amount of molecular mo-
tion (described by a diffusion coefficient D), the field homogeneity amplitude
and on the TE. A T2 measurement of a sample undergoing diffusion using the
method described in the previous paragraph will therefore underestimate T2,
due to diffusion-based signal attenuation having a TE dependence.
A method for reducing the effects of diffusion on T2 measurements is to apply
a series of 180◦ radio-frequency pulses following the initial 90◦ radio-frequency
pulse, known as a Carr-Purcell Meiboom Gill (CPMG) sequence [17, 18]. The
first 180◦ radio-frequency pulse is applied a time TE/2 after the 90◦ radio-
34

 

 	
 	
 	
 	
 	




Figure 2.16: Net transverse magnetisation during a CPMG pulse sequence
frequency pulse and the separation between 180◦ radio-frequency pulses is TE.
An echo train will form with each echo occurring at integer multiples of TE
after the initial 90◦ radio-frequency pulse (as shown in figure 2.16). The effects
of diffusion on the T2 measurement is reduced by using short echo separation
times (TE), limiting diffusion-based phase accumulation.
T1-weighted sequences
Any short TR (TR of the order of T1 or shorter) sequence will have some
T1-weighting, however it is possible to control the T1-weighting using a 180
◦
radio-frequency pulse, applied before the 90◦ radio-frequency pulse. The time
between these two pulses is known as the inversion time (TI). This arrange-
ment can be applied preceding imaging gradients, such as EPI as shown in
figure 2.17. Following a 180◦ radio-frequency pulse, net longitudinal magneti-
sation is inverted and it recovers back to thermal equilibrium values based on
a solution to the Bloch equations, as shown in figure 2.18. This sequence can
be used to measure T1 by repeating the sequence several times, with different
TI values. The TR needs to be long compared with T1, so that longitudinal
magnetisation fully recovers between repeats. This type of sequence is known
as an inversion recovery (IR) sequence.
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Figure 2.17: Inversion recovery (IR) EPI pulse sequence diagram. The TI is the time
between 180◦ and 90◦ radio-frequency pulses and the TE is the time from the 90◦
radio-frequency pulse to the center of k-space, as with other EPI sequences.
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Figure 2.18: A plot of the behaviour of net longitudinal magnetisation following a 180◦
radio-frequency pulse.
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Figure 2.19: Example of an MPRAGE pulse sequence. This consists of three stages;
preparation, imaging and spoiling; as separated by vertical dotted lines. Multiple re-
peats of the imaging and spoiling stages can be performed for a single preparation stage,
to measure multiple kphase and kslice lines. In this case, the k-space center is positioned
to be at the appropriate TI.
Finally, a T1-weighted pulse sequence will be described, which is widely used
to acquire high spatial resolution anatomical images. This is a magnetisation-
prepared rapid gradient echo (MPRAGE) acquisition. An MPRAGE sequence
(as shown in figure 2.19) consists of three stages; preparation, imaging and
spoiling. The magnetisation preparation stage includes a 180◦ radio-frequency
pulse, to control the T1-weighting. The imaging stage can be three-dimensional,
by the use of spatial encoding blips in the slice selection direction. In this case,
slice selection will excite a wide volume, instead of a single slice and the spatial
encoding blips cycle through the slice dimension in k-space (kslice). Short TR
values are typically used, such that spoiler gradients are required to dephase
any remaining net transverse magnetisation before subsequent radio-frequency
pulses. Due to the short TR, the radio-frequency pulses are usually a lot less
than 180◦ and 90◦, respectively, to preserve longitudinal magnetisation for the
next radio-frequency pulse.
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2.3.4 Parallel imaging
It is possible to reduce the time required to acquire an image by reducing the
number of k-space lines acquired. This will effectively reduce the field of view
in the phase encoded direction, so the image will wrap around, leading to the
signal from multiple points in space occupying the same point in the spatially
encoded signal (aliasing). Where multiple receive coils are used, this aliasing
can be resolved by using the spatial sensitivity profiles of each coil, combined
with the wrapped around image from that coil [19]. The relative intensities
measured for each position from each coil can be used to separate out the
aliased signal from multiple positions, using the different sensitivity profiles of
each coil to that spatial position. This technique is known generically as paral-
lel imaging, but when implemented on the Philips scanners used in this work,
it is known as SENSE. One advantage to this method is for EPI, where the
low bandwidth in the phase encoded direction leads to large image distortions
from field inhomogeneities, especially at higher field strengths. Acquiring less
lines of k-space will lead to an increased bandwidth, reducing these distortions.
2.3.5 Safety considerations
The safety issues arising from working around an MRI scanner are briefly
summarised in this section. The static field can disrupt electronic medical
equipment, such as pace-makers, so people with such a device fitted are not
allowed within the 0.5 mT field line surrounding each magnet. For the scan-
ners used in this work, access to these areas in restricted by key-coded doors.
Ferromagnetic objects could become projectiles when brought into proximity
with the strong static magnetic field, so careful consideration is made to ensure
that no one brings such objects into the magnet hall. This especially involves
reminding anyone going into the magnet hall to remove keys, coins and jew-
ellery before entering the magnet hall. In the event of an extreme situation,
the static magnetic field can be ramped down by pressing one of several red
buttons, located in the magnet hall and the control room. This heats up part
of the coil to make it resistive, dissipating the current and quickly reducing
the induced magnetic field. It is likely that this will damage the scanner and
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it will take a significant amount of time to ramp the scanner back up to the
desired field. One reason for this safety precaution would be if a person was
pinned to the magnet by a large piece of ferromagnetic equipment such that
they were in danger of serious harm.
Cryogenic liquids (commonly helium) are used to cool the superconducting
coils. The commercial scanners are designed in such a way that the cryogenic
liquid is vented out through the roof of the scanner, so should not enter the
magnet hall, reducing the risk of a person being exposed to the cryogenic liq-
uid. Also, the static coils and shimming and imaging gradient coils experience
very high voltages. The scanners are designed to be well insulated, such that
the risk of electrocution is negligible so long as this insulation remains intact.
Imaging gradient coils can heat up during use, so water cooling is used to dis-
sipate this heat.
Fast switching imaging gradients exert mechanical forces on the magnet bore,
which causes it to vibrate, causing a loud noise. This is especially so for EPI
acquisition. Therefore anyone present in the magnet hall, especially the vol-
unteer in the bore, requires ear protection. Ear plugs and headphones are
routinely provided for this purpose. For the 7 T scanner, there is a local
head transmit coil, which prevents the use of headphones through spatial con-
straints, so foam padding is used to cover the ears and attenuate the sound.
The walls of the magnet hall attenuate sound sufficiently such that anyone
present outside of the magnet hall, for example in the control room, does not
require ear protection. Another problem with the fast switching imaging gra-
dients is that they can induce currents in nerves peripheral to the imaging
region (an effect known as peripheral nerve stimulation (PNS). This problem
is increased with increasing static field strength, maximum gradient strength
and gradient slew rate. For experiments imaging the head, this can stimulate
peripheral nerves in the shoulders. Typically gradients are limited so that only
a mild form is experienced, such that the subject feels a slight muscle twitch
across the shoulders.
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The radio-frequency time-varying fields can cause some energy absorption by
tissue, which will result in a mild heating of the tissue. The signal attenuation
ratio (SAR) is used to determine whether the energy absorption due to a set of
radio-frequency pulses is safe. Metallic objects will absorb much more energy
than tissue, so any metallic objects, such as jewellery should be removed be-
fore scanning. Some tattoos contain metal pigment, which can heat up under
radio-frequency pulses, therefore care must be taken when scanning subjects
with tattoos. If equipment is required in the bore which uses conducting wires,
then these wires must not touch the subject’s skin. Also, these wires should
not cross over each other.
2.4 functional Magnetic Resonance Imaging
The practice of using MRI to dynamically monitor changes in physiology asso-
ciated with neuronal activity is known as functional magnetic resonance imag-
ing (fMRI). A direct measurement of neuronal activity would be to measure
neuronal firing rate. This can be done using non-invasive methods, by mea-
suring the small electric or magnetic field perturbations arising from neuronal
currents (electroencephalography and magnetoencephalography, respectively).
However, although these methods have high (sub millisecond) temporal reso-
lution, they have low spatial resolution and they are much more sensitive to
signals close to the surface of the head, rather than deep in the brain. The main
advantage of using fMRI to measure cerebral activity is the high spatial resolu-
tion available with MRI. Current fMRI methods measure localised changes in
vascular properties, focussed around changes in neuronal activity. It is worth
noting the different categories of neuronal activity, such as neuronal firing rate,
local field potentials, multi-unit activity and single-unit activity, however local
field potentials are thought to be most closely correlated to fMRI measures [20].
This section introduces the connection between cerebral activity and the asso-
ciated vasculature. The principles underlying T ∗2 -weighted blood oxygenation
level dependent (BOLD) contrast are described, followed by a comparison with
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other fMRI techniques. The concept of calibrated BOLD fMRI is introduced
and some of its limitations are discussed, which will be addressed in the fol-
lowing chapters.
2.4.1 Physiology underlying fMRI
The human brain has a constant energy demand, which is met through the
aerobic metabolism of oxygen (O2) and glucose. Blood vessels supply oxy-
gen and glucose to brain tissue and remove carbon dioxide (CO2) and water
(H2O), which are the products of this aerobic metabolism. Local increases in
neuronal activation will lead to an increased energy demand, which is met by
a local increase in oxygen and glucose metabolism [21, 22]. A local increase in
the supply of oxygen and glucose per unit time to the active tissue is achieved
by a local increase in cerebral blood flow (CBF).
CBF is a measure of perfusion, the volume of blood feeding a unit of tissue
per unit time. Commonly used units for CBF are ml/100g/min (millilitres of
blood supplying 100 grams of tissue per minute). CBF in human grey matter is
of the order of 60 ml/100g/min and approximately three times higher than in
white matter [23]. Another vascular property, which is of importance for fMRI,
is the cerebral blood volume (CBV), which is the volume occupied by blood
vessels, often expressed as a fraction of tissue volume. In an MRI context, it
is useful to consider CBV as the volume fraction of a voxel which is occupied
by blood vessels.
The vascular network consists of artery, arteriole, capillary, venule and vein
blood vessels, as shown in figure 2.20a. Large arteries supply blood to cere-
bral tissue, branching out into smaller arterioles, which themselves branch into
capillaries. Oxygen and glucose pass into neuronal cells from capillaries and
the products of aerobic metabolism (CO2 and H2O) pass into the capillaries.
Capillaries feed into venules, which in turn feed into veins which drain the
cerebral tissue. Arterioles, venules and capillaries are defined as microvascula-
ture, whereas arteries and veins are defined as macrovasculature.
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Figure 2.20: (a) A simple illustration of different types of blood vessels. (b) Blood vessels
contain haemoglobin, which is either bound to oxygen (oxygenated haemoglobin, red
circle) or not (deoxygenated haemoglobin, blue).
Oxygen is transported in blood through being bound to haemoglobin molecules
in red blood cells. Haemoglobin has a high affinity to oxygen, so the majority
of oxygen in blood is bound to haemoglobin. In this case the molecule is de-
scribed as oxygenated haemoglobin (Hb), whereas without oxygen the molecule
is described as deoxygenated haemoglobin (dHb). The oxygen saturation of
haemoglobin in blood is referred to as blood oxygenation (Y), here defined as
the fraction of total haemoglobin molecules that are bound to oxygen
Y =
∑
Hb∑
Hb +
∑
dHb
. (2.13)
For arteries and arterioles, almost all haemoglobin molecules are bound to
oxygen (Y ∼ 1), shown in red in figure 2.20a. Blood oxygenation decreases
through the capillary bed, such that approximately 40 % of haemoglobin is not
bound to oxygen in the venules and veins (Y ∼ 0.6), shown in blue in figure
2.20a.
Accompanying a period of increased neural activity, local CBF increases and
blood vessels dilate causing an increase in local CBV. The increase in CBF
leads to more oxygen being supplied to the active tissue. The increased rate
of cerebral oxygen metabolism (CMRO2) in the active tissue means that more
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oxygen is used. However, upon neuronal activation, local CBF increases exceed
the CMRO2 increases [24], such that although more oxygen is being used by
the active tissue, even more is supplied, so the fraction of total supplied oxygen
that is extracted by the active tissue (the oxygen extraction fraction, OEF) is
reduced upon neuronal activation. Therefore during neuronal activation the
blood oxygenation of venules and veins draining the active tissue increases.
2.4.2 Blood Oxygenation Level Dependent signal con-
trast
The most commonly used form of fMRI is gradient echo blood oxygenation level
dependent (BOLD) signal contrast. The gradient echo BOLD signal is due to
the dependence of T ∗2 on deoxygenated haemoglobin (dHb) [1, 2], providing
a non-invasive method of monitoring neuronal activation, whilst having the
highest signal to noise ratio (SNR) and contrast to noise ratio (CNR) of any
current fMRI method, with the possible exception of contrast agent enhanced
fMRI methods. This section presents the theory of the BOLD signal change
in T ∗2 -weighted images.
BOLD signal models and simulations
Magnetic susceptibility is a property of an object which determines the mag-
netisation of an object in the presence of a magnetic field. The volume sus-
ceptibility (χv) of dHb has been measured as χv = (−0.483 ± 0.013) × 10
−6
[25], whereas oxygenated haemoglobin (Hb) has a volume susceptibility χv =
(−0.749 ± 0.010) × 10−6 which is very close to blood plasma χv = (−0.714 ±
0.007) × 10−6 and water χv = −0.719 × 10
−6 [25]. Therefore tissue (which is
predominantly water), blood plasma and Hb can be considered magnetically
similar, whereas the presence of dHb will cause a field perturbation. Note that
χv is presented in cgs units, for consistency with the literature. These values
can be converted to SI units through multiplication by 4pi.
The effect of dHb on T ∗2 can be separated into two components, one from
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tissue adjacent to the blood vessel (termed extravascular) and one from the
signal within the blood vessel (termed intravascular). The extravascular sig-
nal contribution has been the subject of many simulations and models [26, 27,
28, 29, 30, 31, 32, 33]. The source of the extravascular BOLD signal is the
field inhomogeneity arising from blood vessels containing dHb. An example of
this field inhomogeneity is shown in figure 2.21, which is based on an infinite
cylinder model of a blood vessel [31] and with the main magnetic field (B0)
perpendicular to the cylinder axis. The field inhomogeneity (and hence the
extravascular BOLD signal) depends on the orientation of the blood vessel
to the main magnetic field. If the blood vessel is near parallel to the main
magnetic field, then the field inhomogeneity due to the vessel will be minimal,
whereas if the blood vessel is perpendicular to the main magnetic field, then
the field inhomogeneity is at a maximum.
There are two mechanisms by which the field inhomogeneity will affect ex-
travascular T ∗2 . The first is static dephasing, where different spin isochromats
experience different fields due to the inhomogeneity and precess at different
frequencies, resulting in signal attenuation. The second is diffusive dephasing,
where water molecules move across the field inhomogeneity in a random walk,
accumulating phase based on the field experienced. Where static dephasing
dominates, the transverse relaxation rate R∗2 will vary linearly with the suscep-
tibility difference between the blood vessel and tissue (∆χv). However, where
diffusive dephasing dominates, there will be a quadratic relationship between
extravascular R∗2 and ∆χv [27]. Intermediate regimes are also possible, where
both mechanisms contribute, leading to a relationship between R∗2 and ∆χv
of somewhere between linear and quadratic. Whether the static or diffusive
dephasing mechanism dominates depends on the amount of diffusion and the
size of the gradient of the field inhomogeneity. Simulations have shown that
the dominant mechanism depends on the frequency shift created by ∆χv and
on vessel size [31], with larger vessels and a larger ∆χv leading to the static
dephasing mechanism dominating. This is expanded on in chapters 4 and 5.
∆χv is linearly related to the dHb fraction (1 - Y) [25], so similar linear or
quadratic relationships will hold between R∗2 and (1 - Y). Extravascular R
∗
2 is
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Figure 2.21: Image illustrating the extravascular field perturbations resulting from a
cylindrical blood vessel with a susceptibility difference from the surrounding tissue.
Positive field perturbations are shown in red and negative field perturbations in blue,
with lighter colours showing a larger magnitude perturbation. In this example, the
background field is in a horizontal direction and is perpendicular to the cylindrical
vessel.
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also linearly dependent on CBV, as will be further discussed in chapter 6.
The intravascular BOLD signal arises from water molecules in blood plasma.
The gradient echo signal from these water molecules is both affected by field
inhomogeneities and also by T2 shortening due to nearby dHb molecules. The
relationship between intravascular R∗2 and (1 - Y) is quadratic [34].
The total BOLD signal for a voxel will depend on a combination of extravascu-
lar and intravascular components, weighted by their relative volume contribu-
tions (so (1-CBV) and CBV, respectively). In summary, the BOLD signal will
depend on Y and CBV. Y will depend on both CBF and CMRO2, so the BOLD
signal can be considered as being dependent on CBF, CBV and CMRO2. The
BOLD signal is therefore not a direct measure of neuronal activity, also de-
pending on local vascular structure, causing a haemodynamic variability in
the BOLD signal which is independent of the neuronal activity. The compart-
ment which provides the dominant contribution to the BOLD signal contains
a significant amount of dHb, and as such arterial and arteriolar blood vessels
can be ignored and the CBV contributions from capillaries, venules and veins
can be considered in isolation. Finally, it is worth noting that the BOLD sig-
nal contribution from large veins draining the active tissue will mean that the
BOLD signal has a wider spatial extent than the actual active tissue spatial
extent [3].
BOLD temporal characteristics
The temporal characteristics of the BOLD signal are dependent on the tem-
poral characteristics of the underlying CBF, CBV and CMRO2 changes in
response to the neuronal activation. The dynamic nature of the vascular prop-
erties, such as CBF, CBV and CMRO2, are referred to as haemodynamic prop-
erties. The temporal characteristics of the BOLD signal following an event can
be separated into three features, as shown in figure 2.22. Following the on-
set of a task which increases neural activity, there is an initial reduction in
BOLD signal called the initial dip, with typical duration of approximately ∼2
seconds. There is then a large increase in BOLD signal, sometimes known as
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Figure 2.22: A simulated BOLD signal curve, illustrating the three main features of the
BOLD response to a single event. The dashed line indicates the baseline signal level.
the positive BOLD response or overshoot, occurring ∼6–8 seconds after the
task onset. This is followed by a subsequent decrease in BOLD signal, such
that it drops below the baseline value, called the post-stimulus undershoot,
before slowly recovering back to the baseline value, up to a minute after the
task ended. Here, the baseline value is defined as the signal before the period
of increased neural activity. Note this is not an absolute baseline, which might
imply no neuronal activity or oxygen extraction.
The initial dip is an elusive feature, with a short duration and small ampli-
tude (of the order of 1 % [35, 36]). It is not well understood since most fMRI
paradigms are not sensitive enough to detect it. The source of the initial dip is
thought to be due to an increase in CMRO2 before a CBF increase. This causes
an increase in dHb, leading to a decrease in BOLD signal. One of the reasons
the initial dip is of interest is that it may have better spatial localisation to the
active tissue [35] and might show potential for measuring the relative change
in CMRO2 on activation, due to not being confounded by changes in CBF and
CBV [36].
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The positive BOLD signal may be referred to as an overshoot since it is caused
by a CBF increase which exceeds the CMRO2 increase, causing an increase in
Y, despite an increased oxygen consumption. The amplitude of this feature
depends on the task, local vasculature, field strength and TE, but a typical
value of 3–4 % might be expected at 3 T, with TE = 45 ms. Although the main
feature of the BOLD response is most commonly the positive signal change,
negative BOLD responses have been observed, for example in the motor cor-
tex ipsilateral to hand motion [37, 38] and in the medial occipital cortex [39].
There is interest in identifying whether this negative BOLD signal is neuronal
or vascular in origin [37].
The post-stimulus undershoot occurs several seconds after the end of the task
and has a typical amplitude of approximately half that of the positive BOLD
overshoot. It is the subject of extensive research and the mechanism behind
it is the subject of some debate. One theory is that the negative signal arises
from a delayed recovery of CBV after CMRO2 and CBF have returned to
baseline [40, 41]. Other studies suggest that the negative signal is due to a
sustained CMRO2 increase after CBF and CBV have recovered to baseline
[42, 43, 44, 45]. The post-stimulus undershoot appears to be dependent on the
type of task performed and the task duration, for example static and flash-
ing chequerboards result in similar positive BOLD responses, but different
post-stimulus undershoot amplitudes [46]. The undershoot may provide bet-
ter spatial localisation to the active tissue, compared with the positive BOLD
response [47].
The BOLD signal response can be considered as a convolution of the neuronal
activity with the haemodynamic response function (HRF) acting as a temporal
filter, such that the observed BOLD response is blurred in time compared
to the neuronal activity. Without knowing the underlying haemodynamics,
it is possible to approximate this HRF to a summation of gamma variate
functions [48, 49, 50]. The gamma variate parameters have been optimised
experimentally to form a canonical HRF [49, 50]. The canonical HRF can
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be convolved with the task design to form a model timecourse for statistical
analysis of fMRI datasets, to identify regions of an image whose timecourse
has a significant correlation with this model timecourse.
2.4.3 BOLD experiment design and analysis
This section introduces the concepts behind BOLD experimental design and
typical analysis steps commonly performed. The stimulus or task that will
lead to a change in neuronal activation can be presented continuously over a
long period (called a block paradigm), or for a single instance or short period
on the order of a second or less (called an event-related paradigm). Periods
of stimulus are referred to as the active period. These periods are typically
interspersed with periods with no stimulus, which are referred to as the rest
period. For a block paradigm, the active period typically has a duration of
between a few seconds to a minute, with the rest period duration being of
a similar length or slightly longer. The durations of active and rest periods
depend on the type of stimulus and the experimental objectives.
Typically for gradient echo BOLD fMRI, a fast imaging sequence is used,
which can image a large volume in a short amount of time and as such EPI is
a popular sequence for fMRI. The acquisition parameters are very important
in optimising the SNR and BOLD contrast between active and rest states. A
short TR will lead to a reduced signal, as discussed in section 2.3.3, whilst a
longer TR will limit the dynamic changes that can be monitored. This compro-
mise between signal and temporal resolution will depend on the experimental
objectives, for example as to whether fast dynamic changes are being moni-
tored or changes between steady states. For gradient echo BOLD contrast the
optimal TE is close to the T ∗2 of the tissue of interest (cortical grey matter),
as illustrated in figure 2.23.
Before statistical analysis is performed on the BOLD dataset to locate regions
of significant stimulus-related signal changes, several processing steps are com-
monly performed. These include motion correction or realignment, temporal
filtering, physiological noise correction and spatial smoothing. Motion correc-
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Figure 2.23: Plot illustrating the effect of TE on the signal change due to a change in
T ∗2 . The left hand plot shows a T
∗
2 decay at rest (solid line), compared to a T
∗
2 decay
during an active condition (dashed line), simulated by a 10 % increase in T ∗2 . The
resulting signal difference is shown in the right hand plot, with a maximum when TE
∼ T ∗2 .
tion can be used to partially correct for subject motion through the paradigm.
This works by realigning all dynamic images to a common reference image, us-
ing a 6 parameter rigid body algorithm based on intensity matching. High-pass
temporal filtering will remove low frequency components in the timecourse of
each voxel, thus removing low frequency signal drift. The cut-off frequency for
this filter should be less than the repetition frequency of the stimulus paradigm,
to minimise the effect of the filter on the BOLD response to the task. Low-pass
temporal filtering smooths the dataset in the temporal dimension, improving
temporal SNR at the expense of temporal resolution. Physiological noise cor-
rection corrects for signal intensity changes due to the respiratory and cardiac
cycles. This correction uses data on these cycles recorded during the scan
[51], using respiratory bellows and either a pulse oximeter, or a vector cardio-
gram (VCG) to monitor the respiratory and cardiac cycles, respectively. One
particular method of physiological correction used in this thesis is known as
RETROICOR [51]. Spatial smoothing is often used to sacrifice spatial res-
olution for increased SNR. This is applied by convolving the image with a
smoothing kernel, where a gaussian kernel is typically used. Typical gaussian
smoothing functions have a full width at half maximum of 1.5 × the voxel size.
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Typical statistical analysis performed on the BOLD dataset involves forming
a model timecourse through convolution of the task design with a canonical
HRF. The BOLD dataset is compared to the model timecourse and a statisti-
cal test is performed as follows. Firstly, voxels with significant correlation to
the model timecourse are defined by a Z-score threshold corresponding to a
particular uncorrected P-value. For example, typically a threshold of Z > 2.3
corresponds to an uncorrected P < 0.01, so 1 out of every 100 voxels will be a
false positive result. The second step is to select clusters of voxels passed by
the first test, by considering the familywise error (FWE) to test each cluster
of voxels against a corrected P-value, typically using P < 0.05.
2.4.4 Other fMRI techniques
This section outlines other fMRI techniques, the vascular origin of these sig-
nals used to monitor neuronal activation and compares them to gradient echo
BOLD. The main focus of this section is spin echo BOLD and arterial spin
labelling (ASL) methods for measuring CBF changes, but a number of other
methods are also mentioned to provide an overview of fMRI techniques.
So far, only gradient echo (GE) BOLD has been discussed, BOLD contrast
can also be obtained from spin echo images. The intravascular component of
spin echo (SE) BOLD signal is primarily due to dHb shortening intravascular
T2. Extravascular spin echo BOLD signal arises from the same mechanisms
as extravascular gradient echo BOLD signal, described above. However, the
spin echo refocusses static dephasing, but not diffusive dephasing. Therefore
extravascular spin echo BOLD contrast is based on the diffusive dephasing
mechanism, meaning that extravascular spin echo BOLD signal is restricted
to smaller diameter vessels than gradient echo [31]. The extravascular spin
echo BOLD signal contrast is thus spatially restricted to closer to the active
tissue, rather than including large contributions from large draining veins, as
happens with gradient echo BOLD contrast. As well as being spatially closer
to the neuronal activation than gradient echo, the spin echo BOLD response
has also been shown to be temporally closer to the underlying neuronal activa-
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tion, exhibiting a faster time to peak signal following the onset of a task [52].
Spin echo BOLD is also less susceptible than gradient echo BOLD to large
field inhomogeneities, so can be used in regions where such an inhomogeneity
is present, such as in the orbitofrontal cortex [53]. However, spin echo BOLD
contrast is much lower than for gradient echo BOLD due to an insensitivity
to static dephasing [31]. Therefore the SNR is much lower compared with
gradient echo BOLD. For this reason, gradient echo BOLD is mostly used in
preference to spin echo BOLD in regions without large field inhomogeneities,
especially at lower field strengths where the total available signal is already
low (equation 2.4).
The direct change in CBF due to increased neuronal activation can be mea-
sured using arterial spin labelling (ASL) [54]. The basic principle of ASL
is to label water molecules in a slab of tissue adjacent to the region of in-
terest, wait some time (the post-label delay) for arterial labelled water to
flow into the region of interest and enter tissue through perfusion, then image
that region. The flow-sensitive alternating inversion recovery (FAIR) labelling
method will be described here as an example ASL scheme (since it is used in
this work), however a wide variety of labelling methods have been proposed
and are widely used [55, 56, 57, 58, 59]. The FAIR pulse sequence is simi-
lar to that of an inversion recovery pulse sequence (see figure 2.17), with an
inversion 180◦ radio-frequency pulse a time TI before the 90◦ readout radio-
frequency pulse. In FAIR, alternate dynamics are acquired with the inversion
being non-selective and with the inversion being selective to a slab centred
on, but slightly larger than the imaging volume to be imaged (since a real
inversion spatial profile will not have discrete edges). All spins in the imag-
ing region are inverted in both non-selective and selective dynamics, so the
only difference will be from water molecules which enter the imaging region
from outside the inversion slab in the time TI. The non-selective dynamic is
referred to as the tag image and the selective dynamic is referred to as the con-
trol image, whilst adjacent non-selective and selective dynamics are grouped
as a tag/control pair. Subtracting the tag image from the control image will
remove all signal except from inflowing water molecules, giving the ASL signal.
52
One advantage of CBF fMRI over BOLD fMRI is that changes in CBF occur
primarily in the microvasculature and not in large draining veins, so the active
region measured by CBF fMRI will be more localised to the active tissue [60].
However, due to the limited signal from inflowing arterial water molecules,
ASL has an intrinsically lower SNR than BOLD.
The first human fMRI experiments for mapping neuronal activity were per-
formed using a gadolinium compound (Gd-DTPA), an exogenous contrast
agent [61]. This method is sensitive to the change in total CBV local to
active tissue. When in blood the gadolinium compound does not pass into
tissue, but reduces the T1 of blood plasma and has a susceptibility difference
from tissue. Extravascular R∗2 is increased with the same mechanisms as for
dHb, dependent on the total blood volume (CBV) and on the concentration
of the gadolinium compound in blood. Therefore changes in total CBV can be
measured using the change in signal intensity, assuming a constant concentra-
tion of the gadolinium compound. This method has better SNR than gradient
echo BOLD for a single trial, but due to subject safety (due to the risk of NSF
(nephrogenic systemic fibrosis)) and due to the gadolinium compound taking a
long time to washout, this method is not repeatable, unlike BOLD. This com-
bined with the invasive delivery nature of the gadolinium compound (through
intravenous injection) means that BOLD fMRI is preferred to contrast agent
enhanced fMRI.
An alternative non-invasive measurement for total CBV fMRI has been pro-
posed [62], which exploits the difference in T1 relaxation time between blood
and tissue. This method is called vascular space occupancy (VASO). An inver-
sion recovery type sequence is used where the TI is set to be at the nullpoint
of blood, where the longitudinal magnetisation of blood is zero. Therefore
only tissue signal remains. CBV increases related to neuronal activation are
measured by the decrease in signal associated with tissue being displaced by
increased blood volume. However, cerebral spinal fluid (CSF) can have a sim-
ilar T1 to blood, so can confound CBV measurements. This method also has a
53
low SNR compared with BOLD fMRI measurements and is also strongly de-
pendent on the inversion being homogeneous across the image, so longitudinal
magnetisation from blood across the image is zero at the same TI.
The venous blood volume compartment CBV has been exploited as a source
of fMRI contrast using a technique termed venous refocussing for volume esti-
mation (VERVE) [63]. This technique makes use of the attenuation of a spin
echo by diffusion. It uses two CPMG sequences, one with a very short echo
spacing and one with a longer echo spacing. The difference in signal between
the shorter and longer echo spacing datasets will depend on the volume of the
dHb compartment (venous CBV). However, this technique has a very low SNR.
An fMRI technique which is not entirely vascular in origin is diffusion fMRI
[64, 65]. This is where strong diffusion gradients are applied to suppress the
signal from water with a large diffusion coefficient. It was found that the %
BOLD signal in response to increased neuronal activation was enhanced when
large diffusion gradients were applied. This was attributed to neuronal cells
swelling on increased activation, where cells have a lower diffusion coefficient
than the surroundings. Cell swelling would provide a measure of neuronal ac-
tivation that was more direct than vascular measures. However, a recent study
found a similar % BOLD enhancement using diffusion fMRI with hypercapnia
[66], suggesting that diffusion fMRI has at least some vascular component.
2.4.5 BOLD calibration
The specific local vascular structure will affect the magnitude of the BOLD
signal change, so the BOLD signal magnitude alone cannot be used as a direct
indicator of neuronal activation magnitude. This is especially true in patient
groups with compromised cerebrovascular function, such as stroke [67], or some
cases of cancer [68], diabetes and sickle-cell disease. One method for account-
ing for the haemodynamic variability in the BOLD signal is to calibrate the
BOLD signal [69]. This involves measuring some constant which represents the
vascular contribution to the BOLD magnitude, so the neuronal contribution
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can be separated out.
The method of calibrated BOLD proposed by Davis and co-workers [69] was to
perform an additional hypercapnia stimulus, which can be used to calculate a
calibration parameter. Hypercapnia will be discussed in more detail in chapter
5, but it provides a vasodilatory stimulus (increased CBF and CBV) whilst
assuming that CMRO2 is unchanged by hypercapnia. This allows a probe of
vascular properties independent of CMRO2.
The model theory for calibrated BOLD is detailed here. This uses the sim-
plified assumption that R∗2 is linearly proportional to CBV and is also pro-
portional to the magnetic susceptibility difference (∆χ) between blood vessels
and surrounding tissue, raised to a power β:
R∗2 ∝ CBV(∆χ)
β (2.14)
The value of β depends on vessel size and on the vessel-tissue frequency shift,
such that it takes a value between 1 and 2 as described in section 2.4.2. In the
literature, it is commonly assumed that β = 1.5, a value calculated for 1.5 T
[27, 31]. This relationship only describes the extravascular contribution to R∗2.
Total CBV is commonly used here, but since arterial blood is close to fully
oxygenated, the arterial CBV contribution to R∗2 will be small compared to
the venous CBV contribution, so using total CBV may not be appropriate here.
As mentioned in section 2.4.2, ∆χ is linearly proportional to the concentration
of dHb ([dHb]). Fick’s principle of mass conservation is used such that [dHb] is
linearly proportional to CMRO2 and inversely proportional to CBF [69]. The
resulting change in R∗2 from a rest steady state (subscript rest), to an active
steady state (subscript act), is:
∆R∗2 ∝ CBVact
(
CMRO2,act
CBFact
)β
− CBVrest
(
CMRO2,rest
CBFrest
)β
(2.15)
For a BOLD signal acquired with an echo time TE, assuming that TE∆R∗2 <<
1, a linear approximation can be made relating BOLD and ∆R∗2, such that:
∆BOLD
BOLDrest
∝ CBVrest
(
CMRO2,rest
CBFrest
)β [
1− CBV
(
CMRO2
CBF
)β]
, (2.16)
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where ∆BOLD = BOLDact − BOLDrest, CMRO2 =
CMRO2,act
CMRO2,rest
, CBF = CBFact
CBFrest
and CBV = CBVact
CBVrest
.
The constants of proportionality and resting steady state terms can be grouped
into a single parameter M :
∆BOLD
BOLD
=M
[
[1− CBV
(
CMRO2
CBF
)β]
(2.17)
The parameter M is the maximum possible BOLD signal change, correspond-
ing to a condition where no dHb is present. This is the calibration parameter,
which can be used as a measure of haemodynamic variability. This parameter
can be measured using hypercapnia, as will be described in chapter 5.
A calibrated BOLD experiment is performed by acquiring T ∗2 -weighted BOLD
data and ASL CBF data during both a task and for a period of hypercapnia.
Typically CBV is not measured directly, but the change in CBV estimated
assuming a coupling relationship between the change in CBV and the change
in CBF [70], which will be discussed in detail in chapter 6. This assumed
coupling relationship only holds for steady state conditions, whereas there is
a more complicated relationship during dynamic changes in CBV [71, 72].
Equation 2.17 can be rearranged, such that the relative change in CMRO2
(normalised by the resting steady state value) can be calculated based on the
measured relative changes in BOLD and CBF during the task and the value
of M calculated during hypercapnia. This relative change in CMRO2 provides
an indication of neuronal activity which is independent of local vascular prop-
erties.
Three main issues are associated with this calibrated BOLD approach. Firstly,
the signal model relating R∗2 to [dHb] only applies to the extravascular com-
partment, however this approach was originally applied at 1.5 T where the
intravascular compartment is expected to provide the dominant signal contri-
bution (as will be discussed in more detail in chapter 4). The extravascular
signal model also assumes a supralinear power law relationship between R∗2
and [dHb] with β = 1.5, which was derived for 1.5 T. The frequency shift
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(∆ω = γ · ∆B) around a dHb containing blood vessel increases with field
strength, such that there will be a higher relative contribution of static de-
phasing compared to diffusive dephasing for field strengths above 1.5 T (as
described in section 2.4.2). Therefore the value of β will be closer to 1 at
higher field strengths [31]. This is discussed in more detail in chapter 5.
Secondly, the assumed coupling relationship between CBV and CBF is based
on total CBV measurements [70], whereas the BOLD signal is more sensitive
to the venous compartment, which contains the majority of dHb. Venous CBV
has been shown to increase by less than total CBV due to a large arterial CBV
increase, in response to hypercapnia [73] and forepaw stimulation [74] in rats,
whilst the coupling relationship between venous CBV and CBF in humans
[75, 76] has been shown to be smaller than for total CBV. Therefore using
the total CBV coupling relationship will lead to an overestimation in CMRO2
[75]. The flow-volume coupling relationship will be addressed in more detail
in chapter 6.
Thirdly, CMRO2 calculations are very sensitive to errors in M [77, 78]. Using
hypercapnia to measure M requires a measurement of the relative change in
CBF due to hypercapnia. There is a large error associated with measuring
the CBF response to mild hypercapnia with ASL, due to a small change in
CBF associated with mild hypercapnia in comparison to that from neuronal
activation in response to the task. This error propagates through to an error
in M, which in turn leads to a large error in the calculation of CMRO2. One
solution for reducing the error associated with measuringM is to use hyperoxia
instead of hypercapnia. This approach is described in chapter 6. The hyperoxia
approach does not require a CBF measurement, as it is assumed that CBF is
unchanged during hyperoxia (an assumption that will be discussed in chapter
6).
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2.5 Conclusion
The underlying physics of NMR has been introduced, followed by the appli-
cation of NMR to imaging using spatially varying magnetic field gradients. A
description of the haemodynamic physiology underpinning fMRI techniques
has been presented and the origin of gradient echo BOLD. Finally, the vas-
cular variability associated with fMRI techniques was presented and how this
can be overcome by a calibration experiment to measure changes in oxygen
metabolism.
The issues with fMRI that will be dealt with in this work are listed here. The
BOLD response is delayed with respect to the temporal characteristics of the
underlying neuronal activation. Chapter 4 investigates how this delay is af-
fected by field strength. The vascular nature of the BOLD response means
that differences in vascular structure and reactivity across brain regions will
lead to different BOLD responses from what may be equivalent changes in neu-
ronal activity. Chapter 5 illustrates this vascular source of BOLD variability
by using hypercapnia to measure the inter-hemispheric difference in vascular
reactivity between two equivalent brain regions, the left and right precentral
gyri. The calibrated BOLD approach presented in section 2.4.5 uses a model
for relating R∗2 to blood oxygenation which is derived at 1.5 T and may not
apply at higher field strengths. Chapter 5 measures this relationship at higher
field strengths, using a graded hypercapnia paradigm performed both at 3 T
and 7 T. An assumed coupling relationship between CBV and CBF is required
for this calibrated BOLD approach, which is poorly characterised. This is
addressed in chapter 6, where the task causing increased neuronal activity
is repeated at both normoxia and hyperoxia to account for changes in CBV
without requiring a coupling relationship.
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Chapter 3
Modulation of blood gases
3.1 Introduction
This chapter describes methods for modulating arterial CO2 and O2 content.
The technique used in this work to deliver controlled levels of CO2 and O2 is
discussed, with consideration to implementing this method in an MRI envi-
ronment. Other methods of modulated inspired gases are discussed along with
safety considerations associated with modulating arterial CO2 and O2 content.
Blood CO2 and O2 content are measured in terms of gas partial pressure (PCO2
and PO2 respectively). Since arterial blood gas measurements are invasive, it
is commonly accepted to sample exhaled (end-tidal) gas content, as a close
correlate of arterial gas content. The end-tidal partial pressures of CO2 and
O2 (PETCO2 and PETO2 respectively) best reflect alveolar gas content, which
is in equilibrium with arterial gas content. The standard SI unit of pressure
is the Pascal (Pa), where the approximate atmospheric pressure at sea level
is 105 Pa. However, a non-SI unit system is commonly used when measuring
PCO2 and PO2; mmHg. In this unit system, atmospheric pressure at sea level
is 760 mmHg and approximately 133 Pa corresponds to 1 mmHg. The work
presented here uses mmHg units, the units used by the apparatus, and for
comparison with the literature.
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3.2 Theory
The technique used to control and modulate PETCO2 and PETO2 in this work
is a feed-forward low gas flow method. This technique was implemented us-
ing a RespiractTM system (Thornhill Research Inc., Toronto, Canada). This
section provides an overview of the principles underlying the feed-forward low
gas flow method of controlling PETCO2 and PETO2.
The basis for this method is a rebreathing sequential gas delivery (SGD) circuit,
which can be used to hold PETCO2 and PETO2 fairly constant, independent
of changes in ventilation (breathing depth and pace) [79]. This uses fresh gas,
supplemented by a reserve gas, which has approximately the same composi-
tion as alveolar gas, so only the fresh gas supplied affects arterial blood gas
composition. In this case the reserve gas is previously exhaled gas, which is
assumed to have the same composition as alveolar gas.
The rebreathing SGD circuit used in this work is shown in figure 3.1. A
continuous supply of fresh gas flows into the inspiratory gas reservoir and gas
flows from the inspiratory gas reservoir to the mask upon inspiration. Once the
inspiratory gas reservoir is collapsed, the remainder of the inspiratory demand
is met by reserve gas from the exhaled gas reservoir. The valve system works to
ensure that fresh gas is inspired first before being supplemented by the reserve
gas and the valve system prevents exhaled gas from entering the inspiratory gas
reservoir. Slits in the bottom corners of the exhaled gas reservoir vent excess
reserve gas and these close as the reservoir collapses to prevent entraining room
air.
A simple model of the lungs is used, consisting of two compartments, alveoli
and anatomical dead space. Only gas entering the alveolar compartment can
pass into the bloodstream, and alveolar gas exchanges with blood gas such that
alveolar and arterial PCO2 and PO2 are in equilibrium. The anatomical dead
space includes the trachea, bronchi and bronchioles. The fresh gas composi-
tion can be modulated to control arterial PCO2 and PO2 (PaCO2 and PaO2
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Figure 3.1: Schematic (left) and photograph (right) of the SGD breathing circuit used.
Dashed lines represent valves. Slits in the exhaled gas reservoir are shown by gaps in
the bottom corners.
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respectively). For optimal control of PETCO2, the volume of fresh gas deliv-
ered should be equal to alveolar ventilation (volume inspired into alveoli) [80].
The fresh gas is delivered first, filling the alveoli and the subsequent reserve
gas fills the anatomical dead space. This approach has been shown to control
PETCO2 for up to five times the resting ventilation [80]. For this approach
to work, the participant must avoid shallow breathing, where the inspired gas
does not reach the alveoli before exhalation. If approximate resting metabolic
CO2 production and O2 consumption rates are known, then a model [81] can
be used to modulate the fresh gas composition to target PETCO2 and PETO2
levels on a breath-by-breath basis.
3.3 The RespiractTM and its use in a 7 Tesla
scanner environment
Apparatus
The use of the feed forward low gas flow method in the environment of an MRI
scanner is described here. The apparatus required to implement this method
included four large gas cylinders of different gas mixtures, a small gas cylinder
of a calibration gas, the RespiractTM device and laptop computer, a fresh gas
line, two sample gas lines and the SGD circuit. A pulse oximeter was also
used to monitor arterial O2 saturation during early experiments. However,
after some experience was gained in using this set-up, confidence was gained
in using the exhaled gas sampling to monitor the participant instead of a pulse
oximeter.
Each of the large gas cylinders contains a different gas mixture. These mixtures
are medical air (21% O2, 79% N2), medical oxygen (100% O2) and two special
mixtures (10% O2, 90% N2) and (20% CO2, 10% O2, 70% N2). Each of these
cylinders has an assigned regulator. The regulators are clearly labelled with
which gas to connect to and pin index valves mean that the medical air and
medical oxygen regulators can only be connected to their respective cylinder.
The regulators are each connected to a pipe ending with a gas connector, which
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will open when connected to the RespiractTM. Each pipe is colour-coded at
the gas connector end, indicating which fitting to connect to the RespiractTM
device.
The small gas cylinder contains a calibration gas, consisting of ∼9% CO2, 91%
N2. This cylinder contains no oxygen, so several steps have been taken to en-
sure that this gas is not connected whilst a participant is breathing gas supplied
by the RespiractTM. Unlike the other cylinders, the calibration gas regulator
is not medical grade, so it has a distinctly different connector and connecting
pipe (figure 3.2a), with a distinctly different connection to the RespiractTM
device. This gas is only connected during the calibration procedure, as de-
scribed later. The calibration gas cylinder is removed from the room before
the participant is given the SGD circuit.
The RespiractTM device (figure 3.2c) is a computer controlled gas mixer, which
also includes total pressure, CO2 and O2 partial pressure sensors. This device
is kept outside the 3 mT field line. For the 7 T magnet, the majority of the
control room is inside this line (figure 3.3), so the RespiractTM device is posi-
tioned with the cylinders in a corridor at the edge of the room (figure 3.2b),
just outside the 3 mT line. The 3 T magnet is actively shielded, meaning
that the 3 mT area is much smaller than for the 7 T magnet, as a result the
RespiractTM device can be positioned next to the waveguides giving access to
the magnet hall.
Each participant was assigned their own SGD breathing circuit, which is con-
nected to the RespiractTM device by three gas lines. Fresh gas is supplied to
the circuit through a reinforced (blue) gas line (figure 3.2c). This line can
withstand being stepped on without becoming occluded. The other two gas
lines sample the gas at the nose (figure 3.1 to figure 3.2c), with one line used
to measure the total pressure trace through the breathing cycle, to detect in-
spiration and exhalation, whilst the other line is connected to the CO2 and O2
partial pressure sensors. All three gas lines are approximately 10 metres, which
is the length needed to cover the distance from the device, through waveguides
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Figure 3.2: (a) Calibration gas cylinder and regulator. (b) Positioning of the
RespiractTM device and cylinders during a 7 T experiment (see figure 3.3 for schematic
of this positioning). (c) The RespiractTM device, with three gas lines which connect to
the breathing circuit. N.B. the gas cylinders connect to the opposite side of the device.
64
and to the 7 T magnet bore (figure 3.3). These long gas lines introduce delays
of several seconds in gas sampling. The SGD breathing circuit is compatible
with an MR environment, as it does not have any metal components.
The system is operated using software installed on a dedicated laptop com-
puter (figure 3.4). The software displays PCO2 and PO2 traces, includes the
model for prospectively targeting PETCO2 and PETO2 and a simple program
for picking end-tidal points in the breathing cycle, using the pressure trace.
Calibration
The CO2 and O2 partial pressure sensors need to be calibrated every session.
This was done by alternating gas flow between 100% O2 (0% CO2) and the
calibration gas (∼9% CO2, 0% O2). The calibration procedure was performed
using the software, but required the calibration gas to be connected. PCO2
and PO2 sensors and the delay associated with the gas line were calibrated.
Once the calibration was complete, the calibration gas was removed from the
room and the gas line reconnected to the breathing circuit.
Sequence for controlling PETCO2 and PETO2
During a sequence, medical air is replaced by a mixture of the other three
gases to form the fresh gas flow. The composition of the fresh gas is varied by
changing the individual flow rates of these three gases. Therefore the amount
of CO2 and O2 delivered in the fresh gas can be used to target PETCO2 and
PETO2 levels on a breath-by-breath basis. The model used to calculate the
delivered gas mixtures requires approximate values for the participant’s resting
metabolic CO2 production and O2 consumption rates. The software can then
calculate the fresh gas mixtures required to target PETCO2 and PETO2 levels,
within user-defined constraints, such as the fresh gas flow rate and breathing
rate.
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Figure 3.3: Schematic demonstrating the position of the RespiractTM device and gas
cylinders in the scanner room (not to scale). These need to be kept outside of the 3
mT line, marked by a dashed line.
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Figure 3.4: The RespiractTM software display, including (a) continuous monitoring of
PCO2 and PO2 traces, (b) end-tidal values and (c) the ability to prospectively target
a breath-by-breath sequence of PETCO2 and PETO2 levels.
The participant was instructed to pace their breathing using visual cues and
attempt to empty the inspiratory gas reservoir with every breath during a
sequence. A green ‘IN’ and a red ‘OUT’ on a black background was projected
onto a screen at the end of the magnet bore. When in the 7 T head coil, prism
glasses were used to see the screen. In the 3 T scanner the use of a whole
body transmit coil means that a mirror can be positioned over the receive
coil, which is open between elements, removing the need for prism glasses.
Some participants could detect when the inspiratory gas reservoir collapsed
through a noticeable change in pressure as the valve switched over, or through
the contrast between the dry fresh gas and humid reserve gas. The operator
could use the PCO2 trace to identify whether the inspiratory gas reservoir was
collapsing with every breath (figure 3.5).
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Figure 3.5: Example PCO2 traces. (a) Trace where the inspiratory gas reservoir is not
fully emptied. (b) Trace where the inspiratory gas reservoir fully collapses and fresh gas
is supplemented by some reserve gas. The distinction between (a) and (b) is a shoulder
in trace (b), indicating when reserve gas is being inhaled.
Setting up the subject
After the calibration was completed, medical air was supplied as the fresh gas
unless a sequence was running. With the participant sitting upright on the
scanner bed, they were instructed to place the mask comfortably on their face,
covering both nose and mouth, then skin tape (Tegederm, 3M Healthcare, St.
Paul, USA) was used to create an air-tight seal to the face. The participant
then lay on the bed, out of the scanner bore, for several minutes whilst they
became accustomed to the mask. During this time, some set-up sequences were
run to determine a comfortable flow rate (typically in the range 6–10 Lmin−1)
and breathing frequency and to estimate resting metabolic CO2 production
and O2 consumption rates.
The software can provide estimates of these resting metabolic CO2 production
and O2 consumption rates using the participant’s height, weight, age and sex.
These values are then refined by running a sequence where resting PETCO2 and
PETO2 levels are targeted. If the values are correct then the resulting PETCO2
and PETO2 levels will be maintained at the correct level. If either drifts, then
the estimated value can be changed and the sequence recalculated until the
correct values are found. The participant was then given ear protection and
a patient alarm, positioned comfortably in the head coil and the scanner bed
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manoeuvred so that the head coil was centred in the magnet’s iso-centre.
3.4 Safety
Prolonged hypercapnia (for several hours) causes respiratory acidosis, increases
in blood pressure and heart rate [82, 83] and can cause increased anxiety and
other behavioural changes [84]. However, mild hypercapnia (≤ 5%) is widely
used for short periods of time without adverse effects (see section 5.3 for some
examples). Prolonged hyperoxia can lead to oxygen toxicity, due to increased
tissue oxygenation leading to the formation of oxygen free radicals [85, 86]. For
normobaric hyperoxia, it takes at least four hours for symptoms to develop.
In this work, only mild hypercapnia and normobaric hyperoxia were used, for
periods of less than 6 minutes. These short, mild steps are considered safe for
healthy participants.
For the feed forward low flow gas delivery system, all of the gas blends contains
at least 10% O2. Therefore even if the software crashed in such a way that it
just delivered one of the gas blends, at least 10% O2 would still be provided.
Hypoxia induced by breathing in a 10% gas mixture at sea level (760 mmHg
air pressure) is less severe than the hypoxia experienced due to high altitude
(5400 metres) at the Everest base camp [87]. For this work however, care was
taken to ensure that participant’s arterial PO2 did not go much below 100
mmHg, which is the low end of normoxia. Exhaled gas PCO2 and PO2 traces
were continuously monitored whilst the participant was breathing through the
SGD circuit, to ensure that safe arterial gas levels were maintained throughout.
The RespiractTM device has some built in fail-safes. If at any time communi-
cation is interrupted between the gas mixer and the computer software, then
100% O2 is supplied to the breathing circuit, at a high flow rate. There is
also a large red button on the front of the gas mixer (figure 3.2c), which can
be pressed at any time to supply 100% O2 at a high flow rate. In general,
this is a useful safety precaution, however in an MRI environment, this can
be problematic. Although efficient gradient coils should not do so, there is a
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chance that during gradient switching, sparks could be generated. High flow
rates of 100% O2 could significantly increase the oxygen content of the magnet,
causing a fire risk. Therefore, if at any stage this emergency 100% O2 is ac-
tivated, scanning is stopped immediately and the participant is removed from
the bore. During standard hyperoxia experiments, this is not a problem, since
low flow rates (6–8 Lmin−1) are presented, whilst the circuit design ensures
that only exhaled air enters the bore.
The main risk associated with the SGD method is that the delivered fresh gas
flow rate drops to zero. This could happen if the gas line supplying fresh gas
to the breathing circuit became occluded or if the required flow rate were set
to zero (possible with the software). If the fresh gas flow rate were to stop,
the participant would only breath the rebreathed gas, leading to an increase
in PETCO2 and a decrease in PETO2. Continuous monitoring of these values
means that if this were to happen, the operator can quickly identify this as
a problem and the participant can breath room air through the removal of a
blue plug in the front of the mask (figure 3.1). The fresh gas line is reinforced,
to minimise the risk of it becoming occluded.
Much care was required in handling compressed gas cylinders. There is a risk
of cylinders falling over, which could both cause crush injuries and a possible
risk of the cylinder becoming a projectile, through release of the compressed
gas. To minimise this risk, the cylinders were stored outside in a cage and re-
strained using chains. Cylinder trolleys were used to move the cylinders and to
provide a stable place to hold the cylinders during experiments. Appropriate
footwear (with reinforced toecaps) was used when moving the cylinders. The
cylinders are ferromagnetic, so were never placed near the magnet hall.
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3.5 Other approaches to modulating PETCO2
and PETO2
The simplest method for modulating blood gases is to change respiratory pace
and depth. Breath holding causes an increase in PaCO2 and a decrease in
PaO2, in a sigmoidal relationship with the breath hold duration [88]. Hyper-
ventilation causes PaCO2 to decrease and PaO2 to increase. A controlled form
of hyperventilation has been proposed recently [89], where breathing is paced
at an increased rate for just a couple of breaths. This method has been used to
look at the cerebrovascular response delay across brain regions. Both breath
holding and hyperventilation require no equipment, so are simple to imple-
ment. These tasks cannot separate changes in PaCO2 and PaO2 and have a
large inter-subject variation in response [90, 91].
The most commonly used method for increasing either PETCO2 or PETO2
above resting values is to supply a fixed inspired gas mixture with enhanced
CO2 or O2 content compared to air (∼ 0% CO2, 21% O2). For example, a
typical hypercapnic challenge is to present a gas mixture of 5% CO2, 21% O2,
balanced N2. A typical hyperoxic challenge is to present 100% O2. The re-
sulting change in PETCO2 and PETO2 will vary across subjects, depending on
oxygen metabolism rate, breathing rate and depth. Also, PETCO2 and PETO2
changes are not independent of one another with this method. There is an
increased ventilatory response to hypercapnia, so increased PETCO2 will be
accompanied by an increase in PETO2 [92, 93]. During hyperoxia, the CO2
carrying capacity of blood is reduced (the Haldane effect) [94], resulting in a
decrease in PETCO2 and an associated drop in CBF.
The dynamic end-tidal forcing method [95, 96, 92] allows independent control
of PETCO2 and PETO2. This method achieves targeted PETCO2 and PETO2
values by iteratively changing the gas mixture delivered to the subject. A
computer controlled feedback loop is used to monitor current PETCO2 and
PETO2 values, compare with targeted values and adjust the delivered gas CO2
and O2 composition such that PETCO2 and PETO2 converge on the targeted
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values. Good independent control of PETCO2 and PETO2 values are achieved
as long as respiratory pace and depth are approximately constant. Very high
flow rates are required (70 Lmin−1 [92]) to ensure that the subject does not
re-breath exhaled gas. The main problem with using this method in an MR
environment is that the gas sensors need to be positioned at low magnetic field,
far from the subject. Long sample gas lines introduce a measurement delay
which hinders the feedback mechanism. This would be especially problematic
with our 7 T set-up, where the gas lines need to be approximately 10 metres
from the subject. An advantage of the dynamic end-tidal forcing method
over the feed-forward low gas flow method is that changes in the subject’s
metabolism will not cause slow drifts in end-tidal values.
3.6 Conclusion
This chapter has discussed independent modulation of PaCO2 and PaO2 in an
MRI environment. The SGD technique used in this work has been introduced,
with a brief overview of the underlying theory. A description of the imple-
mentation of this technique in both 3 T and 7 T scanners has been presented,
along with safety considerations. Finally, alternative methods for modulating
PaCO2 and PaO2 have been discussed.
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Chapter 4
Effect of field strength on the
temporal characteristics of the
BOLD response
4.1 Introduction
The motivation for this work was to use the main magnetic field strength as
a perturbation to assist understanding of the BOLD effect and to investigate
changes in the haemodynamic response function (HRF) across field strength.
It has been observed that the spin-echo BOLD response time to peak (TTP)
to a task occurs earlier than the gradient-echo BOLD response TTP to the
same task at 3 T [52] (spin-echo BOLD has been introduced in section 2.4.4).
This was attributed to the spin-echo BOLD signal originating from a larger
venous microvascular (relative to macrovascular) component compared to the
gradient-echo signal. A subsequent study (also at 3 T) modelled the dispersion
of blood oxygenation changes through the venous vasculature, in response to
neuronal activation [97]. That study predicted, and showed experimentally,
an increase in both the TTP and full-width at half-maximum (FWHM) of the
BOLD signal response with the vessel’s distance downstream from the capillary
bed supplying the active neurons. Therefore, the BOLD signal contribution
from capillaries and venules will generally be earlier and the HRF narrower in
time than that from large draining veins.
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Figure 4.1: (a) Plot reproducing Figure 1 of [31]. This plot shows the ∆R∗2 (or ∆R2
for spin echo) dependence on vessel radius for gradient echo (hyperbolic tangent func-
tion) and spin echo (gaussian function) signal, in response to a 0.1 ppm change in the
vessel susceptibility with respect to the surrounding tissue at 1.5 T. (b) Illustrative
plot demonstrating the effect of increasing frequency shift (following the arrow; due to
contrast agent or field strength) on the ∆R∗2 dependence on vessel radius for gradient
echo BOLD.
Monte Carlo simulations of extravascular BOLD signal have found a sensitivity
dependence on vessel size [31]. This is demonstrated in figure 4.1, for gradient
echo and spin echo BOLD contrast for blood vessels with a 0.1 ppm suscepti-
bility shift from surrounding tissue at 1.5 T. Figure 4.1a directly demonstrates
that the spin echo BOLD signal is more sensitive to smaller vessel sizes than
larger vessel sizes, whereas gradient echo BOLD signal has a large component
from larger vessels. The predicted consequence of increasing field strength is
to shift the curves to lower vessel radii and increase the amplitude of signal
changes (due to increased ∆R∗2) resulting in increased sensitivity to smaller
vessels, as shown in figure 4.1b. This results from the vessel-tissue suscepti-
bility difference causing an increased frequency shift at higher field strengths.
Note that in [31] the frequency shift was changed by increasing contrast agent
concentration, but would equally apply to a field strength induced increase in
frequency shift. Therefore the gradient-echo BOLD signal will have a larger
microvascular contribution at higher field strengths. By combining the predic-
tion of an increased microvasculature component at higher field strength [31]
with the observation of an earlier BOLD response from smaller veins, the pre-
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diction can be made that the BOLD response is earlier at higher field strengths.
This may take the form of a faster leading edge (onset) of the BOLD response.
Several studies have investigated the relationship between field strength and
BOLD signal characteristics. The spatial extent of statistically significant ac-
tivation was shown to be greater at 3 T than at 1.5 T for visual and working
memory tasks [98] and a motor task [99]. In the latter study this trend ex-
isted over a wide range of echo times, up to 130 ms. Single-echo %BOLD
measurements in response to visual stimulation have been shown to be higher
at 4 T than 1.5 T [100] for an echo-time chosen to approximate grey matter
T ∗2 at each field strength. Multi-echo acquisitions have been used to show that
∆R∗2 in response to a task increases with field strength from 0.5 T to 7 T
[101, 102, 103, 104]. In a study conducted at 1.5 T, 3 T and 7 T, ∆R∗2 has
been shown to increase linearly with field strength in response to motor [103]
and visual [104] tasks. These studies also confirm that the maximum %BOLD
is found for an echo-time approximately equal to grey matter T ∗2 . All of these
previous cross-field studies employ a block design for task presentation, no pre-
vious studies have considered the effect of field strength on the BOLD signal
temporal characteristics (HRF shape).
Venous blood has a T ∗2 of approximately 60/17/5 ms at 1.5/3/7 T respectively
[105]. Therefore with typical echo-times (TEs) approximately equal to the T ∗2
of grey matter (66/48/28 ms respectively) [106], the intravascular signal com-
ponent will have a much larger contribution to the total BOLD signal at 1.5 T
than at 7 T. The relative extravascular and intravascular BOLD signal com-
ponents can be separated by adding flow suppression bipolar gradients to the
gradient-echo sequence. These gradients dephase the signal from spins moving
above a critical velocity in the direction of the applied gradients, thus remov-
ing the majority of the intravascular signal and providing an upper estimate
of the extravascular BOLD signal. Several studies have used this technique to
estimate the extravascular fraction of gradient-echo BOLD signal at various
field strengths. At 1.5 T, the BOLD signal has been shown to be dominated
by the intravascular component [107, 108], with the extravascular component
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contributing between 0 and 30 % to the total BOLD signal. At 4 and 7 T
an extravascular component of greater than 90 % and approximately 100 %
were measured respectively, although these were measured at long TEs (80 ms
and 55 ms respectively) compared with grey matter T ∗2 , thus further reducing
the intravascular effect. A multiple echo approach was used to measure the
total and extravascular ∆R∗2 BOLD signal contributions in response to a visual
stimulus at 1.5 T, 3 T and 7 T [104], finding 45–70 %, 70–91 % and 91–98
% extravascular contributions respectively (the range of values reflecting two
choices of ROI). Since the ratio of intravascular to extravascular BOLD signal
contributions primarily depends on the difference in venous and grey matter
T ∗2 , then this ratio will strongly depend on the choice of TE.
The aim of this work is to investigate how the temporal characteristics of the
BOLD haemodynamic response function change with field strength. With the
same controlled task performed at each field strength, neuronal and haemo-
dynamic responses can be assumed to be the same, and so any differences in
shape provide information on the different BOLD signal compartments (mi-
crovascular and macrovascular compartments (see figure 4.1), or intravascular
and extravascular compartments). In this work fMRI data was collected both
without and with flow suppression bipolar gradients to suppress the intravas-
cular signal component. This allows separation of the intravascular and ex-
travascular components whose relative BOLD signal contributions will change
with field strength.
4.2 Method
Seven healthy volunteers (5 female, 2 male) participated in this study. All sub-
jects gave informed written consent prior to participating and ethical approval
was given by the University of Nottingham Medical School Ethics Committee.
Each subject was scanned on three separate occasions over a three week pe-
riod, once at each field strength of 1.5, 3 and 7 T. Within the constraints of
volunteer and scanner availability, the field strength order was varied across
volunteers to prevent a systematic bias due to adapting to the task across ses-
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Parameter 1.5 T 3 T 7 T
TE (ms) 55 45 32
SENSE factor 2 2 3
# slices acquired 8 10 10
flip angle (◦) 66 66 60
# dynamics 240 360 360
TR (s) 1 1 1
Table 4.1: Scan parameters
sions.
Data acquisition
Scanning was performed on Philips Achieva 1.5 T and 3 T systems, with whole
body volume transmit and 8 channel SENSE head receive coils, and a Philips
Achieva 7 T system, with head volume transmit and 16 channel SENSE head
receive coil. Scanning consisted of an initial localiser scan to identify the visual
cortex, followed by multiple blocks of the main visual fMRI experiment, which
is described in later paragraphs. Alternate fMRI scans were run without and
with flow suppression bipolar gradients in an order which was randomised
across subjects. The scanner operator spoke to the subject between scans to
ensure that the subject maintained attention throughout. Respiratory bellows
and a pulse oximeter were used at 7 T to monitor the subject’s breathing and
cardiac trace respectively. Only respiratory bellows were used at 3 T, since the
pulse oximeter in that scanner did not work at the time of the study; neither
were used at 1.5 T. Physiological noise is lower at lower field strengths [109]
and for the relatively fine spatial resolution used here (2 mm isotropic) can be
considered insignificant at 1.5 T for the purpose of this experiment.
For both the localiser scan and main fMRI scans, axial gradient-echo EPI data
were acquired with a 2 mm isotropic spatial resolution over a reduced field-of-
view (128×192 mm) centred on the occipital lobe. For the localiser scan, 20
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contiguous slices were acquired in a TR of 2 s and with a flip angle of 80◦, 80◦
and 75◦ (the Ernst angle), at 1.5, 3 and 7 T respectively, 120 dynamics were
collected. Acquisition parameters for the fMRI scans at each field strength are
shown in table 4.1. The reduced slice coverage and number of dynamics at 1.5
T were due to limitations of the gradient set combined with the demands of
applying the bipolar gradients.
The flow suppression bipolar gradients were not applied in the slice direction,
as this was found to cause eddy currents, generating large image intensity
artefacts. Bipolar gradients were applied in both the phase and readout di-
rections with the parameters shown in table 4.2. The gradient amplitudes (A)
used were the maximum achievable with each respective gradient set, and the
shorter duration at 7 T was to allow for the shorter optimal TE. The 1 ms
linear ramp-up and ramp-down slope for each gradient lobe is longer than the
minimum available, but was found to significantly reduce eddy current arte-
facts. The equations for calculating b and venc were taken from [108], which
specify for bipolar gradients
b =
2
3
δ3(2piγA)2 (4.1)
venc = (2γAδ
2)−1 (4.2)
where γ is the proton gyromagnetic ratio, A is the gradient lobe amplitude
and δ is the gradient lobe duration plus half the sum of the rise and fall times.
These bipolar gradients resulted in a diffusion weighting of b = 72.9 s/mm2
at 1.5 and 3 T, and b = 44.3 s/mm2 at 7 T. The bipolar gradients will cause
an attenuation of the signal from moving protons, such that there will be a
distribution of attenuation values across flow velocities. The velocity value of
venc gives an indication as to the lower end of this distribution. In this case,
venc = 3.26 mm/s at 1.5 and 3 T, and venc = 4.83 mm/s at 7 T corresponds
to vessels larger than capillaries and small microvasculature [110].
A visual stimulus (red LED goggles, flashing at 8 Hz) was used, for repro-
ducible stimulus presentation across trials and field strength. All lights in the
magnet hall and bore were switched off throughout the functional experiment.
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Gradient parameters 1.5 T 3 T 7 T
Amplitude A (mT/m) 25 25 30
Duration (ms) 11 11 8
Rise/fall time (ms) 1 1 1
b (s/mm2) 72.9 72.9 44.3
venc (mm/s) 3.26 3.26 4.83
Table 4.2: Properties of the flow suppression bipolar gradients
The stimulus was presented in short blocks to maintain attention, 4 minutes
at 1.5 T, 6 minutes at 3 T and 7 T (the shorter block duration at 1.5 T was
due to the hardware limitation on the number of dynamics). Each block com-
prised an initial 60 s OFF period to identify a clear baseline period, followed
by repeats of 5 s ON and 55 s OFF.
A short TR was required to adequately sample the BOLD HRF temporal
characteristics, which restricted the number of slices acquired. Therefore, to
position the image slab to cover the primary visual cortex, a localiser scan
was performed initially. This localiser had a longer TR allowing wider slice
coverage, a visual stimulus of four cycles of 10s ON and 20s OFF was used
and an online analysis program (inbuilt in the scanner software) was used
to generate real-time BOLD activation maps to identify the primary visual
cortex. To ensure that the same slice coverage was acquired across all three
field strengths, screenshots were taken for comparison (for example see figure
4.2). When planning the slice coverage for the second and third sessions, a
combination of the screenshots from previous sessions and the localiser scan
from the current session were used to position the imaging slab.
Analysis
Data analysis consisted of motion correction, high-pass temporal filtering,
physiological noise correction and voxelwise intensity normalisation. These
steps will be described in detail in the next few paragraphs.
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Figure 4.2: Example of a screenshot taken at 3 T, showing the slice orientation for the
main scan blocks. This was used for reference in slice positioning at the other field
strengths.
Motion correction of this data proved problematic, due to the reduced field-
of-view, low SNR associated with a 1 s TR and the use of diffusion gradients.
The use of motion correction algoritms from FSL (fMRIB, Oxford, UK), SPM
(UCL, London, UK) and AFNI (NIH, Bethesda, USA) were assessed, but
these appeared to add spurious motion to the datasets. The effectiveness of
the motion correction algorithms were judged by manual inspection of the
motion parameter estimates and movies comparing the motion corrected and
original datasets using FSLview (FSL). Using these methods of inspection, it
was decided to not motion correct those datasets which featured no sudden
jumps in the original dataset and had less than 1 mm (half the voxel size) mo-
tion throughout the dataset. From these criteria, 5 datasets (of 84) required
motion correction. These datasets were motion corrected using MRTools, a
Matlab-based toolbox designed for processing fMRI data. This toolbox led to
less spurious motion than the other algorithms, and for these five datasets,
the spurious motion added was less than the actual, corrected motion. This
method of motion correction required a lot of user input and would not have
improved the other datasets, and so was only performed on these 5 datasets.
All datasets were high-pass temporal filtered with a 120 s cut-off period. Physi-
ological noise correction was performed using RETROICOR [51], implemented
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using in-house Matlab code (written by Emma Hall). Both respiratory and
cardiac cycles were used for correction at 7 T, whilst only respiratory cycle
related noise was corrected at 3 T (see data acquisition section). For each
subject, all datasets acquired at a given field strength were first realigned to
the same space, using FLIRT (FSL). This corrected for any small motion be-
tween scans. These transformations were carefully checked using FSLview to
overlay one dataset on another. Spatial smoothing was performed, with a 3
mm FWHM gaussian kernel using SUSAN (FSL). All datasets were intensity
normalised to the OFF periods on a voxel-by-voxel basis, by dividing each
dynamic image by the mean image over the initial 60 s OFF period. For each
subject, all repeated scans were concatenated into a combined dataset. This
resulted in six combined datasets for each subject. Average trials were formed
for each combined dataset by averaging over all trials (60 s periods, starting
from the visual stimulus onset).
Statistical analysis was performed on each combined dataset, using FEAT
(FSL). Clusters of significant activation were chosen using a voxelwise Z-score
threshold of Z > 2.3 and cluster corrected Pcorr < 0.05. A single region of
interest (ROI) was then defined for each subject as follows: the binary clus-
ter masks (Pcorr < 0.05) from the 1.5 T and 3 T combined datasets without
bipolar gradients were moved into 7 T space. This was performed by first
registering an average 1.5 T and 3 T image to a 7 T average image, then ap-
plying the realignment parameters to the binary masks. The registrations were
checked manually using FSLview and no significant differences in distortions
were observed across field strengths. A common ROI was then formed from
the intersection of masks from all three field strengths, so only including voxels
with a significant response at all three field strengths. The common ROI was
then transformed back into 1.5 T and 3 T space, so the same region could be
studied at all three field strengths.
Four parameters were measured in order to characterise the temporal charac-
teristics of the average trials; TTP, FWHM, BOLD amplitude and the onset
time (delay between the start of the stimulus presentation and the BOLD re-
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Figure 4.3: Example of the gaussian (red curve) and linear (blue line) fits to an average
trial %BOLD timecourse (black dots). This demonstration timecourse is averaged over
the common ROI for a single slice of one subject at 7 T. The vertical dashed lines
indicate the window for the gaussian fit (3–15 s). The linear fit was windowed between
3–6 s and the blue line is extended back to 0 s to illustrate the %BOLD = 0 intercept
(horizontal dotted line), in this case at 1.6 s.
sponse onset). A least-squares fit was performed of a gaussian function to the
average trial %BOLD timecourse over timepoints 3 to 15 s after the start of
the visual stimulus. From this fit TTP, FWHM and peak BOLD amplitude
were measured. To measure the onset time, a linear regression was performed
to the timepoints between 3 and 6 s and the fitted line then interpolated back
to the %BOLD = 0 intercept. This analysis of temporal characteristics was
performed on a voxelwise basis, for all voxels included in the common ROI. To
demonstrate the gaussian and linear fits, an average trial %BOLD timecourse
is shown for a single slice in one subject at 7 T in figure 4.3. When measuring
these parameters, slice timing needs to be accounted for. Each slice in the
volume was acquired at a different point in time, spaced evenly across the TR
(equidistant, 0.125 s between slices at 1.5 T and 0.1 s at 3 T and 7 T). To
account for this, the time vector was shifted appropriately when considering
each slice.
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Figure 4.4: Single-subject example of Z-statistic maps, showing the Z > 2.3, Pcorr <
0.05 clusters at all three field strengths for the cases of without (No FS) and with
(FS) flow-suppression bipolar gradients. The images on the right demonstrate how the
common ROI was formed (from the outlined slice) from the No FS binary cluster masks
(Z > 2.3,Pcorr < 0.05), as described in the analysis section text.
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Volume (mm3) 1.5 T 3 T 7 T
NoFS 16407± 8653 45923± 18635 62400± 24274
FS 11145± 5145 36816± 23127 58049± 26305
100×FS/NoFS (%) 68 80 93
Table 4.3: Volume of activation for each field strength (mean±standard deviation over
subjects) for the NoFS and FS case. Also shown is the FS activation volume as a
percentage of NoFS activation volume.
4.3 Results
One subject was discarded, as they reported loss of attention during the 1.5 T
scan, this was supported by there being no clusters of significant activation for
this dataset. Example results for the statistical analysis and the formation of a
common ROI are shown in figure 4.4, for a single subject. From this point on-
wards, datasets acquired without the flow-suppression bipolar gradients will be
referred to as the no flow-suppression (NoFS) case, whilst datasets with flow-
suppression bipolar gradients will be referred to as the with flow-suppression
(FS) case. For the six subjects for which a complete set of data was avail-
able at all three field strengths, the average volume of activation at each field
strength is shown for the NoFS and FS case together with the FS activation
volume as a percentage of the NoFS activation volume (table 4.3).
TTP maps for a single slice in a single subject are shown in figure 4.5a, whilst
TTP histograms of all common ROI voxels in all subjects are shown in figure
4.5b. The equivalent maps and histograms are shown for FWHM in figure 4.6,
for peak BOLD amplitude maps in figure 4.7 and for onset time in figure 4.8.
The histograms indicate the voxel-level variation of each parameter.
To consider any differences in TTP, FWHM and onset time across field strength
and between the NoFS and FS case, a 2-way ANOVA was used on the sub-
ject mean values of each parameter, with post-hoc t-tests between NoFS and
FS cases at each field strength with Bonferroni correction. The crude fitting
technique for measuring the onset time led to some erroneous fits, such as
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negative or very long onset times. The erroneous fit values, including outliers
with magnitude on the order of 100 s, dominate subject average values if a
mean is taken over all common ROI voxels. Therefore a trimmed mean was
calculated only using values of onset time between 0–6 s, to generate average
values which better represent the peak of the histogram. TTP and FWHM
mean values and trimmed mean onset time values for each subject are shown
in figure 4.9. Also shown in this figure are results for the statistical analysis,
which show that the onset time decreases with increasing field strength and
that TTP and onset time were affected by flow suppression at low field (1.5
T), but not at higher field (3 and 7 T).
Voxelwise scatter plots comparing peak BOLD amplitude versus onset time
are shown in figure 4.10. They might be expected to show some correlation
of later onset times for higher peak BOLD amplitude, since voxels containing
large draining veins would be expected to have a large peak BOLD amplitude
and a later onset time compared with tissue voxels. However, the scatter plots
actually show an approximately normal distribution, centred on the mean val-
ues reported in figure 4.9c. Voxels with high peak BOLD amplitude, which
may be expected to have a more accurate onset time fit, are also situated close
to the mean onset time value. Monte Carlo simulations and improved fitting
functions may help to determine whether this lack of a positive correlation
between peak BOLD amplitude and onset time is due to limitations of the
sensitivity of this method or the choice of ROI.
85


	

 

 
 
	
	
	













	 	
Figure 4.5: Voxelwise time-to-peak (TTP) results. (a) Single-subject example of the voxelwise TTP maps for the NoFS and FS case at
each field strength. (b) Histograms of the voxelwise TTP maps, formed from common ROI voxels for all subjects.
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Figure 4.6: Voxelwise full-width-half-maximum (FWHM) results. (a) Single-subject example of the voxelwise FWHM maps for the NoFS
and FS case at each field strength. (b) Histograms of the voxelwise FWHM maps, formed from common ROI voxels for all subjects.
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Figure 4.7: Voxelwise results for peak BOLD amplitude, the amplitude of the gaussian fit. (a) Single-subject example of the voxelwise peak
BOLD maps for the NoFS and FS case at each field strength. (b) Histograms of the voxelwise peak BOLD maps, formed from common
ROI voxels for all subjects.
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Figure 4.8: Voxelwise onset time results. (a) Single-subject example of the voxelwise onset time maps for the NoFS and FS case at each
field strength. (b) Histograms of the voxelwise onset time maps, formed from common ROI voxels for all subjects.
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Individual subject average trial timecourses are shown for the NoFS and FS
cases and for each field strength separately in figure 4.11. These normalised
timecourses were constructed by dividing each slice’s common ROI average
trial %BOLD timecourse by the gaussian-fitted peak BOLD amplitude value
(BOLD(peak)), then performing a weighted average over slices, using the num-
ber of common ROI voxels in each slice as the weighting factor. The time-axis
scale was determined by a weighted average of slice timing values over slices.
The horizontal lines in the top right hand corner of each plot show two weighted
standard deviations of the slice timing across slices, one for each subject. A
comparison of these average trial timecourses across field strength is shown in
figure 4.12, both for the average timecourse across subjects and for a single
subject example. These plots show an earlier onset time at 7 T (red lines)
compared to 1.5 T (blue lines) for both NoFS and FS cases. The TTP is very
similar at all field strengths in the NoFS case, but in the FS case it is later
at 1.5 T compared to 3 T and 7 T. FWHM is similar across field strengths in
both the NoFS and FS cases. These observations are in agreement with the
histograms shown earlier.
The post-stimulus undershoot did not appear to be attenuated with the bipo-
lar gradients, consistent with the literature [111] suggesting that it is predom-
inantly extravascular in nature. However, a thorough analysis of the post-
stimulus undershoot was not performed due to limited contrast-to-noise ratio
of the feature and due to an oscillation observed in 3 out of the 6 subjects at
7 T, only in the post-stimulus undershoot, which was localised to the visual
cortex (figure 4.13). This oscillation might be attributed to a visual rebound
after-effect [112]. Further study of this oscillation was not performed due to it
not being robustly repeatable across subjects or across repeated scan sessions.
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Figure 4.9: Plots showing (a) TTP, (b) FWHM and (c) onset time for each subject,
taken from the voxelwise fit values averaged over the common ROI. The connecting
lines demonstrate the change across field strengths for each subject. Mean ± standard
error across subjects is displayed above the x-axis for each field strength. Also shown
on the right are results for the 2-way ANOVA, with significant results of P<0.05 are
marked by ∗. Significant differences between NoFS and FS cases at each field strength
of P<0.05 (Bonferroni corrected paired t-tests) are shown by ∗ in the plots.
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Figure 4.10: Scatter plots of peak BOLD amplitude versus onset time for every voxel in
the common ROI of every subject. Note that the plots have been windowed to exclude
isolated outliers for both peak BOLD amplitude and onset time.
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Figure 4.11: Average normalised trial timecourses for all 6 subjects, formed by the
weighted average over slices. Each subject’s timescale is determined by the weighted
average slice timing and the horizontal lines in the top right hand corner show two
weighted standard deviations of the slice timing across slices for each subject. The
weighting factors were determined by the number of common ROI voxels in each slice.
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Figure 4.12: NoFS (a & b) and FS (c & d) average normalised trial timecourses compared across field strength. Timecourses (a & c)
are averaged over all subjects’ timecourses from figure 4.11, with the timescale determined from the average slice timing across subjects.
Timecourses (b & d) show a single subject example average trial timecourse, where the vertical error bars show the weighted standard
deviation BOLD/BOLD(peak) over slices and the horizontal lines in the top right corner show two weighted standard deviations of slice
timing over slices.
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4.4 Discussion
This study has predicted and found a significant difference in the BOLD re-
sponse onset to a visual stimulus with field strength in both NoFS and FS data,
higher field strength data showing a shorter onset time. This prediction was
based on the BOLD signal sensitivity to vessel radius [31], being dependent
on the frequency shift between the vessel and surrounding tissue, as shown
in figure 4.1. Frequency shift is itself affected both by the susceptibility dif-
ference (dependent on haemoglobin oxygen saturation) and on field strength.
At higher field strength, the BOLD signal has increased sensitivity to smaller
venous vessels, which are predicted to be associated with an earlier onset of
the BOLD response [97]. The results of this study demonstrate a shorter onset
time in the BOLD response, relative to the start of the visual stimulus, with
increasing field strength.
The statistically significant trends with field strength were inferred by voxel-
wise consideration, rather than through averaging over the whole common ROI,
before consideration of the temporal characteristics. The reason this method
was followed is that there will be a within-subject distribution of temporal
characteristics due to local differences in vascular structure. This variation
may blur the BOLD dynamic response, obscuring any differences across field
strength. The voxelwise consideration was used to account for this distribu-
tion, however the common ROI averaged timecourses were still able to separate
out these differences, despite this within-subject variation, as shown in figure
4.12.
Bipolar diffusion gradients were used to suppress the signal from fast moving
spins, such as in large vessels. Application of these gradients lengthened the
BOLD TTP and onset time at 1.5 T (see figure 4.9), where the intravascular
BOLD signal contribution from large veins are expected to be dominant. A
possible explanation for this is that the short repetition time (1 s) could have
led to inflow effects, which dominate the differences in BOLD response function
and would be suppressed by the bipolar diffusion gradients. The contribution
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Figure 4.13: Post-stimulus oscillations, shown for the subject where they are most
pronounced. (a) Average trial timecourse for the subject, at 7 T in the NoFS case,
calculated in the same way as for figure 4.12b. (b) A 3×3 voxel ROI, centred on the
voxel with maximum Z-statistic from the original FEAT analysis (FSL) was used to form
the average trial timecourse shown here (solid line). To separate the oscillations from
the post-stimulus undershoot, a fourth order polynomial was fit to timepoints after the
average trial timecourse first becomes negative (dashed line). A correlation analysis was
performed (FEAT, FSL), to identify the spatial characteristics of the oscillations, where
the oscillations, post-stimulus undershoot and positive BOLD response were considered
as separate components. (c) Z-statistic map of significant correlation (Z > 2.3, Pcorr <
0.05) to the oscillations found in the 3×3 voxel ROI, again for the NoFS case at 7 T
for this subject. Significant correlation with the oscillations is restricted to the visual
cortex.
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of inflow could be assessed in the future by acquiring data with a multiple
echo sequence, where the fitted S(TE = 0) would show inflow effects and T ∗2
would be independent of inflow effects. Assuming that these inflow effects are
suppressed by the bipolar gradients, the source of the trend for later TTP at
1.5 T compared with 3 T and 7 T supports the hypothesis of an increased
sensitivity in BOLD signal to large vessels at 1.5 T and reduced sensitivity to
microvasculature.
As discussed in the methods section, flow suppression bipolar gradients were
only applied in-plane, as through-slice gradients were found to cause large im-
age artefacts due to eddy currents. This means that only in-plane motion is
suppressed by these gradients. Bipolar gradient amplitude and duration were
chosen to maximise the diffusion weighting and minimise the cut-off velocity
venc, with the compromise of not making the TE too long, especially at 7 T.
Here, signal from water protons moving faster than venc will be suppressed by
the bipolar gradients. Due to the limitation of TE, the achieved venc of 3.26
mm/s at 1.5 T and 3 T, and 4.83 mm/s at 7 T is faster than typical blood
velocities of capillaries and some of the microvasculature [110]. Thus in this
study the bipolar gradients will mostly suppress the intravascular signal from
veins and larger venules, however from the literature of intra-voxel incoherent
motion (e.g. [113]), a diffusion weighting of b ≥ 200 s/mm2 is required to com-
pletely suppress the intravascular signal.
This paragraph aims to discuss the limitations in scan parameters for this ex-
periment and explain the choices that were made based on these limitations.
The 2 mm isotropic spatial resolution was chosen as a balance between re-
ducing physiological noise at 7 T through smaller voxel volumes [109], whilst
maintaining sufficient signal-to-noise at 1.5 T, where thermal noise dominates.
This spatial resolution, combined with the use of flow suppression bipolar gra-
dients meant that the minimum TE for a full-head acquisition would be too
long for reasonable BOLD contrast. Therefore a reduced field-of-view was
used, covering approximately the posterior two thirds of the brain. To pre-
vent the remaining anterior part of the brain wrapping into the image, the
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frequency encoded direction was chosen to be in the left–right direction. TE
values used were chosen to be approximately equal to grey matter T ∗2 [106],
however due to the constraints of first applying the bipolar gradients, the TE
used at 7 T was slightly longer than grey matter T ∗2 (TE = 32 ms; T
∗
2 ≃ 28 ms),
but this was the minimum available without significantly reducing the diffu-
sion weighting of the bipolar gradients. Ideally, a multi-echo acquisition would
have been used, to probe the dependence of TE as well as field strength. How-
ever, a single-shot multi-echo acquisition was not used, as the shortest second
echo would have been too long for a reasonable signal-to-noise ratio or BOLD
contrast and would have lengthened the TR and caused the gradients to over-
heat. Multiple single-echo repeats, each at a different TE were ruled out due
to time constraints, as the experiment already included multiple repeats with
and without flow suppression bipolar gradients.
The visual paradigm consisted of flashing LED goggles which, although a crude
stimulus, was chosen for repeatability between the three scanner sites. The
paradigm of 5 s ON and 55 s OFF was short enough to resolve the BOLD
response temporal characteristics, whilst a shorter ON period, was not used as
this would lead to reduced activation, which may not be robust for temporal
characterisation at 1.5 T.
This study used a common ROI across all three field strengths. The ROI selec-
tion was based on regions of common activation in the NoFS case at all three
field strengths. This was to ensure that the same region (with the same vascu-
lar structure) was considered and was chosen to reduce variability, for example
from the inclusion of a large draining vein in one ROI and not in another.
One potential problem with this is that this method may lead to bias based
on the activated region at one field strength. Although not presented here, the
whole activated ROI at each field strength was considered separately and the
similar trends were observed, although with increased variance expected from
comparing slightly different regions. Another possible problem could be due to
different image distortions at each field strength due to field inhomogeneities,
particularly at 7 T. This would reduce the accuracy of the registrations between
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field strengths and so the accuracy of the common ROI. However, careful con-
sideration in checking each registration between field strengths, using an image
viewer to compare the reference image and realigned image, showed that the
registrations worked well, suggesting that the distortions were similar across
field strengths. This was aided by the small field-of-view in the phase-encoded
direction, meaning that the acquisition was of a short train length, reducing
distortions. In summary, the choice of an ROI formed from the intersection of
activated regions at all three field strengths ensured that the same tissue was
considered across field strengths.
The temporal characteristics presented here are measured using some crude
fitting techniques, which have associated errors. The gaussian fit to measure
TTP and FWHM assumes that the BOLD response curve is symmetric, which
is not the case. Also, fitting the rising slope to a straight line for onset time
measurement assumes the leading edge of the BOLD response is fairly linear,
whereas in reality it is curved. The limited number of timepoints that are used
for this fit also means that it is very sensitive to noisy data points. Despite
these limitations in the fitting values, structures, such as large draining veins
can be seen in the voxelwise temporal characteristics maps and average values,
calculated across the ROI and averaged over subjects gives values which are
consistent with the timecourse averaged over subjects (figure 4.12). Improved
fitting techniques could be used in the future, such as fitting a gamma variate
function (which is not limited to being symmetrical), or a cubic splines fit-
ting (which do not assume a shape for the BOLD response function). Monte
Carlo simulations could be performed to assess the possibility of these trends
arising by chance. However, despite these limitations in the fitting methods,
the trends that have been observed are also seen in the timecourses formed by
averaging over the common ROI.
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4.5 Conclusion
This chapter has considered the effect of field strength on the BOLD response
to a short visual stimulus, with the aim of assessing the different vascular
contributions to BOLD temporal characteristics. A significant difference was
found with field strength in the BOLD response onset time. This is consis-
tent with BOLD signal Monte Carlo simulations [31], which predict a greater
sensitivity to vessels with smaller radii at higher field strengths, and with the
observations that smaller vessels contribute to an earlier BOLD response than
larger veins [52, 97]. Future work will attempt to make use of more robust fit-
ting techniques for measuring voxelwise temporal characteristics. Also, these
results will be applied to existing dynamic BOLD models [114, 97, 106], to
generate an improved model to account for these differences in sensitivity to
vessel sizes and the associated change in temporal characteristics with field
strength.
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Chapter 5
Investigating cerebral
haemodynamics using
hypercapnia
5.1 Introduction
Cerebral vasculature is sensitive to changes in partial pressure of arterial car-
bon dioxide (PaCO2). The cerebral vascular response to hypercapnia, an in-
crease in PaCO2, can be a useful tool for investigating (and specifically cali-
brating) the BOLD signal to neuronal activity, by providing a global vascular
perturbation. Through use of a hypercapnic challenge it is possible to sepa-
rate oxygen consumption from the vascular components of the BOLD response
[69, 77]. This is important as oxygen metabolism will be more closely corre-
lated to the underlying neuronal activity [21, 22] than the vascular response
and BOLD signal. CO2 perturbations can be used to test the capacity of local
vasculature to dilate and constrict, which is important for understanding the
haemodynamic response to neuronal activation and clinically for assessing the
vascular reserve [115].
This chapter aims to use the measurement of cerebrovascular reactivity (CVR)
in response to hypercapnia to improve our understanding of the BOLD signal.
Here, two different CVR mapping paradigms are evaluated; graded hypercap-
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nia and sinusoidal modulations in CO2. The relationship between PaCO2 and
grey matter transverse relaxation rate (R∗2) is assessed using small, well re-
solved graded steps in PaCO2, over a normal physiological range, at 3 T and
7 T, which can be used to improve calibrated BOLD calculations [69] (see
section 2.4.5) at field strengths above 1.5 T. A sinusoidal CO2 challenge at 7
T is used to assess CVR across brain regions, specifically the left and right
hemisphere primary motor cortices, where handedness may result in a bias
between hemispheres. Such changes may cause an underlying modulation in
the BOLD signal, independent of the underlying neuronal activation.
5.2 The effect of hypercapnia on the vascula-
ture
This section provides a literature review of the reported effects of hypercapnia
on haemodynamic properties. This gives an insight into how hypercapnia can
be used as a tool for assessing vascular variability in the BOLD signal, as ex-
plored in later sections of this chapter.
With the onset of hypercapnia, increased inspired CO2 diffuses into blood, lead-
ing to an increase in PaCO2. When a sequential gas delivery (SGD) breathing
circuit (described in chapter 3) is used, it has been shown that end-tidal PCO2
(PETCO2) is a good approximation to PaCO2 [116]. Arterial CO2 is dissolved
in plasma, forming carbonic acid, so increasing PaCO2 will decrease arterial
pH. This decrease has been widely observed in arterial blood samples taken
during hypercapnia [117, 118, 119].
Hypercapnia is a potent vasodilator [117], causing an increase in both cerebral
blood volume (CBV ) and cerebral blood flow (CBF). Invasive measures in
rhesus monkeys have shown the change in CBF with PaCO2 to be sigmoidal
over the range of 5–418 mmHg PaCO2 [118] centred on 40 mmHg (the nor-
mocapnic value), and approximately linear over a normal physiological range
of PaCO2 values. In a positron emission tomography (PET) study, also in
rhesus monkeys [70], CBF and CBV were both shown to have approximately
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linear relationships with PaCO2, over the PaCO2 range of 15–76 mmHg. The
average grey matter CBF response to hypercapnia has been measured using
pulsed ASL (PICORE Q2TIPS) fMRI [120, 121], finding a CBF response of 4–
6 %/mmHg. In another pulsed ASL study, resting CBF was found to correlate
linearly (4 mL/100g/min/mmHg) with PaCO2, measured by blood samples in
patients [122].
Perturbations of PaCO2 have been used to investigate the coupling relation-
ship between CBF and CBV, originally in rhesus monkeys [70] and later in
humans [119] using PET. The coupling relationship between CBF and the ve-
nous component of CBV has been measured using fMRI [76], this is important
as it is the venous blood volume compartment that is the predominant source
of BOLD contrast. A significant increase in arterial CBV and decrease in arte-
rial transit time has been observed under hypercapnia [123]. In the same study,
the relationship between CBF and arterial CBV was measured for hypercapnia
and also for a visual task. Whilst similar CBF – arterial CBV coupling was
observed in the microvasculature in both cases, the larger artery contribution
showed significantly different CBF – arterial CBV coupling for hypercapnia
and visual activation, with a higher arterial blood volume increase relative to
CBF increase on hypercapnia.
It is widely assumed that mild hypercapnia will not affect cerebral oxygen
metabolism rate (CMRO2) and therefore oxygen demand [69]. However at-
tempts to measure global cerebral oxygen consumption in humans [117, 124,
125] give conflicting and inconclusive results as to whether there is a significant
change in cerebral oxygen consumption during mild hypercapnia. CMRO2
measured both during normocapnia and graded hypercapnia found no sig-
nificant change in CMRO2 using nitrous oxide washout CBF measurements
combined with oxygenation measurements of blood samples [117]. In another
study, no significant change was found using both pulsed ASL and phase con-
trast flow measurements combined with a venous T2 measurement for blood
oxygenation measurements [124]. However contrary to these findings, CMRO2
measured both during normocapnia and at a single level of hypercapnia (5
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% CO2), using phase contrast flow measurements, combined with a venous
T2 measurement for blood oxygenation measurements, found a reduction in
CMRO2[125]. Furthermore these methods do not account for potential local
variations, such as a sensory response to the hypercapnia. Whether hypercap-
nia alters CMRO2 is an important issue, since either a global change or a local
inhomogeneity in oxygen consumption in response to hypercapnia would lead
to systematic errors in calibrated BOLD experiments [69].
5.3 Applications of hypercapnia in MRI
Hypercapnia has a wide range of applications in combination with MRI. These
span from using the global nature of the hypercapnia BOLD response to test
imaging techniques [126, 127], to using hypercapnia to assess local physiology
[69, 128, 129]. This section provides an overview of these applications.
Small resting fluctuations in ventillation will cause fluctuations in PaCO2 on
the order of ± 1 mmHg [130], resulting in small changes in CBF, blood oxy-
genation and the BOLD signal. Measurements of natural PETCO2 fluctuations
(as a non-invasive indicator of PaCO2) have been correlated with BOLD signal
fluctuations at 3 T to map BOLD CVR without the need to present a respi-
ratory challenge [130]. This demonstrates that resting PaCO2 fluctuations are
of sufficient amplitude to have a significant contribution to the BOLD sig-
nal. Unlike respiratory noise resulting from a global field shift caused by chest
motion [131], PaCO2 related BOLD fluctuations are delayed with respect to
ventillation and are not removed using typical physiological noise correction
techniques, such as RETROICOR [51]. Measurements of respiratory tidal vol-
ume have been shown to account for some of these BOLD fluctuations [132]
and to correlate with measured PETCO2 fluctuations [133]. Therefore, PaCO2
related BOLD fluctuations can be partially corrected for using respiratory tidal
volume measurements, which are more comfortable for the volunteer than end-
tidal gas measurements.
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The BOLD response to hypercapnia has been used to identify the brainstem
respiratory control centres [134]. However, the measurement of these brain cen-
tres which control the neuronal response to hypercapnia is itself confounded
by the global vasodilation due to hypercapnia. In that study [134] the ap-
proach that was used to account for this effect on the BOLD signal was to
measure the BOLD response to resting PETCO2 fluctuations and the BOLD
response to a 2–4 mmHg increase in PETCO2, controlled using the dynamic
end-tidal forcing method. Areas of neuronal activation to the hypercapnic
challenge itself were determined from those voxels which had a statistically
significantly higher %BOLD/mmHg response to hypercapnia than to resting
PETCO2 fluctuations [134]. In an alternative approach, the neuronal response
to paced breathing was mapped using isocapnic hyperventilation [135]. Iso-
capnia was achieved using the method proposed by Banzett et al. [79] (de-
scribed in chapter 3), where freshly supplied gas is supplemented by gas with
the same composition as alveolar gas to prevent the hyperventilation causing
hypocapnia-related vasoconstriction.
The use of BOLD contrast as a measure of neuronal activation is known to be
confounded by spatially heterogeneous vascular properties. An attempt to ac-
count for these vascular properties was proposed by Bandettini andWong [136].
They assumed blood oxygenation changes to be spatially localised to neuronal
activation, whereas the BOLD signal was also dependent on resting blood vol-
ume, which would not correspond to the site of neuronal activity. The BOLD
signal due to hypercapnia was used to map this resting blood volume depen-
dence, providing a good representation of the vascular spatial heterogeneity.
Under this model, dividing the BOLD signal related to neuronal activation by
the hypercapnia BOLD signal would remove the dependence on resting blood
volume, with the remainder being a better representation of blood oxygena-
tion and thus the underlying neuronal activation. Furthermore, it must be
remembered that the hypercapnic BOLD response is actually dependent on
vascular properties other than resting CBV, such as resting CBF and vascular
responsiveness (the capacity of the local vascular tree to react). All of these
properties will contribute to the BOLD signal to conceal the underlying neu-
105
ronal activation. Their effect will therefore be reduced by normalising by the
hypercapnic BOLD signal, providing a better representation of the underlying
neuronal activation, less effected by vascular variability. This normalisation
method has been shown to reduce the differences of field strength and differ-
ences between T ∗2 - and T2-weighted images on activity localisation [137]. There
may however be some systematic bias in this method [138], which has been
attributed to a mismatch between hypercapnic and functional CBF responses.
Another approach to account for the vascular variability of the BOLD signal
uses the isometabolic assumption during mild hypercapnia to calibrate the
BOLD response to neuronal activity. CBF and BOLD responses to neuronal
activation and hypercapnia are separately measured, from which the relative
metabolic change (CMRO2) due to the neuronal activation is calculated. Sev-
eral similar models have been proposed, relating changes in CBF, CBV and
CMRO2 to BOLD signal [69, 128, 129], but the most widely accepted ap-
proach has become known as calibrated BOLD [69]. This involves using the
hypercapnic CBF and BOLD responses to calculate a calibration parameter:
M =
BOLD− 1
1− CBFα−β
, (5.1)
which represents the theoretical maximum BOLD signal increase, where all the
blood becomes fully oxygenated. Here, BOLD and CBF are the responses to
hypercapnia, normalised to normocapnia values, α is the CBV/CBF coupling
relationship power law and β is the power law relationship for the effect of
blood oxygenation on extravascular R∗2. The method and values mentioned
here are discussed in detail in section 2.4.5, however it is worth noting that a
commonly assumed value of β = 1.5 is used in the literature, derived for 1.5
T, whereas this value is expected to be closer to 1 at higher field strengths [31].
Hypercapnia has been used to investigate the effect of modulating CBF on
the shape and size of the BOLD response to visual stimulation in humans
[136, 77, 139, 140, 141, 142, 143, 144]. The effect of hypercapnia on the mag-
nitude of the visual %BOLD response has produced conflicting results. Some
studies measured an attenuation with hypercapnia [136, 142, 143, 144] and
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augmentation with hypocapnia [142], other studies conclude that the visual
BOLD signal is independent of hypercapnia [77, 139]. A complex relationship
has been observed over a large range of PETCO2, with the visual %BOLD re-
sponse increasing with PETCO2 up to a maximum at ∼50 mmHg, then falling
sharply for higher PETCO2 values. In comparison, there is much better agree-
ment as to the effect of modulating PaCO2 on the shape of the visual BOLD
response. The delay and width of the visual BOLD response have both been
shown to increase with increasing PaCO2 [140, 142, 143]. In one study in
anaesthetised monkeys [145], delivery of 6% CO2 totally suppressed the CBF
and CBV responses to visual stimulus and the %BOLD signal decreased signif-
icantly. The authors interpreted this as the vasculature becoming so stressed
by the hypercapnic challenge that the visual BOLD contrast was due only to
increased deoxygenated haemoglobin resulting from the increased CMRO2.
Hypercapnia has been used to assess the vascular contribution of diffusion-
weighted fMRI [66]. Strongly diffusion-weighted fMRI is thought to have a
close correlation with neuronal activity through cell swelling, due to increased
activation leading to a decrease in diffusion coefficient. Therefore the diffusion-
weighted fMRI signal should be insensitive to local vascular changes and so a
purely vascular challenge, such as hypercapnia, is hypothesised to not effect the
diffusion-weighted fMRI signal. Miller et al. [66] challenged this hypothesis by
observing a strong diffusion-weighted fMRI signal increase with hypercapnia,
demonstrating a significant vascular component.
Other examples of the application of hypercapnia include: Hypercapnia pre-
sented with susceptibility-weighted imaging showing that the susceptibility
difference between grey and white matter cannot be explained by their dif-
ferent vascular densities [146]. The plausibility of spinal cord fMRI has been
assessed using hypercapnia [126]. A reduction in cerebrospinal fluid (CSF)
volume has been observed in response to increased CBV, using the global va-
sodilatory nature of hypercapnia [147]. Recently, hypercapnia has been used
to test the effect of changes in blood velocity on pseudocontinuous ASL la-
belling efficiency, to optimise acquisition parameters [127]. Hypercapnia has
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been used as a global BOLD stimulus for a novel approach to venous vessel
size imaging [148]. Finally, two novel respiratory challenges have been pro-
posed; cued deep breathing [89] and sinusoidal CO2 modulation [149], which
are both designed to be sensitive to measuring relative delays in BOLD CVR
to changes in PaCO2. These methods have been proposed to add extra degree
of information (delay as well as magnitude) for CVR mapping studies, which
may be especially of use in studying cerebrovascular disease.
Clinical applications
The main clinical use of hypercapnia in MRI is the assessment of cerebrovascu-
lar disease. Compared with resting CBF measurements, vascular reactivity to
hypercapnia provides an extra degree of information as it assesses the capacity
of the vasculature to dilate. CVR mapping highlights abnormal behaviour in
the vascular bed associated with cerebrovascular disease. Feasibility of this
approach was shown in healthy volunteers where a linear correlation between
PETCO2 and the associated BOLD response in grey matter was shown with
BOLD CVR being homogeneous across grey matter [115]. Reduced CBF CVR
has been shown to correlate with higher scores in a standard vascular risk pro-
file [150], whereas no correlation is found for resting CBF. Mandell et al. [67]
showed that BOLD CVR is correlated to CBF CVR, even in occluded re-
gions. CVR maps can be used to identify ischaemic regions and help to plan
treatment and treatment outcome can also be assessed with hypercapnia CVR
mapping [151].
Negative CVR has been observed in white matter, both using BOLD and
ASL to map CVR under hypercapnia [152]. This has been attributed to a
vascular steal phenomenon, where blood supply to an area is reduced to meet
the demand from another area. The negative CVR regions in young, healthy
volunteers were found to occur in locations vulnerable to white matter disease
in elderly patients. Another study [153] found that negative CVR regions in
patients exhibited an increased white matter diffusion coefficient, consistent
with damage to the white matter. In this case, CVR mapping could provide
an early diagnosis of white matter disease.
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5.4 Cerebrovascular reactivity at 3 and 7 Tesla
5.4.1 Introduction
As discussed in section 2.4.2, the relationship between blood oxygenation and
transverse relaxation rate (R∗2) is complicated, depending on the relative con-
tributions from intravascular and extravascular compartments, and on both
static and diffusing spin dephasing regimes. The BOLD response to hypercap-
nia, which is a tightly controlled stimulus, should provide some insight as to
the dominant transverse relaxation mechanisms. A supralinear power law re-
lationship was assumed between R∗2 and blood oxygenation in a model derived
for 1.5 T [69], but this is unlikely to be appropriate at higher field strengths.
Better characterisation of this power law relationship at 3 T and 7 T would
improve BOLD calibration at these field strengths [69] (see section 2.4.5).
This study used a feed-forward, low gas flow system to target small (3 mmHg),
clearly resolvable steps in PETCO2 to assess the relationship between R
∗
2 and
PETCO2 over a normal physiological range. The R
∗
2 CVR measurement was
assessed at both 3 T and 7 T and was used to explore the relationship between
blood oxygenation, vasodilation and BOLD signal.
This study has been published (Driver et al. [154]). Figures which have been
reproduced from the published paper have been cited as such.
5.4.2 Echo time optimisation
To improve the accuracy of the R∗2 calculation, simulations were performed to
optimise the gradient echo (GE) EPI echo times used. If the GE EPI signal
(S(TE)) is assumed to decay monoexponentially then the natural logarithm of
S has a linear relationship with TE:
logn(S) = logn(S0)− TE ·R
∗
2, (5.2)
where S0 = S(TE=0). TE values that minimised the noise associated with
the R∗2 calculation were found by considering noise propagation through a least
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Figure 5.1: Thermal noise contribution to the simulated signal decay. Error bounds
due to thermal noise are given by the dashed lines. (a) Exponential signal decay with
constant thermal noise over TEs. (b) Natural logarithm of signal varies linearly with
TE, whilst the effect of thermal noise increases with TE. (c) Plot illustrating a cut-off
TE, where the signal drops below the level of thermal noise, causing an underestimation
of R∗2.
squares fit to a straight line [155]. Thermal noise (σ0) will cause an error in
measured S, assumed to be constant with TE (figure 5.1a). If R∗2 is calculated
from a linear fit of logn(S) against TE, then the thermal noise contribution to
the fit error will increase with TE (figure 5.1b). It is then necessary to weight
the noise by the inverse of the signal [156]:
σ(logn(S)) = σ(S)/S = σ0/S (5.3)
This uncertainty can be used to estimate the error propagation into the gra-
dient (R∗2) of the linear fit [155]. Echo times were chosen to minimise this
error. Note that the error is dependent on R∗2, so the optimisation required a
prior estimate of R∗2, chosen as a literature value for GM average T
∗
2 (= 1/R
∗
2)
as 66.0 ms at 3 T and 33.2 ms at 7 T [157]. These values may be slightly
higher than those measured with EPI here, as the method by which they were
calculated included a correction for large-scale field inhomogeneities.
There will also be a low signal limit, where the signal drops below the back-
ground noise level in the modulus images, causing the noise to dominate the
linear fit (figure 5.1c) and R∗2 to be underestimated. This imposes an upper
limit on TE. Hardware constraints also place a lower limit on TE, allowing
time for the spatial encoding gradients (dependent on the gradient set, matrix
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size and number of slices).
To acquire data at multiple echo times, either data can be acquired with one
TE per T ∗2 decay, alternating between TEs across dynamics, or multiple TEs
can be acquired per shot, where there is a minimum echo spacing, approx-
imately equal to the readout duration per echo, to fit the spatial encoding
gradients. In reality, for the case of multiple TEs within a single T ∗2 decay,
for the matrix size (96 × 96) and the imaging gradient sets used only two
echoes could be acquired, as further echoes would exceed the upper limit on
TE mentioned in the previous paragraph. Therefore, this case will be referred
to as a double echo sequence.
Optimum echo times were found by calculating the error (relative to σ0/S0) for
all combinations of two TE values (in spacings of 0.1 ms and range: scanner
defined minimum TE – 100 ms) and finding the minimum error. For the
double echo sequence, the optimum echo times were found to be the shortest
possible TE and an echo time approximately T ∗2 later than the minimum TE.
This is a balance between the largest possible echo spacing and the increased
error associated with a longer TE. At 7 T, the optimum value for the second
echo was shorter than allowed, due to the required minimum echo spacing for
image encoding with the available gradients, so the minimum allowed spacing
(of 37 ms at 7 T) was used (giving the lowest estimated noise possible with
this limit). Note that this method only considers thermal noise and does not
account for physiological noise, which will also depend on TE [109].
5.4.3 Development of paradigm
This section discusses the development of the hypercapnia paradigms used in
this study. All development was performed at 7 T.
Initially, single echo GE EPI data were acquired with 3 mm isotropic voxels
over a 192×192 mm2 field-of-view and 10 axial slices, with no slice gap, in a
1 s TR. The GE EPI echo time alternated between TE = 20.0, 55.6, 55.6 ms,
repeating every three dynamics. Thus, one R∗2 map could be acquired every 3
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Figure 5.2: (a) Grey matter averaged R∗2 timecourse corresponding to (b) the boxcar
PETCO2 paradigm.
s. The combination of one short TE and two long TE repeats was to account
for the lower SNR at the long TE. R∗2 maps were formed by combining each
block of three dynamics using a least squares linear fit, based on equation 5.2.
Echo times were chosen to minimise noise in the R∗2 calculation, as described
in section 5.4.2, using the constraint of a minimum TE = 20 ms. As each TE
was acquired separately, there was no minimum spacing between echo times.
Grey matter R∗2 timecourses were formed (see section 5.4.4 for a complete
method) which showed a periodic oscillation repeating approximately every 6
seconds (figure 5.2), corresponding to the breathing frequency, which is thus
likely to be respiratory noise [131]. The three datasets combined for R∗2 calcu-
lation will each have been acquired at a different stage in the breathing cycle,
so each include a different respiratory noise contribution. Therefore a large
respiratory noise contribution is associated with acquiring an R∗2 map from
three single echo scans with different TEs, acquired over 3 s.
To reduce the respiratory noise contribution, a double echo acquisition was
used, such that the data at the two different TEs are acquired within a single
T ∗2 decay, so are effectively acquired at the same stage in the breathing cycle.
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Figure 5.3: (a) Grey matter averaged R∗2 timecourse corresponding to (b) the pseudo-
randomised graded PETCO2 paradigm.
The double echo dataset was acquired with TEs of 20 and 57 ms in 1.5 s. Also
the in-plane voxel size was reduced to 2 mm, as this finer spatial resolution has
been shown to reduce physiological noise at 7 T [109]. With these adjustments,
the scan acquisition parameters are the same as used for the main study, which
will be fully described in section 5.4.4.
The first hypercapnia paradigm attempted was a simple box-car design. This
type of paradigm is popular, due to its simplicity, and it is used in the majority
of hypercapnia applications in MRI (see section 5.3). The boxcar hypercapnia
paradigm consisted of four repeats of 2 minutes of mild hypercapnia (45 mmHg
PETCO2 targeted) followed by 2 minutes of normoxia (40 mmHg PETCO2
targeted). Grey matter masks were formed (see section 5.4.4 for a complete
method). The grey matter averaged −R∗2 timecourse is shown in figure 5.2a,
and can be seen to closely follow the PETCO2 timecourse (figure 5.2b).
Due to the clearly resolved transitions in both PETCO2 and grey matter aver-
aged R∗2, a new graded respiratory paradigm was devised to provide improved
dynamic range. This consisted of 5 levels of targeted PETCO2, between 37–49
mmHg in 3 mmHg steps, with each level presented in a pseudo-randomised or-
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der. The paradigm comprised two minutes at each level, followed by 1 minute
at normocapnia (40 mmHg PETCO2 targeted). This respiratory paradigm is
the same as used for the main study, which will be fully described in section
5.4.4.
The grey matter averaged −R∗2 timecourse for the pseudo-randomised graded
paradigm is shown in figure 5.3a, which can be seen to closely follow the
PETCO2 timecourse (figure 5.3b). The analysis to generate these timecourses
will be detailed in section 5.4.4.
This section has described the paradigm development for this study. A double
echo acquisition, with both echoes acquired in a single T ∗2 decay, was preferred
to multiple single-echo acquisitions over several seconds, each at a different TE,
due to physiological noise across the respiratory cycle causing large oscillations
in the calculated R∗2 timecourse. The resolved transitions in both PETCO2
and grey matter averaged R∗2 meant that instead of a simple boxcar design, a
graded PETCO2 paradigm provided an increased dynamic range of PETCO2
transitions, suitable for studying the form of relationship between PETCO2
and R∗2.
5.4.4 Method
Five healthy male subjects, mean age of 25 years (range 23-29 years), took
part in the study. Approval for the study was obtained from the University of
Nottingham Medical School Ethics Committee and all subjects gave written
informed consent.
The hypercapnia challenge is described in section 3.3. PETCO2 was targeted
at 40 mmHg (baseline) for an initial 3 minutes, followed by five repeats of 2
minutes of a target PETCO2 level, followed by one minute of baseline. The
targeted PETCO2 level differed in every repeat in a pseudo-randomised order
of 49, 43, 37, 40, 46 mmHg. The pseudo-randomised order is used instead of
a sequential increase or decrease in PETCO2 level, as a sequential design is
susceptible to bias from low order signal drift, which could be reflected in the
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R∗2 timecourse and as a systematic error in CVR measurements. PETO2 was
targeted at 100 mmHg throughout. When not performing the challenge, the
participant returned to spontaneous ventilation of medical air (21 % O2, 79 %
N2).
Scanning was performed on a Philips Achieva 3 T system, with a whole body
volume transmit and 8 channel SENSE head receive coil, and a Philips Achieva
7 T system, with head volume transmit and 16 channel SENSE head receive
coil. Axial images were acquired every 1.5 s throughout the hypercapnia chal-
lenge (800 dynamics) using a double-echo, single shot GE EPI sequence. Imag-
ing parameters of SENSE factor=2, TE=16/81 ms with 30 ms readout per echo
at 3 T, TE=20/57 ms with 37 ms readout per echo at 7 T were used. The
longer readout per echo at 7 T was due to lower maximum gradient amplitude
and slew rate (30 mTm−1 and 100 mTm−1ms−1) compared to 3 T (40 mTm−1
and 200 mTm−1ms−1). Echo times were optimised for R∗2 measurement rather
than BOLD contrast (see section 5.4.2). Images consisted of 2×2×3 mm3 vox-
els, with a 192×192 mm field of view, over 9 slices at 3 T and 10 slices at 7 T,
and no slice gap. Figure 5.4 shows the typical slice coverage at both 7 T and
3 T.
After the hypercapnia challenge, inversion-recovery (IR)-EPI datasets were
acquired for tissue segmentation. This had the same geometry as the double-
echo sequence, with grey matter (GM), white matter (WM) and CSF nulled
(TI=600/900/1900ms at 3 T and TI=600/1100/2200 ms at 7 T). The im-
age bandwidth was kept the same as for the double-echo sequence, to match
EPI distortions. For vein segmentation, a high-resolution (0.8 mm isotropic)
T ∗2 -weighted fast field echo (FFE) FLASH (TR/TE=50/20 ms, EPI factor=3,
bandwidth=167 Hz) image which minimises geometric distortions was also ac-
quired at 7 T.
The double-echo data were motion corrected using MCFLIRT (FSL, fMRIB,
Oxford, UK) by realigning the shorter TE images (20 ms) to the first dy-
namic, then applying the registrations to both sets of images. The higher
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Figure 5.4: Screenshots from the 3 T and 7 T scanners, showing the survey image and
typical (subject 5) slice coverage. The loss of signal below the brain at 7 T is due to a
more restricted spatial sensitivity of the receive coil array at 7 T compared with 3 T.
The susceptibility effects of adjacent airspaces can also be seen at 7 T, at the interface
between the brain and frontal sinus.
SNR of the shorter TE images helped with the accuracy of the motion correc-
tion algorithm. R∗2 was calculated on a voxel-by-voxel basis for each timepoint
by combining the signal (S) at both echo times, assuming a monoexponential
decay, using the following equation:
R∗2 =
lognS(TE1)− lognS(TE2)
TE2 − TE1
(5.4)
The IR-EPI datasets were segmented, using BET (FSL) on the CSF-nulled im-
ages to remove non-brain voxels, then the FAST algorithm (FSL) was applied
to generate a GM mask and GM, WM and CSF partial voume estimates. The
WM mask only included voxels that were estimated to be at least 99% WM,
to avoid significant partial-voluming from GM reactivity. The close correla-
tion between PETCO2 and R
∗
2 meant that timepoint-by-timepoint comparison
could be made to assess CVR, rather than averaging over steady state periods
for each level. The PETCO2 trace was linearly interpolated (MATLAB, The
MathWorks, Natick, USA) to match the sampling frequency of the double-
echo data, then manually shifted to temporally align the PETCO2 timecourse
with the R∗2 timecourse averaged over all GM voxels. The estimated error of
116
this alignment is one interpolated timepoint. This allowed the actual level of
PETCO2 and R
∗
2 to be compared on a point-by-point basis across a range of
PETCO2 levels (rather than simply comparing the signal change at prescribed
PETCO2 levels). Linear regressions were performed to calculate average GM
and WM R∗2 CVR to PETCO2, defining R
∗
2 CVR as the absolute change in R
∗
2
(measured by the gradient of the linear regression) for a 1 mmHg change in
PETCO2. The fit uncertainties were used to assess the error in R
∗
2 CVR.
In order to consider the R∗2 CVR of tissue alone, excluding large vessels, the
FLASH T ∗2 -weighted image acquired at 7 T was used to identify veins, at 7
T veins have a shorter T ∗2 than tissue (∼ 5 ms [105] compared with 28 ms
[106]) and so lower signal intensity than the surrounding tissue (figure 5.5a).
Initially, regions outside of the brain were removed from the images using BET
(FSL). The image was inverted, so that voxels dominated by veins had a high
intensity and a third-order polynomial filter was applied to remove large-scale
inhomogeneities (figure 5.5b). Nearest-neighbour smoothing was performed
and the smoothed image was then subtracted from the unsmoothed image to
locate voxels with a significant venous fraction [103] (figure 5.5c). Intensity
thresholding was performed to produce a binary mask of voxels dominated by
veins and cluster analysis was performed to remove any isolated voxels (figure
5.5d). The FLASH image was resized to 2×2×3 mm3 and co-registered to
both the 7 T and the 3 T double-echo datasets and these transformations were
then applied to the resized binary mask. This mask was applied to the R∗2
timeseries to remove these voxels before averaging, thus allowing a comparison
of GM and WM R∗2 CVR with and without the inclusion of large vessels.
Voxelwise maps of CVR were formed to confirm the global nature of the BOLD
response to hypercapnia and to demonstrate the contrast in CVR between GM
and WM. To do this, the linear fitting technique was performed on a voxel-by-
voxel basis, rather than over an averaged timecourse. However, it was found
that the R∗2 data was too noisy to calculate reasonable R
∗
2 CVR maps. Instead,
the double echo data were combined using a weighted summation of data ac-
quired at each echo time [16], to improve the BOLD contrast of the data, since
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Figure 5.5: Vein segmentation method. (a) Original T ∗2 -weighted image, where veins
appear dark. (b) Inverted and third-order polynomial filtered image. (c) Difference
image (minus nearest-neighbour smoothed image), highlighting veins. (d) Binary vein
mask, generated using thresholding and cluster analysis. Note the ring around the edge
of the brain is due to an imperfect brain mask and should not be mistaken for veins.
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Figure 5.6: Corresponding timecourses for (a) GM averaged −R∗2 (veins excluded), (b)
PETCO2 and (c) PETO2 for Subject 5 at 7 T. −R
∗
2 is plotted to show the tight linear
correlation between PETCO2 and −R
∗
2. The dotted vertical line indicates the end of the
initial baseline period. The dashed trace shows targeted PETCO2 levels. This figure is
reproduced from [154].
the echo times used were not optimal for BOLD contrast (as shown in section
2.4.3). The weighting was based on a T ∗2 map calculated from the average
baseline (PETCO2 = 40 mmHg) signal at both echo times. For every voxel
the weighted summation signal was calculated over every timepoint, then the
voxel’s timecourse was normalised to the voxel’s weighted summation average
baseline signal. For each voxel, a linear fit was performed between the voxel’s
normalised weighted summation timecourse and PETCO2. The gradient of the
linear fit gave a value for weighted summation % BOLD CVR.
5.4.5 Results
Similar changes in PETCO2 level were achieved across all subjects. Figure 5.6
shows a representative subject at 7 T, whilst figure 5.7 shows all subjects at
both 7 and 3 T. Across all subjects, the step sizes were consistently a third
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Figure 5.7: All five subject’s timecourses at 7 T (a,b) and 3 T (c,d) for GM averaged
−R∗2 (a,c) and PETCO2 (b,d).
less than targeted. Despite this, clearly resolvable PETCO2 transitions were
achieved (figure 5.7(b & d)) whose level was well maintained over the 2 min
period. The PETO2 levels reached a steady state within the initial 3 min base-
line period (figure 5.6c) and then had a maximum range of 5 mmHg (across
all subjects and all PETCO2 challenges).
The R∗2 timecourses closely followed the PETCO2 timecourse at both field
strengths (figure 5.6a and figure 5.7(a & c)). Table 5.1 shows individual GM
R∗2 reactivities both including and excluding voxels dominated by veins. Fig-
ure 5.8(a & b) plots the GM averaged R∗2 reactivity against PETCO2 at 7 and
3 T including data for each of the five subjects, also showing the linear fits.
Average GM R∗2 reactivities agreed well between subjects (figure 5.8). Includ-
ing voxels dominated by veins, GM R∗2 CVR was 2.0 ± 0.4 times higher at 7
T than at 3 T (averaged over all subjects): GM R∗2 CVR was 0.074 ± 0.007
s−1 mmHg−1 at 3 T and 0.145± 0.020 s−1 mmHg−1 at 7 T. Excluding voxels
dominated by veins GM R∗2 reactivity was 2.1±0.5 times higher at 7 T than at
3 T (averaged over all subjects): GM R∗2 CVR was 0.066± 0.004 s
−1 mmHg−1
at 3 T and 0.141± 0.008 s−1 mmHg−1 at 7 T. There was a significant increase
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GM average including
venous voxels
R∗2 CVR (s
−1 mmHg−1)
7 T 3 T 7 T/3 T
Subject 1 −0.173± 0.005 −0.067± 0.004 2.6
Subject 2 −0.146± 0.009 −0.086± 0.005 1.7
Subject 3 −0.163± 0.008 −0.072± 0.004 2.3
Subject 4 −0.133± 0.010 −0.075± 0.002 1.8
Subject 5 −0.109± 0.006 −0.073± 0.005 1.5
Mean (across subjects)
± standard deviation
−0.145± 0.025 −0.074± 0.007 2.0± 0.4
GM average with
venous voxels excluded
R∗2 CVR (s
−1 mmHg−1)
7 T 3 T 7 T/3 T
Subject 1 −0.168± 0.005 −0.058± 0.004 2.9
Subject 2 −0.134± 0.009 −0.081± 0.005 1.7
Subject 3 −0.163± 0.008 −0.070± 0.004 2.4
Subject 4 −0.128± 0.009 −0.065± 0.002 2.0
Subject 5 −0.109± 0.006 −0.060± 0.005 1.8
Mean (across subjects)
± standard deviation
0.141± 0.025 −0.066± 0.009 2.1± 0.5
Table 5.1: Grey matter R∗2 CVR for all subjects, calculated using a linear regression.
in the GM R∗2 CVR 7 T/3 T ratio between the case when vessels were included
and when they were excluded (P=0.06, Wilcoxon paired). Contrast-to-noise
ratio (CNR) was calculated for GM R∗2 CVR as 0.88 mmHg
−1 at 7 T and 0.98
mmHg−1 at 3 T. This was calculated by dividing the GM R∗2 CVR by the
variance (GM R∗2 standard deviation) of the 40 mmHg PETCO2 step, averaged
over all subjects.
The paradigm provided sufficient sensitivity to detect an average WM R∗2 CVR
(table 5.2) of 0.021±0.003 s−1 mmHg−1 at 3 T and 0.040±0.007 s−1 mmHg−1
at 7 T with veins removed. 7 T WM R∗2 CVR is 1.6± 0.5 times higher than at
3 T, although interpretation of this ratio should be limited, due to the smaller
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WM average with
venous voxels excluded
R∗2 CVR (s
−1 mmHg−1)
7 T 3 T 7 T/3 T
Subject 1 −0.035± 0.006 −0.001± 0.002 31.7*
Subject 2 −0.031± 0.011 −0.020± 0.002 1.6
Subject 3 −0.061± 0.009 −0.028± 0.004 2.2
Subject 4 −0.050± 0.005 −0.036± 0.003 1.4
Subject 5 −0.022± 0.004 −0.020± 0.002 1.1
Mean (across subjects)
± standard deviation
−0.040± 0.015 −0.021± 0.013 1.6± 0.5*
Table 5.2: White matter R∗2 CVR for all subjects, calculated using a linear regression.
* The 7 T/3 T ratio for Subject 1 is treated as an outlier and has been ignored in the
cross-subject mean calculation.
WM contrast to noise ratio compared with GM. Figure 5.8(c & d) plot the
WM averaged R∗2 reactivity at 7 and 3 T for each of the five subjects.
Example CVR maps from the graded hypercapnia paradigm are shown in fig-
ure 5.9 for the same subject, acquired both at 3 T and 7 T. The CVR maps
showed good grey matter contrast and clear distinction between grey and white
matter.
5.4.6 Discussion
This study has combined a versatile and accurate method for controlling and
measuring PETCO2 and PETO2 with a quantitative R
∗
2 measurement to pro-
vide a new time point-by-time point approach to monitoring CVR using MRI.
Small, readily tolerable steps in PETCO2 over a naturally occurring range of
PETCO2 (37-49 mmHg) were used. The rapid sampling of the PETCO2 and R
∗
2
allowed point-by-point temporal analysis which improved sensitivity in CVR,
allowing measurement of GM reactivity and detection of significant WM reac-
tivity, at both 3 and 7 T.
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Figure 5.8: GM averaged R∗2 reactivity at (a) 7 T and (b) 3 T and WM averaged
reactivity at (c) 7 T and (d) 3 T for all subjects (veins excluded). Averaged R∗2 reactivity
is shown by the scatter plots and linear fits are shown as lines. Each subject is plotted
in a different colour. This figure is reproduced from [154].
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Figure 5.9: (a) 3 T and (b) 7 T weighted summation % BOLD CVR maps, calculated
using a voxelwise linear fit to the PETCO2 trace.
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The technique to control blood gases used in this study allowed independent
control of PETCO2 and PETO2, to provide transitions to and between sta-
ble PETCO2 levels, clearly resolvable in 3 mmHg steps, whilst maintaining
PETO2 at a constant level. PETCO2 transitions were achieved within one or
two breaths. Although good control over PETO2 allowed independent assess-
ment of reactivity to changes in PETCO2 [158], the small changes in PETO2
associated with a fixed inspired CO2 challenge (of the order of ∼20 mmHg) are
unlikely to have had a significant effect on venous blood oxygenation, BOLD
signal and R∗2 (see section 6.4). The main advantage over a fixed inspired CO2
challenge is the reproducibility of ∆PETCO2 across subjects [93], which for
fixed inspired CO2 challenges will depend on the subject’s ventilation and on
their metabolism. Measured ∆PETCO2 transitions were approximately a third
less than the targeted values. This was due to the version of the RespiractTM
software model at the time. CVR calculated using targeted values would there-
fore have been underestimated, showing the importance of measuring PETCO2.
This study measured the change in R∗2, rather than % BOLD signal change (ex-
cept for calculating voxelwise CVR maps). The R∗2 measurement, from a dou-
ble echo acquisition was based on the assumption that the voxel’s transverse
relaxation is monoexponential. This would not be true if there were signifi-
cant contributions from different compartments, with different spin dephasing
mechanisms (for example intravascular and extravascular compartments, or a
mixture of static and diffusive regimes of spin dephasing [28]). Advantages
of measuring R∗2 as opposed to % BOLD are that it should be less sensitive
to inflow effects, as it is independent of initial magnetisation (at TE = 0 ms)
and R∗2 is applicable to models relating the effects of blood oxygenation on GE
signal [30]. There was a low frequency temporal drift seen in some of the GM
R∗2 timecourses. The pseudo-randomised paradigm was designed to minimise
bias in CVR measurement from this drift, by not having a systematic increase,
or decrease in PETCO2 which could be falsely matched to the drift. However,
a simple temporal filter could be used to remove this drift, so long as care is
taken to avoid filtering out some of the changes in R∗2 related to ∆PETCO2,
which changes with a low temporal frequency compared with a typical fMRI
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experiment.
Previously, T ∗2 (not R
∗
2) CVR has been measured using a multi-echo acqui-
sition [141], with a non-linear relationship observed over large (10 mmHg)
PETCO2 steps. PETO2 was not controlled and the high gas flow rates used
to achieve high (70 mmHg) and low (20 mmHg) PETCO2 target levels would
have induced hyperventilation, leading to increased PETO2 (not monitored),
arterial oxygenation and a further increase in T ∗2 , which may have accounted
for some of the non-linearity. However, a rough conversion of their results from
T ∗2 to R
∗
2(= 1/T
∗
2 ) shows an approximately linear relationship between R
∗
2 and
PETCO2 from 40-60 mmHg.
This study used high spatial resolution compared to previous CVR studies,
and so will have reduced partial volume effects between GM and WM. In this
study, R∗2 CVR was found to increase with field strength, which is consistent
with a previous cross-field BOLD CVR study [137]. Removing voxels with
large venous components reduced the R∗2 CVR at both field strengths, consis-
tent with the intravascular/perivascular signal dominating the BOLD signal
change. As expected this reduction in reactivity was larger at 3 T than 7 T,
since the R∗2 of blood is much greater at 7 T, so the direct signal contribution
from blood is reduced.
Results also suggest that the power law relating the change in R∗2 to frequency
shift (due to change in relative intravascular susceptibility or field strength)
(7 T:3 T R∗2 ratio of 2.1 ± 0.5) is close to linear (7/3 = 2.3) between 3 and 7
T, and by excluding voxels dominated by veins the 7 T:3 T R∗2 reactivity ra-
tio was increased. Yablonskiy and Haacke [30] predicted a linear relationship
for extravascular spin dephasing. A linear relationship between R∗2 and fre-
quency offset is expected in the static dephasing regime, whereas supralinear
relationships are associated with intermediate and fast dephasing regimes [31].
The effect of diffusion on transverse relaxation around a vein will depend on
vessel size and frequency offset due to the vein as well as echo time. For the
echo times used here, as the frequency offset increases, the vessel size at which
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the static dephasing limit dominates decreases [28]. Monte Carlo simulations
predict supralinear behaviour at 1.5 T [27, 69], with 3 T being the boundary
between linear and supralinear behaviour [31]. It should be noted that the
BOLD calibration method [69] was first developed at 1.5 T and so the power
law relationship proposed in that work between intravascular oxygenation and
R∗2 of 1.5 may not be appropriate at higher fields.
For WM, the power law does seem to be < 1 (7 T:3 T R∗2 ratio of 1.6± 0.5).
WM has a different vascular structure with much smaller blood volume than
GM, and also restricted extravascular water diffusion (due to myelination of
the axons). This might alter the relationship between intravascular suscep-
tibility, the microscopic field distribution in the tissue and the resulting R∗2.
This requires further investigation since WM reactivity data must be inter-
preted with caution due to the reduced SNR of this data.
In this study, the gas sampling data could not be electronically time locked
to the scanner acquisition due to hardware limitations, so the respiratory se-
quence was manually synchronised with the imaging sequence (∼ ±1.5 s).
There was also a delay between gas delivery and sampling of about 5 s caused
by the transit time between the mask and the gas sensors. The data signals
therefore had to be aligned manually during processing, so it was not possible
to estimate the absolute delay between the PETCO2 change and associated
CVR. This could potentially add noise to the R∗2 CVR curves but this effect
will not be significant since the PETCO2 data were resampled from ∼ 6 s sam-
pling interval to 1.5 s sampling interval. Any error due to manually aligning
the timecourses is small compared with the 120 s at each gas level. It is inter-
esting to note that there was a close correlation between PETCO2 stimulus and
the associated BOLD response on both the up and down transitions, with no
sign of a post-stimulus undershoot, suggesting that the post-stimulus under-
shoot often observed in the BOLD signal evoked by neuronal activation is not
vascular in origin [159], although further experiments are required to confirm
this conclusion.
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Hardware limitations meant that the optimal (short) echo times required at
7 T could not be reached. Therefore, although better contrast was achieved
at 7 T, similar contrast-to-noise was observed at both field strengths in GM
due to the non-optimal TE and increased physiological noise at 7 T. This was
shown by increased R∗2 variance at 7 T over 3 T (p<0.003), which agrees with
the findings of Triantafyllou et al. [109]. Respiratory noise was particularly
pronounced because of pacing of the respiratory cycle and because the subjects
increased their depth of breathing during the respiratory challenge. This can
be seen in figure 5.6a, where there is a ∼6 s oscillation throughout the BOLD
timecourses.
In summary, this study has demonstrated measurement of the R∗2 CVR rela-
tionship to PETCO2. The method for gas delivery allowed small, well resolved
transitions in PETCO2 to map out an approximately linear relationship be-
tween R∗2 and PETCO2. Significant grey and white matter CVR was measured.
The cross-field comparison of grey matter R∗2 CVR suggests an approximately
linear relationship between grey matter R∗2 and the blood-tissue susceptibility
difference, which is proportional to both venous blood oxygenation and field
strength.
5.5 Assessing vascular asymmetry in the pri-
mary motor cortex
5.5.1 Introduction
The main objective of fMRI is to identify and ideally quantify the neuronal re-
sponse to a particular task. However the BOLD signal results from a complex
interaction between cellular oxygen metabolism (which is tightly coupled to
neuronal activity [21, 22]) and local vascular structure. Although the vascular
response is partially coupled to oxygen metabolism (and neuronal activity), it
is also strongly dependent on local vascular state, which will confound con-
clusions about the underlying neuronal activity from the measured BOLD sig-
nal. The vascular contribution to the BOLD response (namely CBF and CBV
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components) will depend on the relative contributions from arteries, arterioles,
capillaries, venules and veins [73], the presence of a large draining vein [3], or
on the resting CBF [141, 140, 142]. An important goal of fMRI is to disentan-
gle the metabolic component from the vascular component of the BOLD signal.
BOLD fMRI has been used to investigate the functional lateralisation of hand-
edness [160, 161, 162, 163, 164]. Studies of right-handed individuals have shown
stronger BOLD signal responses to neural activity (hand motor task) in the
dominant motor cortex compared to the non-dominant one [161, 164], sug-
gesting a greater CBF response to neuronal activation in the dominant motor
cortex. However, it is unclear as to whether this stronger BOLD response has
a neuronal origin, or whether it is, at least in part, due to an asymmetry in
vascular structure between dominant and non-dominant motor cortices.
For this work a novel CO2 challenge was used that was developed in Notting-
ham [149], making use of the breath-by-breath PETCO2 targeting, afforded
by the feed-forward, low gas flow system, to generate a sinusoidal PETCO2
waveform. In this section, such a sinusoidally varying PETCO2 respiratory
challenge is used to map % BOLD CVR in the dominant and non-dominant
motor cortices of right handed individuals. The aim of this experiment was to
assess whether a CVR mismatch is present between the right and left motor
cortex, two brain regions frequently associated with a regional mismatch in
BOLD response to hand motion.
5.5.2 Method
Eight healthy right-handed male volunteers (aged 26 ± 5 years, range 20 – 34
years) participated in this study. Approval for the study was obtained from
the University of Nottingham Medical School Ethics Committee and all par-
ticipants gave written informed consent. A laterality questionnaire [165] was
completed by the participants prior to the MR measurements.
This experiment involved subjects completing both a motor task and a res-
piratory challenge. First, subjects were instructed to perform a unilateral
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sequential finger tapping task, alternating between right hand and left hand
motion, with four repeats of (12 s Right, 19.2 s rest, 12 s Left, 19.2 s rest).
This task was visually cued with the words ‘TAP RIGHT’, ‘TAP LEFT’ and
‘REST’, shown in white on a black background, projected onto a screen at the
end of the magnet bore (which the subject viewed through prism glasses). The
subsequent respiratory challenge consisted of 10 cycles of sinusoidally modu-
lated PETCO2, targeted between 35 and 45 mmHg, with a period of 60 s per
cycle. This used the feed-forward low gas flow method to target levels on a
breath-by-breath basis. PETO2 was targeted at 110 mmHg throughout. De-
tails of the respiratory challenge are described in section 3.3.
Scanning was performed on a Philips Achieva 7 T system, with head volume-
transmit and 16-channel SENSE head receive-coil. Axial GE EPI data were
acquired every 2.4 s throughout the motor task and respiratory challenge. Im-
ages were acquired with a spatial resolution of 2×2×3 mm3, with a 192×192
mm2 field-of-view and either 15 or 21 slices, with no slice gap, covering the
motor cortex. Data was collected with a single-echo acquisition of TE = 25
ms using SENSE factor = 2. A whole-head MPRAGE image was acquired at
0.5×0.5×1 mm3 resolution.
The motor task dataset was motion corrected using MCFLIRT (FSL) and
smoothed with a 3 mm FWHM Gaussian kernel. Z-statistic maps were formed
for each of the right and left hand motion using FEAT (FSL).
The respiratory challenge dataset was motion corrected using MCFLIRT (FSL)
and smoothed with a 3 mm FWHM Gaussian kernel. The timecourse of each
voxel was normalised to its mean value and multiplied by 100 to give the
voxel’s %BOLD timecourse, linear de-trending was performed to remove any
linear MR signal drift. The PETCO2 timecourse was linearly interpolated to
the same temporal frequency as the MR data (2.4s). Figure 5.10 shows an
individual subject’s PETCO2 timecourse, the corresponding %BOLD signal
timecourse (averaged over voxels determined to have CVR > 0.5 %/mmHg)
and the fast Fourier transform (FFT) of these signals. To isolate the sinu-
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Figure 5.10: (a) CVR BOLD signal change during the sinusoidal CO2 challenge (single
subject, averaged over voxels with CVR > 0.5 %/mmHg), (c) corresponding PETCO2
trace and their respective Fourier magnitude spectra(b) and (d).
soidally varying component of the signals, FFTs were calculated for both the
interpolated PETCO2 timecourse and each voxel’s %BOLD timecourse. The
frequency component of the FFT of the PETCO2 trace which had the greatest
magnitude was determined (∼1/60 Hz for all participants, figure 5.10d) and
the voxel’s CVR was calculated from the magnitude of the FFT of the %BOLD
signal (figure 5.10b) at that frequency divided by the magnitude of the FFT
of the PETCO2 signal (figure 5.10d) at that frequency.
Two regions of interest (ROI) were selected in each hemisphere to assess the
laterality in CVR (figure 5.11). These were taken from each individual’s
MPRAGE image, after this image was realigned and downsampled (FLIRT,
FSL) to the same space as the EPI data. The first ROI was the precentral
gyrus, manually drawn on the MPRAGE image (in EPI data space) and iden-
tified as the gyrus located between the central and precentral sulcus. The
second was the whole hemisphere, segmented simply by dividing the brain
along the inter-hemispheric fissure and then applying a standard brain mask
(BET, FSL). The whole-hemisphere region was analysed to check for any global
left-right differences in CVR not limited to the motor cortex. The investiga-
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Figure 5.11: Example of (a) precentral gyrus ROIs with dominant M1 (left) shown in
blue and non-dominant M1 (right) shown in red and (b) left (blue) and right (red)
whole hemisphere ROIs.
tor was blind to the orientation convention (radiological or neurological) when
drawing the regions. The motor task Z-statistic maps were used to manually
select the 7 slices for each subject which covered the hand motor region. Only
these 7 slices were used in the following analysis.
The motor BOLD response laterality was assessed within the 7 slices contain-
ing the precentral gyrus region, to assess whether the data showed similar
behaviour as to those in other right-handed studies [162, 163]. The ipsilateral
extent fraction (I ) [162] was calculated for each subject, for both the right and
left hand tasks separately:
I(task) =
ipsilateral extent
ipsilateral extent + contralateral extent
. (5.5)
The activation extent was measured by counting the number of voxels within
the region which had a Z-statistic > 5 for that task. The ipsilateral region
for the right hand task would be the right hemisphere 7 slice precentral gyrus
region, whilst the left hemisphere is the ipsilateral cortex for the left hand
task. The value of I indicated the laterality of the BOLD response to the
corresponding motor task. This can range between a completely contralateral
response (I = 0) to a completely ipsilateral response (I = 1), with I = 0.5
indicating a bilateral response.
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For each subject, the average CVR was calculated for each region by averag-
ing over each voxel’s CVR value within the region. This meant that for each
subject, four average CVR values were calculated, for the left and right hemi-
sphere precentral gyrus ROIs and the left and right whole hemisphere ROIs.
To assess the spatial distribution of precentral gyrus CVR, group averaged
CVR contour maps (figure 5.15a) were generated by registering each subject’s
MPRAGE to the MNI152 standard space 2mm-isotropic atlas image (FSL),
using a non-linear registration (FNIRT, FSL). This registration was used to
realign the subject’s CVRmap into the standard space. In this space, voxelwise
averaging of CVR values was performed across all subjects to form an average
CVR map, from which the CVR contour plot could be constructed.
5.5.3 Results
The laterality score (24± 5, mean ± standard deviation; range of sample: 18
to 31; range of test: 18 = right-handed to 90 = left-handed) confirmed that all
participants were strongly right-handed. The manually drawn precentral gyrus
ROIs showed no significant difference in size between left and right hemispheres
(P=0.96, 2-tailed paired t-test, mean # voxels for left hemisphere = 968 ±
189, mean # voxels for right hemisphere = 965 ± 114) The ipsilateral extent
fraction (I ) for right hand motion (I(R) = 0.12± 0.12) was significantly lower
(P=0.005, 1-tailed paired t-test) than for left hand motion (I(L) = 0.20±0.14).
Individual subject values are shown in figure 5.12. For two of the subjects, no
voxels passed the threshold in either hemisphere, so their values are displayed
as zero. If these subjects are discarded, I(R) = 0.16± 0.11 is still significantly
less (P<0.002) than I(L) = 0.27± 0.08.
The PETCO2 timecourses from all subjects showed clearly resolvable sinusoidal
components, with peak-to-peak amplitudes of 5.2 ± 0.4 mmHg. An example
CVR map is shown in figure 5.13, in this case without spatial smoothing to
clearly demonstrate the shape of the grey matter sulci. A statistically signifi-
cant (P<0.03, 1-tailed paired t-test) asymmetry in CVR was observed in the
precentral gyrus (figure 5.14a), with the left hemisphere CVR = 0.45 ± 0.11
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Figure 5.12: Comparison of individual subject values of I between right and left hand
motor tasks. Higher values indicate a more bilateral BOLD response. Note that for
two subjects no voxels passed the Z > 5 threshold, so they have I = 0 in this plot.







Figure 5.13: Sinusoidal hypercapnia % BOLD CVR map, calculated using the Fourier
analysis method on unsmoothed data.
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%/mmHg being higher than right hemisphere CVR = 0.37±0.06 %/mmHg. No
significant (P=0.25) asymmetry was observed in the CVR averaged across the
whole hemisphere (figure 5.14b), with global left hemisphere CVR = 0.48±0.11
%/mmHg and right hemisphere CVR = 0.49± 0.14 %/mmHg.
The origin of the CVR asymmetry in the precentral gyrus appears to be due to
both a general elevation of CVR values and an increase in maximal CVR values.
This is demonstrated in the histogram of CVR for all voxels in the precentral
gyrus ROI for all subjects (figure 5.14c), which shows both a decrease in the
number of voxels with low CVR and an increase in the maximum CVR in
the region in the left hemisphere. The histograms for each individual subject
(figure 5.14d) all show this similar feature. This is also demonstrated on figure
5.15, which shows the average spatial distribution of CVR across the precentral
gyri for the group and for an individual, representative subject.
5.5.4 Discussion
This study has combined the advantages of precise measurement of PETCO2
and a novel, vasoactive sinusoidal respiratory challenge with the increased
SNR and BOLD CNR available at 7 T for CVR mapping. CVR in the left
(dominant) precentral gyrus was found to be significantly higher than in the
right (non-dominant) precentral gyrus in right-handed men, the first reported
evidence for a difference in vascular responsiveness between two homologous
brain regions. These results appear to reflect a greater vascular compliance in
the dominant (compared with non-dominant) motor cortex.
The haemodynamic origins of the BOLD signal means that it depends not only
on the extent and amplitude of functional activation, but also on the structure
and compliance of the local vasculature. The asymmetry observed here shows
an example of two brain regions (left and right precentral gyri) with different
vascular properties. Studies using fMRI that compare the neuronal activation
of these regions [160, 161, 162, 163, 164] should account for the differences
in underlying vascular properties (as observed here for reactivity) before us-
ing the BOLD response to assess any inter-region differences or similarities
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Figure 5.14: Individual subject hemisphere-averaged CVR for (a) precentral gyrus and
(b) whole hemisphere regions. Mean ± standard deviation CVR across subjects and
1-tailed paired t-test results shown on the respective plot. (c) Histogram of CVR for
all precentral gyrus voxels in all subjects. (d) Individual histograms of CVR for all
precentral gyrus voxels in that subject (symbols correspond to individual labels used in
(a) and (b)). Black bars show the right hemisphere, white bars show the left hemisphere.
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Figure 5.15: CVR contour maps of the precentral gyrus, demonstrating the spatial
variation of CVR. Colours indicate CVR values: blue < 1/3 ≤ green < 2/3 ≤ yellow
< 1 ≤ red %/mmHg. (a) Average CVR over all subjects, after non-linear registration
into MNI152 space. (b) Single subject CVR (• in figure 5.14).
in the size or extent of neural activation. The motor task results presented
here are in agreement with other studies of BOLD laterality of right handed
subjects [162, 163], where a more bilateral BOLD response is observed from a
left (compared with right) hand motor task. However, in the context of the
left precentral gyrus having a higher CVR than right precentral gyrus, it is
possible that at least part of this difference in BOLD laterality between tasks
could be due to differences in the vascular response, rather than an actual
difference in the neuronal response.
The use of Fourier analysis to analyse the BOLD response to a sinusoidally
varying PETCO2 stimulus provided a method of reducing the effect of physio-
logical noise signals in the CVR maps (provided that these would not alias into
the frequency selected for analysis). For example, respiratory noise, caused
by chest motion during the breathing cycle, can be clearly seen in the EPI
timecourse magnitude spectrum (figure 5.10b), at the frequency of 0.17 Hz.
Furthermore this analysis approach requires no assumption as to the shape of
the haemodynamic response function.
This sinusoidal paradigm and Fourier analysis technique can be superficially
compared to the graded hypercapnia paradigm and linear regression analysis
technique used in section 5.4, since one subject happened to participate in
136
both studies (figures 5.9 and 5.13). Note however that the scan parameters for
both studies were different, such that a weighted summation combination of a
double echo dataset was used for the graded hypercapnia paradigm, whereas
a single echo dataset was acquired for the sinusoidal paradigm. The sinu-
soidal paradigm possibly has more finely resolved grey matter structure and
less artefacts. This may reflect that the Fourier analysis approach requires
no assumption as to the shape of the haemodynamic response function and is
less sensitive to the effects of physiological noise. However, the approach used
for the sinusoidal paradigm appears to have slightly less distinction between
grey and white matter. This could be due to the sinusoidal analysis method
calculating the magnitude response, independent of the sign, or the delay of
the response, whereas the graded hypercapnia analysis does not account for
delayed WM response. The sinusoidal approach has been used to estimate
relative delays in CVR [149], showing white matter to have a delayed CVR
compared with grey matter, which may partially explain this.
Due to inter-subject variability in the shape and size of the precentral gyrus,
the precentral regions were manually drawn for each subject, rather than us-
ing a standard space template. Once realigned into the individual subject’s
space, it was found that the standard space templates did not follow the sulci
closely, so the manual method was preferred. Operator bias and human error
appeared to be be less than the errors associated with using standard space
templates.
The statistically significant regional asymmetry in CVR, with left precentral
gyrus CVR being significantly higher compared to the right, shows that the
vasculature in the left precentral gyrus has a greater capacity to supply in-
creased levels of oxygen to activated tissue. Histograms (figure 5.14c & d)
and contour maps (figure 5.15) of BOLD CVR show that the origin of the
asymmetry corresponds to higher CVR in the left precentral gyrus close to
the cortical surface as well as an increase in the maximum value of CVR in
the region. This excludes the possibility of the asymmetry being due to a sin-
gle large draining vein, which would cause small clusters of high CVR rather
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than a general increase in CVR. The asymmetry in CVR is localised to the
precentral gyrus, rather than across the whole hemisphere (figure 5.14b), in-
dicating that it is not due to any global systematic bias, such as coil sensitivity.
There may be several possible explanations for the vascular asymmetry in the
precentral gyrus. The asymmetry may be independent of handedness, with
a natural bias to higher CVR in the left hemisphere precentral gyrus. There
could be an innate asymmetry, based on handedness, but present from birth
and independent of experience. Another possibility is that the vascular asym-
metry is formed over time, through experience, due to an extensive preference
to use the right hand for complex tasks [166, 167]. It may be that the source
of the asymmetry arises from a combination of all three possibilities. A future
objective could be to test these three hypotheses. The first two would involve
repeating the study with a left handed group and maybe also left handed sub-
jects who were taught to write with their right hand. For the third possibility,
of an experience related cause, a different subject group would be needed, such
as taxi drivers [168], bilingual subjects [169], or musicians [170], where changes
in structure (plasticity) have been observed in brain regions associated with the
corresponding task. An advantage of using these groups over the handedness
model is that control groups can also be studied for comparison. Finding the
source of this vascular asymmetry is an important goal, as it provides insight
into brain development.
5.6 Conclusion
This chapter has investigated the use of hypercapnia as a means to measure
vascular reactivity and its implications for better understanding the BOLD
response to neuronal activation. A gas delivery system with the ability to
target PETCO2 levels on a breath-by-breath basis and to generate transitions
resolvable to within 3 mmHg has been used to develop paradigms for modu-
lating arterial CO2 levels with novel graded and sinusoidal patterns, for accu-
rately probing the resulting effect on BOLD signal. The boxcar is the simplest
paradigm and is easiest to analyse, but it typically involves large steps, which
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are not useful in characterising the relationship between the BOLD signal and
PETCO2. To test this relationship, a graded paradigm was used, which was
presented in a pseudo-randomised order to prevent bias from low frequency sig-
nal drifts, such as due to a subject relaxing over the course of the experiment.
The final paradigm discussed in this chapter is the sinusoidal modulation of
PETCO2. This is not appropriate where steady state periods are required, for
example for calibrated BOLD experiments [69]. However, the sinusoidal ap-
proach is advantageous for measuring relative delays in response to CO2 [149].
It is also less sensitive to physiological noise than the other approaches, as the
analysis only considers a narrow frequency range, not typically associated with
respiratory and cardiac frequencies.
The relationship between grey matter R∗2 and PETCO2 at both 3 T and 7
T has been used to test models of the effect of blood oxygenation on R∗2,
finding an approximately linear relationship at these field strengths. This re-
sult will be useful in translating calibrated BOLD experiments [69] to field
strengths above 1.5 T. A sinusoidal CO2 modulation has been used to map
CVR across the primary motor cortex, finding a difference between left and
right hemisphere precentral gyrus CVR. This has implications for any study
which compares BOLD, or even CBF responses to a motor task to compare
the neuronal response across these two regions. Comparison of the underly-
ing neuronal activation between these regions cannot be made without first
accounting for the observed differences in vascular response, which will affect
both BOLD and CBF responses.
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Chapter 6
Improved BOLD calibration
using hyperoxia
6.1 Introduction
The observation that the gradient echo MRI signal (GE) contrast of large
veins changes with hyperoxia [171] was a key step towards the discovery that
the blood oxygenation level dependant (BOLD) GE signal is spatially corre-
lated with increased neuronal activity [1]. Respiratory challenges modulate
blood gases, where inspired gas mixture is changed under normobaric condi-
tions (methods of which are described in chapter 3). Hyperoxia is one such
challenge which refers to the state of increased lung alveolar oxygen partial
pressure, caused by inhalation of a gas with oxygen composition greater than
21 %, the inspired fraction of oxygen (FiO2) of room air is typically ∼21 %.
Calibration of the BOLD signal is an important goal in neuroscience, as it aims
to separate neuronal from vascular components of the BOLD signal. Hyperoxia
can be used to calculate a calibration parameter for BOLD imaging [172], as
will be described in more detail in section 6.2. However, current methods of
BOLD calibration require the assumption that cerebral blood flow (CBF) and
cerebral blood volume (CBV) are coupled through a power law relationship:
CBV ∝ CBF α, (6.1)
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where α = 0.38 is the coupling constant [70]. This coupling relationship has
several limitations as it is poorly characterised in humans, does not reflect the
venous CBV nature of BOLD contrast [75] and may vary with brain region
and local vascular structure.
This chapter proposes and implements a new method for BOLD calibration
by presenting a stimulus both at normoxia and hyperoxia. This method uses
the assumption that hyperoxia does not affect CBF or oxygen metabolism to
measure the relative change in venous blood oxygenation due to the stimu-
lus. It does not require any assumption about the coupling between CBF and
CBV, since the relative change in venous CBV can be calculated using hyper-
oxia. To support this method, the effect of hyperoxia on vascular properties is
first assessed through a literature review. The magnetic properties of gaseous
oxygen is considered both in the context of being dissolved in blood and of
changing the magnetic properties of air spaces around the head. The results
of an experiment are presented which aims to quantify the effects of increased
oxygen in air spaces on field homogeneity and the associated consequences for
GE EPI distortions. Finally, results from an experiment which implements the
new method for BOLD calibration are presented. This approach uses hyper-
oxic contrast to estimate venous blood oxygenation changes associated with
changes in brain activity. This provides a means to estimate changes in oxygen
metabolism without the need to assume a coupling relationship between CBF
and CBV.
6.2 Uses of hyperoxia in MRI
This section provides an overview of the applications of hyperoxia in MRI
literature. This illustrates how combination of hyperoxia with MRI provides
potential for investigating vascular properties and as a tool for clinical assess-
ment.
Hypercapnia is typically used as a method for calibrated BOLD. However,
an alternative to hypercapnia-based calibration of the BOLD response has
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been proposed [172], which instead makes use of the change in venous blood
oxygenation due to hyperoxia to estimate the calibration constant originally
proposed by Davis et al. [69]. A model (detailed in section 6.4) is used to
estimate the change in global venous blood oxygenation (qh) due to a change
in PaO2. This is then used, along with the GE BOLD signal change resulting
from the change in PaO2, to estimate the calibration constant M :
M =
BOLD− 1
1− qhβ
, (6.2)
where BOLD is the relative signal change in response to hyperoxia (normalised
to the normoxia value) and β is the power law relationship for the effect of
blood oxygenation on extravascular R∗2 (∆R
∗
2 ∝ qh
β). Additional corrective
terms are also proposed in that work, to account for changes in CBF asso-
ciated with a fixed inspired fraction hyperoxia challenge, where hypocapnia
occurs during hyperoxia. This method of hyperoxia calibration avoids mea-
surement of the CBF response to hypercapnia [69], which is subject to low
SNR. It does however rely on a global estimate of oxygen extraction fraction,
which may vary across brain regions and across participants, especially in some
patient groups.
The venous contrast provided by hyperoxia has also been identified as a means
to measure cerebral blood volume. Absolute cerebral blood volume measure-
ments have been made using the hyperoxia BOLD signal at 3 T [173]. In
that study mild hyperoxia (50 % O2) was used to minimise hypocapnia based
vasoconstriction. The venous nature of hyperoxia BOLD contrast means that
this method is sensitive to venous and capillary compartments, rather than
arterial CBV, since arterial blood is close to fully oxygenated. For CBV quan-
tification, the hyperoxia BOLD signal needs to be normalised to an entirely
venous voxel, which was chosen as the sagittal sinus. The major problem with
this normalisation method is that the venous voxel will have a predominantly
intravascular BOLD signal, whereas tissue will have both intravascular and
extravascular components. As a result, the voxel’s CBV content may not scale
linearly with the hyperoxia BOLD signal.
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At 7 T, and using the optimum TE for GE BOLD contrast (such as 25 ms),
the intravascular signal component is negligible [174], except for voxels with a
large venous volume fraction. This means that at 7 T the hyperoxia BOLD
signal of a venous voxel cannot be compared with tissue voxels using the simple
model used in [173] at 3 T. However, the dominant extravascular signal at 7
T has been combined with hyperoxia BOLD contrast to measure the relative
change in venous CBV due to neuronal activation [175]. This method makes
use of an analytical extravascular BOLD signal model [30], which requires the
assumption that static spin dephasing is the dominant ∆R∗2 relaxation mech-
anism.
Furthermore, hyperoxia has been used to test a novel method for measuring
changes in cerebrospinal fluid (CSF) oxygen partial pressure (PO2), based on
T1 [176]. Phantom results of saline with known PO2 contents found a tight
linear correlation between dissolved PO2 and measured R1 relaxation rate.
This observation was applied to calculating CSF PO2 in-vivo by measuring
CSF T1. Hyperoxia was used to test this model and it was found that it took
the measured T1 of CSF approximately 10 minutes to decrease to a steady
state after the onset of hyperoxia, suggesting that it takes up to this time for
arterial dissolved oxygen to pass into CSF.
Clinical and pre-clinical applications
There may be some potential for using normobaric hyperoxia MRI contrast
to aid treatment planning in ischaemic stroke patients [177]. The theory is
that the T ∗2 - weighted signal response to hyperoxia is a marker for tissue
metabolism. The ischaemic core of a stroke region is not metabolically active,
and thus does not produce deoxygenated haemoglobin, so as haemoglobin is
oxygenated, the T ∗2 - weighted signal will not change with hyperoxia. The
border zone, or ischaemic penumbra, which is characterised by being hypoper-
fused and having some recoverable neurons, is still metabolically active. The
ischemic penumbra has a high oxygen extraction fraction (OEF) compared
with healthy tissue, since CBF is low. This means that this region will have
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a larger T ∗2 - weighted signal increase due to hyperoxia than for healthy tis-
sue. This theory has been successfully tested in an animal model [177], but
initial patient results have proved less conclusive [178]. If successfully im-
plemented, this approach would help identify recoverable tissue and inform
treatment options. The advantage that this method has over the existing ap-
proach of combined perfusion and diffusion MRI to classify a lesion, is that it is
related to the underlying metabolism, defining the ischemic penumbra, rather
than cellular structure. It may be able to identify some recoverable tissue that
the diffusion/perfusion mismatch would class as unrecoverable [177]. However,
limitations of this method are the spatial blurring of the BOLD response due
to its vascular nature, and the possible signal enhancement due to a decreased
T1 with hyperoxia.
Normobaric hyperoxia has been suggested as a possible source of MR con-
trast in tumours, which are largely hypoxic. Changes in R∗2 have been used
to show that blood oxygenation in meningiomas is increased during hyper-
oxia [179], useful as increased meningioma blood oxygenation has been linked
to an improved response to radiotherapy. An interesting emerging technique
focusses on angiogenesis, which is an indicator of active tumor growth [180].
Newly formed vasculature (neovasculature) can be distinguished from mature
vessels, using the difference in BOLD contrast between hypercapnia and hy-
peroxia. Neovasculature has little vasodilatory capacity, and so only mature
vasculature has an fMRI response to the vasodilator hypercapnia [181]. Both
neovasculature and mature vasculature have an fMRI response to hyperoxia,
which acts to increase blood oxygen content. The presence of neovasculature
indicates angiogenesis, allowing identification of the parts of the tumor which
are most responsive to treatment [181]. Agreement with other biomarkers
of angiogenesis [180] suggest that this method could be promising as a non-
invasive technique for use with antiangiogenic treatment for tumors [181]. A
limitation of this technique is the fundamental limit on spatial resolution due
to spatial blurring associated with GE BOLD contrast (e.g. downstream of
the dilating vessel).
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6.3 A new approach to BOLD calibration us-
ing hyperoxia
As discussed above, the hyperoxic BOLD contrast due to an increase in venous
cerebral blood oxygenation (Yv) has been considered as a means of measuring
venous CBV, both for absolute resting values [173] and to measure the rela-
tive change due to neuronal activity [175]. This is due to the assumption that
hyperoxia does not affect CBF or oxygen metabolism. It should also be possi-
ble to measure the relative change in Yv due to neuronal activity. This section
proposes a model to this end. The addition of a subsequent CBF measurement
also provides an estimate of the relative change in oxygen metabolism due to
the motor task. Unlike previous approaches, this method does not require an
assumed relationship between venous CBV and CBF.
To model the effect of hyperoxia on tissue R∗2, an analytical model is used [30].
R∗2 = kV (1− Y ) +R
∗
2,0 (6.3)
k =
4
3
pi∆χ[Hbtot]B0 (6.4)
This is an extravascular signal model, based on the static dephasing regime of
spin diffusion around randomly orientated blood vessels. R∗2,0 is the transverse
relaxation rate of tissue containing only fully oxygenated blood vessels, includ-
ing R2 (the spin-spin relaxation rate), Y is the blood haemoglobin oxygen sat-
uration fraction and V is the volume fraction occupied by blood vessels. The
term k is a constant, including the susceptibility of deoxygenated haemoglobin
relative to oxygenated blood (similar to tissue) ∆χ, and the static magnetic
field B0. There is also a term for the effect of vessel geometry, which in this
case is 4
3
pi to model vessels with a random orientation. [Hbtot] is the total
haemoglobin concentration.
In this model, R∗2 has a linear relationship to V and (1-Y), which is an assump-
tion which may not be true at field strengths below 7 T, especially at 1.5 T,
where there will be a significant intravascular contribution and diffusion will
make a significant contribution to extravascular R∗2. The effect of hyperoxia
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is to increase venous oxygenation Yv. The venous deoxygenated haemoglobin
fraction at hyperoxia can be described by Q(1 − qh), where Q(= (1 − Yv))
is the normoxic resting value and qh is the relative change due to hyperoxia
(relative to the normoxic resting Q). If the same task were performed both
at normoxia and hyperoxia, the transverse relaxation rates during the related
neuronal activation R∗2,act and rest R
∗
2,rest are modelled as
R∗2,rest = kV Q(1− qh) +R
∗
2,0 (6.5)
R∗2,act = k(V + Vact)Q(1− qact − qh) +R
∗
2,0
= k(V + Vact)Q(1− qh)− k(V + Vact)Qqact +R
∗
2,0
(6.6)
where k is defined in equation 6.4; V is the resting venous CBV; Vact is the
change in venous CBV due to the neuronal activation; qact is the relative change
in venous deoxygenated haemoglobin fraction due to the neuronal activation
(relative to the normoxic resting Q); R∗2,0 is the transverse relaxation rate of
tissue containing only fully oxygenated blood vessels.
Values of Q and qh can be estimated from the model which will be presented
in section 6.4 (based on exhaled gas composition), or experimentally, either
using blood T2 [182], or susceptibility-based oximetry [183] measurements, both
during normoxia and hyperoxia. The gradient of the R∗2,rest versus (1−qh) plot
is kV Q, which is the calibration constantM used in previous calibrated BOLD
experiments [69, 172] (see equation 6.2 and section 2.4.5). The gradient of the
R∗2,act versus (1−qh) plot is k(V +Vact)Q, which will be referred to as M
′. The
difference in intercepts of the rest and activation curves is k(V + Vact)Qqact,
which can be divided by M ′ to give qact. The ratio of rest and activation
gradients is the relative venous CBV change on activation,
M ′
M
= (1 +
Vact
V
). (6.7)
If the relative change in CBF on activation can be measured (e.g. using ASL),
then Fick’s principle [69] can be used together with the value of qact to estimate
the relative change in CMRO2:
(1 +
∆CMRO2
CMRO2,rest
) = (1 + qact)(1 +
∆CBF
CBFrest
). (6.8)
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This method does not require the assumption of a coupling relationship be-
tween CBV and CBF [70]. However, this method assumes a linear relationship
between R∗2 and deoxygenated haemoglobin fraction [30]. It also assumes that
there is negligible vasoconstriction due to hyperoxia over the period of neuronal
activation [184]. Finally, it is also assumed that qh and qact are independent of
one another, so the change in oxygen consumption due to neuronal activation
is independent of hyperoxia.
6.4 The effect of hyperoxia on the vasculature
In this section, the effect of hyperoxia on haemodynamic properties is consid-
ered through a literature review. This understanding is important in order
to build up a model for calibrated BOLD using hyperoxia and to assess the
validity of assumptions which need to be made.
The common method for inducing hyperoxia is to present 100% fixed inspired
oxygen fraction (FiO2). However, this method typically induces mild hypocap-
nia [185], which complicates the vascular response. To reduce this hypocapnic
side effect, lower oxygen fractions can be presented, balanced with nitrogen,
or mixed with room air. Carbogen, which is oxygen, balanced with a small
fraction of CO2 (typically 95% O2, 5% CO2), can also be used, but this causes
both hyperoxia and hypercapnia. Two methods for minimising hypocapnia
during hyperoxia are the feed-forward [158] and the dynamic end-tidal forcing
[92] techniques (both previously outlined in chapter 3).
The effect of hyperoxia on vasoconstriction is a matter for debate, but is a vital
consideration if hyperoxia is to be considered as a non-invasive contrast agent.
CBF measurement techniques, including nitrous oxide washout [117] and MRI
methods, such as phase-contrast angiography [186] and Gd-DTPA contrast-
enhanced perfusion [187] measurements, have shown that CBF decreases upon
inhalation of 100 % O2. The CBF response to hyperoxia is slowly varying
[186], taking several minutes to react significantly and up to 10 minutes to
reach a steady state after the onset of a transition. Graded hyperoxia has
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been investigated [188] using ASL (QUIPPSII), with statistically significant
decreases in CBF (relative to room air) being shown, even for an FiO2 of 0.4
(40 %). In that study the hypocapnic response to hyperoxia was shown at high
temporal resolution and was seen to be slowly varying, possibly on a similar
timescale to the CBF response, but unfortunately the CBF timecourse itself
was not reported in this case. Whether the decrease in CBF is entirely due
to hypocapnia associated with hyperoxia, or also in part directly a reaction
to increased FiO2 is unclear. This question has been addressed [94], by mod-
ulating inspired CO2 (0 %, 4 % and 6 %) both during hyperoxia (balanced
O2) and normoxia (balanced air, i.e. 21 % O2). Using a continuous-ASL ac-
quisition, an offset was found in CBF between the normoxia and hyperoxia
response curves to CO2, which appears to show a CBF response to increased
FiO2, independent of CO2. However, more recent work [184] using continuous-
ASL found that the apparent decrease in CBF during 100 % O2 inhalation was
mostly accounted for by a change in arterial blood T1 due to hyperoxia, rather
than an actual CBF decrease. The relationship between hyperoxia and CBF,
independent of hypocapnia, is still poorly understood. To draw an accurate
conclusion as to how hyperoxia affects CBF and vasoconstriction, hypocapnia
needs to be minimised and either arterial blood T1 changes accounted for, or
phase-contrast methods used (which are less sensitive to the T1 changes).
During hyperoxic periods, arterial oxygen partial pressure (PaO2) is increased,
arterial haemoglobin, which is already almost fully saturated at normoxia,
becomes fully saturated and the level of oxygen dissolved in arterial plasma
increases. The oxygen dissociation in blood is modelled by a widely accepted
model [189]. This model depends on temperature and blood pH, but for 310 K
and pH of 7.4 the relationship between arterial haemoglobin oxygen saturation
(SaO2) and PaO2 is
SaO2 = (
23400
PaO2
3 + 150PaO2
− 1)−1. (6.9)
Venous haemoglobin oxygen saturation (SvO2) can be estimated as follows
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[172]. The total arterial blood oxygen content (CaO2) is the sum of the oxygen
bound to haemoglobin and dissolved in plasma
CaO2 = (φ.[Hb].SaO2) + εPaO2 (6.10)
where φ = 1.34 mlO2/g is the oxygen carrying capacity, [Hb] = 15 g/dlblood is
the concentration and ε = 0.0031 mlO2/(dlblood.mmHg) is the solubility coeffi-
cient, of haemoglobin [172]. Dissolved oxygen meets part of the tissue oxygen
requirement, reducing the amount of venous deoxyhaemoglobin [190]. The
total venous blood oxygen content (CvO2) is the remainder after oxygen is
extracted from capillaries, and is given by
CvO2 = CaO2 − CaO2,0.OEF (6.11)
where CaO2,0 is the normoxia CaO2 value and OEF is the oxygen extraction
fraction assumed to be 0.4. Since venous haemoglobin is not close to being
fully saturated under normobaric hyperoxia, an assumption can be made that
a negligible amount of the total CvO2 is dissolved oxygen. This means that
the venous oxygen saturation can be calculated using
SvO2 = CvO2/φ.[Hb]. (6.12)
This model thus relates PaO2, which can be estimated by measuring exhaled
gas oxygen fraction, to SvO2, as shown in figure 6.1. Since the change in
deoxyhaemoglobin is the source of BOLD contrast the hyperoxia-perturbed
BOLD signal can therefore be used to assess local venous vascular properties.
6.5 Magnetic Properties of O2
Oxygen molecules are paramagnetic, with a molar susceptibility χm = +3415×
10−6cm3mol−1 at room temperature [191]. By modulating the level of inspired
oxygen, the amount of of oxygen both dissolved in arterial blood plasma and
in air spaces around the head (such as the oral cavity and frontal sinus) will
change, affecting local magnetic properties. These are important considera-
tions in modelling the effect of hyperoxia on the BOLD signal.
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Figure 6.1: Model response of SaO2 and SvO2 to PaO2. The broken lines indicate
arterial and venous oxygen saturation for 110 mmHg (∼21 % O2, normoxia) and 500
mmHg (∼60 % O2). Model values used for this plot are PaO2,0 = 110 mmHg, OEF =
0.4, φ = 1.34 mlO2/g, [Hb] = 15 g/dlblood and ε = 0.0031 mlO2/(dlblood.mmHg).
For this section, all magnetic susceptibility values are given in cgs units. The
volume susceptibility of an ideal gas is given by:
χv =
ρχm
M
=
χm
103.Vm
, (6.13)
where ρ is the gas density (g/cm3), M is the molar mass (g/mol) and Vm is the
molar volume, the volume occupied by one mole of ideal gas, which at room
temperature (298 K) and atmospheric pressure (101 kPa, or 760 mmHg) is 24.5
L/mol. Assuming that oxygen behaves like an ideal gas, volume susceptibility
can be expressed as a function of fraction by volume (FO2).
χv(FO2) =
3415× 10−6
24.5× 103
.FO2 (6.14)
This gives values of χv(100%) = 0.139 × 10
−6, χv(60%) = 0.083 × 10
−6 and
χv(21%) = 0.029× 10
−6, when balanced with nitrogen (N2), since for nitrogen
gas, χm = −12 × 10
−6cm3mol−1 at room temperature [191], so nitrogen only
contributes to χv to the fourth decimal place in these calculations. This means
that the difference in χv between 100 % and 21 % O2 gas is ∆χv = 0.110×10
−6.
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The relevance of values for 60 % O2 is with reference to the experimental sec-
tions of this chapter, where an ∼60 % O2 challenge is presented.
The susceptibility contribution of dissolved oxygen in plasma can be calculated
based on
FO2 = ε.PaO2 (6.15)
where ε = 3.1× 10−5LO2/(Lblood.mmHg) is the solubility coefficient of oxygen
in blood [172]. Normobaric dissolved oxygen makes a negligible contribution
to plasma χv, of χv(FO2) = [0.0005, 0.0022, 0.0033]× 10
−6, for 110 mmHg (∼=
21 %), 500 mmHg (∼= 60 %) and 760 mmHg (∼= 100 %) PaO2 respectively.
In-vitro measurements of human blood at 1.5 T and 8.45 T [192] show a linear
relationship between FiO2 and T1. This study also showed a similar linear re-
lationship with plasma and saline, suggesting that the T1 dependence on FiO2
is due to the amount of dissolved O2, rather than blood oxygenation (the level
of oxygen bound to haemoglobin). In-vivo measurements [193, 194] at 1.5 T
have shown that arterial blood T1 decreases with 100 % O2 inhalation. The
change in arterial T1 between an FiO2 of 0.21 and 1.00 has been measured
in-vivo at 1.5 T as −142 ± 37 ms [193] in the left ventricle or −226 ± 57 ms
[194] in the femoral artery. The difference may be due to the flow rate at
which hyperoxia was presented (10 L/min and 15 L/min respectively) causing
different alveolar oxygen content. The arterial T1 dependence of hyperoxia has
not been measured in-vivo at higher field strengths, but it has been estimated
at 3 T by scaling the values based on the arterial blood T1 value at normoxia
at 3 T [188], to correct for CBF measurement. Applying this scaling up to
7 T, with a normoxia arterial T1 of 2070 ms [195], arterial T1 would reduce
by 350 ms between an FiO2 of 21 % and 100 %. Venous blood T1 shows no
significant change with hyperoxia [194], which can be attributed to the extra
oxygen being bound to haemoglobin, rather than dissolved in plasma.
The T2 of arterial blood (femoral artery) shows no significant change on in-
halation of 100 % O2, whereas the T2 of venous blood (femoral vein) shows a
significant increase of 23 ± 5 ms at 1.5 T [194]. This is consistent with the
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increased blood oxygenation of venous blood with hyperoxia, which is closely
correlated with T2. Increased haemoglobin oxygen saturation reduces field in-
homogeneities caused by deoxyhaemoglobin, which reduces the T2 dependence
on water diffusion. The fact that the arterial blood T2 shows no change with
oxygenation also suggests that dissolved O2 does not have a large effect on
blood T2.
6.6 Image artefacts caused by hyperoxic chal-
lenges and their effect on R∗2 quantification
6.6.1 Introduction
Hyperoxia is typically induced by increasing the oxygen volume fraction of
inspired air, this will increase the oxygen fraction in the oral cavity and
frontal sinus. As shown in section 6.5, increasing the oxygen fraction will
increase the volume susceptibility of inspired air. This will act to increase
the air-tissue(paramagnetic-diamagnetic) susceptibility difference and will am-
plify the effect of respiration-dependent noise in GE EPI images [131]. As a
result, hyperoxia-induced BOLD signal artefacts have been observed close to
the frontal sinus and the ventricles [196, 197]. The perturbation of hyperoxia
on field homogeneity around air-tissue boundaries has been used to attempt
to model the large phase shift due to the air-tissue boundary in phase imaging
and subsequently filter the naturally occurring effect due to the susceptibility
difference at the boundary [198].
Changes in field homogeneity will affect GE EPI magnitude data in the fol-
lowing ways. Field inhomogeneities will combine with the imaging spatial
encoding gradients to create position encoding errors. This will cause image
distortions which are dependent on the relative amplitudes of imaging gradi-
ents and the field inhomogeneity. For an EPI acquisition, the amplitude of
each imaging gradient depends on the bandwidth in each respective direction
(readout, phase-encode and slice directions). Intra-voxel spin dephasing is also
dependent on field homogeneity, as a field inhomogeneity across a voxel will
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lead to unrecoverable spin dephasing under a GE (T ∗2 -weighted) acquisition,
causing signal attenuation. In this section, dynamic mapping of the field shift
due to hyperoxia is used to attempt to quantify the effects of hyperoxia on GE
EPI data. This is crucial for an accurate model of the effects of hyperoxia on
the BOLD signal, as this change in field homogeneity is time-locked to periods
of hyperoxia, but will alter GE EPI magnitude data in a manner that is not
related to blood oxygenation.
6.6.2 Method
Five healthy volunteers (3 male, 2 female; mean age = 25 ± 3 years, range
22–29 years) participated in this study. All subjects gave informed written
consent prior to participating and ethical approval was given by the Univer-
sity of Nottingham Medical School Ethics Committee.
The preparation for the respiratory challenge is described in section 3.3. How-
ever, unlike for the earlier hypercapnia experiments, where breathing rate was
paced by visual cues, the subject was instructed to breath at a steady, but
comfortable pace and asked not to hold their breath. So that the subject
emptied the sample gas bag with every breath, a lower flow rate was used,
compared to when breathing was paced, due to the subject being less aware
of their breathing. The purpose of not pacing the breathing rate was mainly
the subject’s comfort, but it also reduced subject motion during scans. The
low flow rate, along with the existing ventilation system in the scanner bore
helped to ensure that no build-up of oxygen occurred in the magnet bore dur-
ing hyperoxic periods.
The subject lay on the scanner bed, out of the bore, for approximately five
minutes. This gave the subject time to become accustomed to the mask and
this period was also used to estimate the flow rate at which the subject could
comfortably breath the supplied gas and some of the neutral gas with every
breath. The scanner bed was then positioned so the head coil lined up with
the magnet iso-centre.
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Targeted PETO2 was modulated between the subject’s baseline value (∼110
mmHg; normoxia) and 500 mmHg (hyperoxia), for two cycles of three minutes
of normoxia followed by three minutes of hyperoxia, followed by a final three
minute period of normoxia. Isocapnia was maintained at the subject’s baseline
(∼40 mmHg PETCO2).
Scanning was performed on a Philips Achieva 7 T system, with head volume
transmit and 16 channel SENSE head receive coils. GE EPI data were ac-
quired every 2.4 s throughout the respiratory challenge. Images consisted of
2 mm isotropic voxels, with a 192×192 mm2 field-of-view, 30 axial slices were
acquired (2 mm thickness, no slice gap) spanning from the ventricles to the
motor cortex. Imaging parameters of TE = 25 ms, SENSE factor = 3, voxel
band-width = 41.5 Hz, TR = 2.4 s and flip angle = 75◦ were used. Both
magnitude and phase data were saved. An additional set of GE EPI data were
acquired before the respiratory challenge to map the static B0 field component.
This data had the same parameters as above, but with the echo time modulat-
ing between 25 and 28 ms for alternate dynamics, with 10 averages at each TE.
The relative change in B0 field across dynamics during the respiratory chal-
lenge was then calculated using a technique developed by Jack Harmer, based
on the work of Hahn et al. [199]. This makes the assumption that there is
a temporally invariant component of phase (φ0) [200], due to radio-frequency
phase inhomogeneities, which can be separated from dynamic changes. As a
result, φ0 can be subtracted from the phase data and the remaining phase
change over time can be used to calculate the underlying relative changes in
B0 over time.
The temporally invariant phase component (φ0) was first calculated based on
a static ∆B0 map, formed using the phase difference between images taken at
the two different echo times [15]. A seventh order three dimensional polyno-
mial fit was applied to the static ∆B0 map to reduce the effect of noise. The
high order was required to accurately represent the large susceptibility effects
around the frontal sinus. This polynomial fit was taken as the temporally in-
154
variant component of ∆B0, from which φ0 was calculated. Therefore the static
B0 map was used to calculate φ0, which was combined with the phase data
acquired during the hyperoxia challenge to map the relative changes in B0 over
time.
Maps of the field shift due to hyperoxia were then formed by subtracting the
average normoxia from average hyperoxia periods (average over the last two
minutes of each period). Comparing this map with the voxel acquisition band-
width (41.5 Hz) indicated how much EPI distortion will result from the change
in field homogeneity during hyperoxia. For this purpose, the field shift map
was considered in terms of frequency shift (∆f , units of Hz), related to field
shift by ∆f = γ∆B0/2pi.
To assess the changes in the GE EPI signal due to this hyperoxia-related
field shift, intra-voxel spin dephasing was simulated. A seventh order three
dimensional polynomial fit was applied to the field shift map. Each voxel was
subdivided into 10×10×10 spin isochromats, in a square grid such that the
distance between isochromats is the same, even across voxels. The polynomial
fit coefficients were used to estimate the change in field homogeneity (∆f) at
the location of each isochromat. The phase of each isochromat was allowed
to evolve over the echo time by φ = 2pi∆fTE. For each voxel, the phase
of all isochromats were combined by vector summation to estimate intra-voxel
dephasing. This provided a measure of signal attenuation due to the hyperoxia-
induced change in field homogeneity across each voxel.
6.6.3 Results
The frequency shift induced by hyperoxia is shown for a typical subject in fig-
ure 6.2a. The magnitude of this shift is largest in the frontal sinus, up to 20 Hz
(50% of the voxel bandwidth) and reduces with distance from the frontal sinus,
but never drops to zero. Single-subject timecourses of the frequency shift from
the frontal sinus (black), motor (blue) and visual cortices (green) are shown
in figure 6.2e. The hyperoxia-induced frequency shift in a 5×5 voxel ROI in
the motor (M1) and visual (V1) cortices (as shown in figure 6.2d) is 3.1± 0.2
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Figure 6.2: Single subject (a) Map of resonance offset change (in Hz) due to hyperoxia
(1 sagittal and 2 axial slices); (b) Polynomial fit to (a); (c) Map of the simulated signal
attenuation (%) due to hyperoxic changes in field homogeneity; (d) The location of the
5×5 voxel V1 and M1 ROIs, overlaid on an average magnitude image; (e) Timecourses
of frequency shift during the 15 minute hyperoxia paradigm, from the M1, V1 ROIs
together with an ROI from the frontal sinus. The red dashed line shows a scaled PETO2
timecourse.
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Hz in M1 and 2.1 ± 0.7 Hz in V1 (mean ± std over subjects), corresponding
respectively to 7% and 5% of a voxel volume in the phase-encode direction.
The corresponding polynomial fit to figure 6.2a, used for the intra-voxel de-
phasing simulation, is shown in figure 6.2b. Figure 6.2c shows the map of
simulated signal attenuation due to field inhomogeneity for this subject. Sim-
ulations indicate that the change in field homogeneity due to hyperoxia will
cause a signal attenuation of only 8 ± 9 × 10−4 % in M1 and 4 ± 4 × 10−4 %
in V1 (mean ± std over subjects).
6.6.4 Discussion
This experiment has considered the effect of changes in field homogeneity due
to hyperoxia on GE EPI data. Dynamic mapping of the field shift can be
calculated using phase data from a standard GE EPI fMRI experiment [199],
just with the addition of a short extra scan to calculate φ0.
The measured hyperoxic field shift was largest over the frontal sinus, but ex-
tended over the whole head (figure 6.2a). The simulated intra-voxel dephasing
due to the change in field homogeneity did not significantly change the trans-
verse relaxation rate (< 0.05% signal attenuation, as seen from figure 6.2c)
apart from in voxels neighbouring the frontal sinus.
The measured hyperoxic field shift will cause a significant change in the EPI
distortions, which will lead to the voxel composition changing under hyperoxia
(by 7% in M1 and 5% in V1) in the phase-encode direction. Where the voxel
lies at a boundary, such as between grey matter and white matter, a distor-
tion could change the partial voluming in that voxel and result in a significant
GE EPI signal change. Dynamic distortion correction techniques may be able
to compensate for this, in the same way as static field homogeneities can be
corrected [15].
The analysis assumed that the effect of oxygen in the sinuses could be modelled
using a seventh order polynomial. This is based on evidence from respiration-
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induced resonance field offsets [131], where the effect on B0 showed a global
low frequency spatial distribution. The polynomial fit was found to be reason-
able, except in some deep grey matter regions (figure 6.2a).
In summary, hyperoxia-induced artefacts arising due to oxygen in the sinuses
or oral cavity will not significantly contaminate the results of hyperoxia BOLD
measurements, although small shifts in voxel position must be considered. The
change in field homogeneity due to hyperoxia has been shown to have a negligi-
ble effect on signal attenuation in M1 and V1, regions where calibrated BOLD
experiments are commonly used. However, this may not be the case with
anterior regions which are close to the frontal sinus, such as the orbitofrontal
cortex. This technique could be used in future hyperoxia fMRI studies to mon-
itor the temporal variations in B0 induced by hyperoxia, especially in regions
close to the oral cavity and frontal sinus.
6.7 Venous blood oxygenation and calibrated
BOLD measurements
6.7.1 Introduction
This section implements the method of measuring relative changes in venous
blood oxygenation and CMRO2 proposed in section 6.3 , by repeating the
same motor task at both normoxia and hyperoxia. The addition of an ASL
CBF measurement also allows an estimate of the relative change in oxygen
metabolism due to the motor task. A thorough discussion is also presented
outlining the assumptions and issues raised in previous sections.
6.7.2 Method
Nine healthy volunteers (3 male, 6 female; mean age = 27 ± 3 years, range
23–30 years) participated in this study. All subjects gave informed written
consent prior to participating and ethical approval was given by the Univer-
sity of Nottingham Medical School Ethics Committee.
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Figure 6.3: An illustration of the combined hyperoxia and motor task for (a) the 30 s
ON/ 30 s OFF paradigm and (b) the 30 s ON/ 60 s OFF paradigm. The motor task is
shown in grey. Trials marked with an * were used in the analysis.
All subjects were asked to perform a motor task during a respiratory challenge,
such that the same motor task was repeated both at normoxia and hyperoxia.
The motor task consisted of a bilateral sequential finger tap. This was visually
cued, with the word ‘TAP’ displayed in red (with a dark background) onto
a projector screen at the end of the magnet bore. This was replaced by a
white ‘+’ fixation point during rest periods. The motor paradigm consisted
of blocks of two trials of 30 s ON/ 30 s OFF for each gas level, such that the
block finishes just before the start of a transition between gas levels (see figure
6.3). Apart from the first four subjects, the other subjects were also asked
to complete an additional motor task, for ASL acquisition. This additional
motor task was performed with the subject breathing medical air, consisting
of 10 trials of 30 s ON/ 30 s OFF, but was otherwise the same as the previous
motor task.
The preparation for the respiratory part of the task was performed as out-
lined previously (section 6.6.2). For the first seven subjects, the respiratory
challenge consisted of two repeats of three minutes of normoxia, followed by
three minutes of hyperoxia, with a final three minutes of normoxia at the end.
For the normoxic condition, both PETO2 and PETCO2 were maintained at the
subject’s resting values (∼110 mmHg and ∼40 mmHg, respectively). For the
hyperoxic condition, PETO2 was targeted at 500 mmHg, whilst PETCO2 was
159
maintained at the resting value.
After reviewing the BOLD response from the first seven subjects, a signal drift
was observed during the hyperoxic periods only. This would cause a system-
atic error, discussed later. Therefore for the final two subjects, to minimise
the effect of this signal drift, the paradigm was modified such that the respira-
tory paradigm consisted of an initial two minutes of normoxia, followed by two
repeats of two minutes hyperoxia and four minutes of normoxia. The motor
paradigm was changed to 30 s ON/ 60 s OFF repeated throughout the respi-
ratory challenge, with the two trials occurring during hyperoxia starting one
minute after the transition to hyperoxia (see figure 6.3b). With this design,
every other trial does not fall at the correct part of the respiratory paradigm to
be used, but helps to maintain the subject’s attention. For these two subjects,
the motor task collected during ASL acquisition consisted of 8 motor trials of
30 s ON/ 60 s OFF.
Scanning was performed on a Philips Achieva 7 T system, with head volume
transmit and 16 channel SENSE head receive coils. GE EPI data were acquired
every 2.4 s throughout the respiratory and motor task. Images consisted of 2
mm isotropic voxels, with a 192×192mm2 field-of-view, and 20 axial slices (2
mm thickness, no slice gap) spanning the motor cortex. Imaging parameters of
TE = 25 ms, SENSE factor = 3, voxel band-width = 41.5 Hz, TR = 2.4 s and
flip angle = 75◦ were used. ASL datasets were acquired with a FAIR labelling
scheme, with TI = 1400 ms; selective thickness 10 mm wider than the imaging
volume; non-selective thickness of 300 mm; background suppression pulses at
402 and 639 ms [201]; in-plane pre- and post-saturation were used. Images
consisted of 2×2×4 mm3 voxels, with a 192×192 mm2 field-of-view, and 8 ax-
ial slices (4 mm thickness, no slice gap) with the same orientation and centre
as the GE EPI data. Imaging parameters were TE = 14 ms, SENSE factor =
3, voxel band-width = 41.5 Hz, TR = 3 s (6 s for a tag/control pair). Two
base images (same parameters as for the ASL, except with no inversion and
a long TR of 10 s) were acquired, one before and one after the ASL acquisition.
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GE EPI datasets were motion corrected using MCFLIRT (FSL, fMRIB, Ox-
ford, UK). Voxelwise linear detrending was then performed using a linear fit
(MATLAB, The MathWorks, Natick, USA) over timepoints defined as ‘base-
line’. These ‘baseline’ timepoints were during periods of normoxia and not
within 30 s of a previous finger tap, so as to not include the post-stimulus
undershoot. Linear detrending involved removing the linear component of
the timecourse, using the linear fit coefficients. This method was chosen in
preference to a high-pass temporal filter, due to the long cycle lengths of the
paradigm. Each voxel’s timecourse was normalised by dividing every time-
point by the average value over all baseline timepoints. Maps of statistical
significance of the BOLD response to the motor task were formed using the
FEAT (FSL, fMRIB, Oxford, UK) general linear model. This was done on
the datasets before voxelwise normalisation, but after motion correction and
linear detrending. A boxcar design, representing the hyperoxia response was
included in the model design as an independent regressor, so the hyperoxia-
based BOLD response could be separated from the motor response in the
analysis. ‘BOLD motor activation masks’ were formed of clusters of voxels
with Z > 5 and Pcluster < 0.05 for the response to the motor task. The general
linear model analysis contained separate regressors for the motor task and the
hyperoxia challenge and although the statistical maps for the BOLD response
to hyperoxia were not considered in forming the masks, significant activation
was found to follow grey matter sulci and in large vessels.
To assess motion during the ASL datasets, the two base images were compared
to see if there was any systematic motion between the start and end of the
ASL dataset. For all subjects, the two base images appeared reasonably well
aligned, when one was overlaid on the other. ASL datasets were not motion
corrected, since the motion correction algorithm struggles with background
suppressed data, as it removes static signal and hence key features in the im-
ages, which the registration uses for alignment. An interleaved acquisition of
tag and control images meant that temporal interpolation was required be-
fore subtraction. Linear temporal interpolation (MATLAB, The MathWorks,
Natick, USA) was performed to both the tag and control datasets, such that
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an interpolated tag timepoint is calculated at the time of acquisition of each
control timepoint and vice versa. Subtraction was then performed, between
interpolated tag and control datasets, resulting in a CBF-weighted timecourse
with timepoints every 3 s. Note, however that the acquisition effectively has
a 6 s sampling rate, so changes on the timescale of 3s cannot be resolved.
Maps of statistical significance of the CBF response to the motor task were
formed using the FEAT (FSL, fMRIB, Oxford, UK) general linear model. In
this analysis, the high-pass filter in FEAT was used, with a cut-off period of
twice the trial length. This was 120 s for the three subjects with a 30 s ON/
30 s OFF paradigm and 180 s for the last two subjects with a 30 s ON/ 60
s OFF paradigm. ‘CBF motor activation masks’ were formed of clusters of
voxels with Z > 2.3 and Pcluster < 0.05. The lower Z-statistic threshold was
used due to the intrinsically lower SNR of ASL compared with GE EPI.
Timecourses of measured PETO2 were used to estimate the relative change in
venous deoxyhaemoglobin fraction due to hyperoxia (qh)(see section 6.4). A
resting OEF of 0.4 was used and the assumptions were made that oxygen con-
sumption is not affected by hyperoxia and hematocrit remains constant both
during hyperoxia and the motor task.
Timecourses were formed for the GE EPI datasets by averaging the normalised
dataset over all voxels passed by the BOLD motor activation mask. To min-
imise the error due to the hyperoxic drift, only the first motor trial during
hyperoxia periods and the last trial during normoxia periods were considered.
Averages of rest and active (motor task) periods were made, providing a rest
and an active % change (%BOLD) for each trial relative to the normoxic base-
line (as defined earlier). These % changes were converted to ∆R∗2 using the
approximation ∆R∗2 ≈ −%BOLD/(100.TE), for use in the qact calculation
(division by 100 is to convert from %BOLD to a fraction, for use in the ap-
proximation). Linear regressions (MATLAB, The MathWorks, Natick, USA)
were performed to fit ∆R∗2 as a linear function of qh, separately for the rest
and active conditions. The fitted parameters were then used to estimate qact
and (1 + Vact
V
), as proposed in section 6.3.
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Figure 6.4: An example of the formation of the combined mask. (a) BOLD activa-
tion map (Z-statistic). (b) CBF activation map (Z-statistic), overlaid on the average
subtraction. (c) Combined mask formed of the intersection of (a) and (b).
A new, ’combined mask’ was formed for each of the five subjects for which
ASL data were acquired. This involved finding the intersection of the BOLD
motor activation mask and the CBF motor activation mask (see figure 6.4).
The reason for this is that it was found that using the BOLD motor activation
mask to form a CBF-weighted timecourse resulted in a dilution of the measured
CBF response, underestimating the CBF change. The CBF-weighted data
(after interpolation and subtraction) were normalised to the rest periods, by
dividing by the average of the last half of all rest periods. For each subject, a
timecourse was generated by averaging over all voxels included in the combined
mask. The % change in CBF was calculated by averaging over the active
(motor task) period of all trials, multiplied by 100. New values of qact were
calculated using the same method as described above, for the combined mask
rather than the BOLD motor activation mask. %CBF changes and qact were
used to calculate %CMRO2, using equation 6.8.
6.7.3 Results
Transitions in ∆PETO2 of 330 ± 20 mmHg (mean±SEM over subjects) were
achieved. Using these measured PETO2 values results in a predicted increase
of ∆Yv = 0.068± 0.003 during the hyperoxia periods (section 6.4), an 11% in-
163




	








	
















Figure 6.5: Examples of BOLD (a,c) and PETO2 (b,d) timecourses, from a single subject
each for (a,b) the 30s ON/ 30s OFF paradigm and (c,d) the 30s ON/ 60s OFF paradigm.
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crease over the resting normoxia value. ∆PETCO2 = −0.5±0.1 mmHg during
hyperoxia (compared with normoxia), with a range of -1.1 – 0 mmHg across
subjects, this was assumed too small to have a significant effect on CBF and
the resulting BOLD signal.
Figure 6.5 shows example BOLD and PETO2 timecourses for both the 30 s
ON/ 30 s OFF and the 30 s ON/ 60 s OFF paradigms. The BOLD signal
increased by 6.7± 0.8 % due to hyperoxia. The BOLD response to the motor
task was increased by a factor of 39±6 % at hyperoxia compared to normoxia.
An example of the average trial of the motor task at normoxia and hyperoxia,
as well as an example of the linear fits are shown in figure 6.6. From the linear
fits, values of M and M ′ were calculated as M = 38±4 % and M ′ = 50±5 %.
Individual subject values for the relative increase in vCBV, relative decrease
in deoxyhaemoglobin fraction (qact) and corresponding absolute increase in
∆Yact(= 1−Q(1− qact)) during the motor task are reported in table 6.1.
For the combined mask, the average CBF trial timecourse is shown in figure
6.7 (formed by averaging over all trials for each subject, and then by averaging
over all subjects). From the linear fits, values of M and M ′ were calculated
as M = 28± 2 % and M ′ = 34± 4 %. Results based on the combined mask,
CBF, qact and the relative increase in CMRO2 are reported in table 6.2.
6.7.4 Discussion
This experiment has demonstrated the implementation of a new method for
estimating the relative change in CMRO2 due to increased neuronal activa-
tion associated with performing a task. This method uses a simple BOLD
signal model and the perturbation of venous blood oxygenation provided by
hyperoxia. Performing the same task at hyperoxia in addition to normoxia
provides an extra degree of contrast with which to better understand the vas-
cular nature of the BOLD signal. As a result, this model does not require any
assumption about the coupling between CBV and CBF.
The model proposed here is based on the analytical model proposed by Yablon-
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Figure 6.6: (a) Average motor trial %BOLD timecourses during hyperoxia (above) and
normoxia (below). (b) Example of the linear fit between ∆R∗2 and (1− qh). Numbered
arrows show the value of Q(1− qh) at that point. Data from (a) and (b) are from the
same subject, which is the subject featured in figure 6.5(a & b).
Subject # vCBV (%) qact (%) ∆Yact
1 36.8 -36.9 0.15
2 23.6 -56.1 0.22
3 33.3 -33.6 0.13
4 33.7 -39.9 0.16
5 30.5 -32.2 0.13
6 32.1 -31.0 0.12
7 30.7 -35.2 0.14
8 10.0 -17.8 0.07
9 44.6 -43.4 0.17
mean±SEM 31± 3 −36± 3 0.14± 0.01
Table 6.1: Individual subject results for the BOLD motor activation mask ROI
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Figure 6.7: The %CBF response to the motor task, averaged over trials then across
subjects. The dashed lines indicate the range of values across subjects.
Subject # qact (%) CBF (%) CMRO2 (%)
5 -35.2 58.0 2.5
6 -29.8 57.8 10.9
7 -25.8 87.2 39.0
8 -13.6 50.8 30.3
9 -40.9 87.4 10.7
mean±SEM −29± 5 68± 8 19± 7
Table 6.2: Individual subject results for the combined mask ROI
167
skiy and Haacke [30]. This is an extravascular signal model, which assumes
that transverse relaxation occurs in the static dephasing regime. The short
T ∗2 of venous blood at 7 T [105] means that the intravascular GE signal con-
tribution is small compared to the extravascular GE signal contribution [174].
It is therefore reasonable to assume that the extravascular signal contribution
dominates, except for the case of voxels which have a large vascular compart-
ment, such as those containing a large draining vein. Field inhomogeneities
cause larger frequency shifts at 7 T compared with lower fields. At 7 T the
frequency shifts caused by a nearby venule are sufficient to fulfil the static
dephasing condition [31, 28]. The resulting predicted linear relationship be-
tween R∗2 and blood oxygenation is consistent with the tight linear correlation
between R∗2 and PETCO2 in chapter 5. Random vessel orientation is assumed,
however the contribution of vessel orientation on transverse relaxation is in-
cluded in the constant k, described in equation 6.4. The model proposed here
does not require knowledge of this constant, so the assumption of vessel orien-
tation could be relaxed.
The model used in this method becomes equivalent to the model proposed by
Chiarelli and co workers [172] if vCBV were calculated first [175], replacing
the Grubb relationship, and a linear relationship assumed between R∗2 and
blood oxygenation. The values of M calculated here are the first reported
human values for 7 T. Equivalent values for the motor cortex calculated us-
ing hyperoxia at 3 T are M ≈ 5–6 % [172, 202], using hypercapnia at 3 T
are M ≈ 4–6 % [203, 202] and using hypercapnia at 1.5 T are M ≈ 5–9 %
[204, 37, 205, 206]. The value of M depends on field strength and TE, but the
value reported here of M = 38 ± 4 (9 subjects) is a factor of 5 higher than
at lower field strengths, which is consistent with increased BOLD contrast at
7 T and smaller voxel volume causing less partial voluming. With the tighter
combined mask, the new value of M = 28 ± 2 (5 subjects) is lower than for
the BOLD motor activation mask, this could be due to the exclusion of large
draining veins. Calculated CMRO2 increases agree with previous studies using
a bilateral finger tap, with ∆CMRO2 = 16± 9 % [204] and ranging from 5–45
% [203], both using hypercapnia-based calibration and with a positron emis-
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sion tomography (PET) study [207], using a right-handed finger tap, giving
∆CMRO2 = 11± 13 % in the left (contralateral) precentral gyrus.
Previous calibrated BOLD experiments [69, 172] rely on an assumed coupling
relationship between total CBV and CBF (equation 6.1, α = 0.38), which
was originally measured in rhesus monkeys, using PET and hypercapnia [70].
Due to deoxygenated haemoglobin being the source of BOLD contrast, the
venous, rather than total blood volume compartment should be considered in
the calibrated BOLD model. The venous compartment reacts passively to flow
changes, so would be expected to have a different coupling relationship com-
pared with the arterial compartment, which is lined with muscles for active
constriction and dilatation. The vascular response to a global hypercapnia
challenge may also be different to the local response to increased neuronal ac-
tivity. The coupling relationship between venous CBV and CBF has recently
been investigated in humans using the VERVE technique and ASL during both
neuronal activation (α = 0.23± 0.05) [75] and hypercapnia (α = 0.18± 0.02)
[76]. Although the coupling was slightly different in those two studies, the use
of different ROIs makes comparison difficult. Much work is required to better
characterise the coupling relationship and investigate inter-region and inter-
subject variability. One possible area of variability could be that there could be
a dependence of vascular size on the coupling relationship (e.g. venules might
have a different relationship to veins). Despite better understanding of this
coupling, it remains preferable to avoid use of an assumed coupling constant.
There is a change in arterial blood oxygenation due to hyperoxia (see figure
6.1), which will contribute to the hyperoxia BOLD signal. This is a problem
that will effect any hyperoxia-based calibration study. Equation 6.5 can be
used to assess the scale of the arterial contribution to hyperoxia BOLD sig-
nal. For the case shown in figure 6.1, with arterial resting CBV assumed to
be a third of venous resting CBV [73], the venous signal contribution is 14
times larger than the arterial signal contribution. The effect of this will be to
cause a small underestimation of relative vCBV change and qact. This change
in arterial oxygenation fraction of 0.0169 (from 110 – 500 mmHg PaO2) will
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cause a decrease in susceptibility of ∆χv = −0.0018× 10
−6, based on a hema-
tocrit fraction of Hct = 0.4 and ∆χv(fully deoxygenated – fully oxygenated
haemoglobin) = 0.264 × 10−6 [25]. Another possible issue may be if small
arteriolar blood oxygenation at normoxia is significantly lower (on the order
of ∼ 90%) compared to arterial blood oxygenation. On hyperoxia, these arte-
rioles would become closer to fully oxygenated, leading to an overestimation
in the BOLD response to hyperoxia at rest.
However, as shown in section 6.5, increased dissolved oxygen in arterial plasma
will cause a small increase in arterial susceptibility. For the change in PaO2 of
110 – 500 mmHg, there will be an increase of ∆χv = +0.0017×10
−6. This will
have an opposing effect to that of increased arterial blood oxygen saturation, as
discussed in the previous paragraph, causing a small overestimation of relative
vCBV change and qact. These opposing effects will almost cancel each other
out, leading to an insignificant change in arterial susceptibility. For a sense of
scale of susceptibility changes, the estimated venous oxygenation changes of
0.068± 0.003 due to hyperoxia and 0.14± 0.01 due to the motor task will give
susceptibility changes of 0.0072×10−6 and 0.0148×10−6 respectively. Combine
this with the smaller resting arterial CBV, typically a third of venous CBV,
and both the change in arterial blood oxygenation and the increased dissolved
oxygen will not give a significant contribution to the hyperoxia BOLD signal
(approximately two orders of magnitude smaller).
The estimation of qh from PETO2 assumes that OEF is 0.4 (see equation 6.11).
OEF is thought to be fairly constant across a healthy subject group, how-
ever it may vary considerably in patients. OEF does not affect the absolute
venous blood oxygenation change estimation, however it will bias the rela-
tive change qh, since this is normalised to Q (≡ OEF). Calculation of relative
vCBV changes are independent of errors in OEF. A systematic error in qact
will occur, linearly proportional to the error in OEF. One way around this is
to measure venous blood oxygenation in a large draining vein [182, 183], but at
the moment it is not known whether the errors associated with these methods
will be less than the errors associated with estimating OEF. Neither method
170
would account for possible local variations in OEF.
For the R∗2 model, it is assumed that qh and qact are independent of one another.
This essentially means that the amount of oxygen extracted is not dependent
on arterial oxygen content. This is reasonable so long as there is no metabolic
response to hyperoxia and that CBF is the same in normoxic and hyperoxic
periods.
Another possible source of error could be due to local increases in hematocrit
during neuronal activation [208]. This possibility has been attributed to a
local mismatch in plasma and red blood cell velocities during neuronal acti-
vation. This would influence equation 6.6, as the constant k will be different
compared to in equation 6.5. A local increase in hematocrit would cause an
overestimation of M ′, so an overestimation of relative vCBV changes and an
underestimation of qact.
In this experiment, PETCO2 was monitored throughout and was found to de-
crease by ∆PETCO2 = −0.5 ± 0.1 mmHg during hyperoxia. This very mild
hypocapnia is less than that seen with an equivalent fixed inspired hyperoxia
method (∆PETCO2 ∼ −3 mmHg during a 60 % O2 challenge) [188]. The
magnitude of the decrease in PETCO2 is on the order of resting fluctuations,
throughout the course of the experiment. The effect on CBF and resulting
BOLD signal is expected to be insignificant (on the order of ∼ 2% and ∼ 0.2%,
respectively).
A signal drift was observed in the BOLD timecourses of all subjects (see figure
6.5a). This drift was a slow decrease, which only occurred during hyperoxic
periods. If unaccounted for, this would cause an underestimation of the hy-
peroxia %BOLD, underestimating M. The analysis approach attempted to
minimise the effect of the drift by only considering the first motor trial of each
hyperoxic period and the immediately preceding normoxic motor trial. In this
case, the effect of the drift is thought to be minimal over the first minute of
hyperoxia, where the motor trial takes place. For the final two subjects, a
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modified paradigm with shorter hyperoxia periods was used, to try to account
for the drift. The cause of the drift was unknown at the time of performing this
study, however it is the subject of current work and has since arisen that the
cause of the drift may be due to an overshoot in PETCO2 of 1–2 mmHg during
the transition up to hyperoxia. This overshoot has recovered back to baseline
values by the time of the motor task, but may be the source of the drift. The
overshoot was attributed to a limitation with the RespiractTM software, which
can be fixed and therefore should not be a problem in the future.
As with any experiment which combines BOLD and CBF measurements, the
choice of ROI should be the subject of careful consideration. Reproducibility
studies of hypercapnia calibration [209] have found that an ROI defined by
significant CBF activation gives the results with least variability. It has also
been observed [60] that an ROI defined by significant CBF activation will ex-
clude large draining veins, which have a large resting CBF, but small ∆CBF
response. These large veins typically have a large BOLD response, due to
draining active tissue, but do not contain active tissue. In this work, a com-
bined ROI was formed, only including regions where both significant BOLD
and CBF response to the motor task was found. As a result, large draining
veins were discarded, which helps to meet the extravascular signal assumption,
whilst also limiting the ROI to significant BOLD activation, helping the model
for estimating qact.
The paradigm used here features trials with varying time between onsets. With
30s between the end of one trial and the start of the next, it is expected that
the vasculature may not recover fully. As a result, the subsequent trial’s BOLD
response may be attenuated, not being in the same state as for a trial with
longer to recover. The original paradigm was designed without foreseeing the
hyperoxia BOLD signal drift, so would have been treated as a block of two
trials, repeated at normoxia and hyperoxia. To justify the analysis used here,
there seems to be no significant difference in the shape or size of the two con-
secutive trials in each normoxia period. This is not ideal and is addressed in
the last two subjects, where the trial length is fixed at 90s throughout. This
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needs to be considered in the paradigm design for future studies.
The concept of comparing an event both at normoxia and hyperoxia requires
the assumption that the event is identical for both repeats. This will not be the
case, as the subject might relax during the course of the experiment, or expe-
rience some training through the repeats, so may perform the task differently.
The design of two repeats of normoxia and hyperoxia is designed to minimise
the effect of any systematic change in task performance over time. Some of
the variability in task performance could be reduced by changing the task, for
example to a sensory stimulus. The motor task was chosen as being simple
to set up and implement in the scanner environment alongside the respiratory
paradigm. The problem of task variability also applies to the subsequent ASL
measurement. This can be solved through simultaneous BOLD and ASL mea-
surement.
The method for estimating qact has been designed to work at 7 T. At the clini-
cally accessible field strengths of 1.5 T and 3 T, some modifications need to be
made to the assumptions. At these field strengths, the intravascular contribu-
tion to BOLD signal becomes significant. An extra compartment is needed in
the BOLD signal model to account for this, which makes it more complicated.
An alternative might be to suppress the intravascular signal component us-
ing bipolar diffusion gradients. The extravascular BOLD signal at these field
strengths gains a significant diffusive component. The assumption of static
spin dephasing to describe transverse relaxation is no longer reasonable. This
means that the relationship between R∗2 and Q is no longer linear. When not
in the static dephasing regime, this relationship is complicated, but has been
the subject of much investigation using Monte Carlo simulations [27, 28, 31].
The approach from the existing calibrated BOLD model [69] is to use a supra-
linear relationship, relating R∗2 and Q by the power β (section 2.4.5). A similar
supralinear relationship could be adopted here.
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6.8 Conclusion
This chapter has considered the use of hyperoxic BOLD contrast to assess
cerebral vascular properties. A new approach was proposed and implemented,
which uses hyperoxic BOLD contrast to estimate the relative changes in venous
blood oxygenation and venous CBV during a motor task. By the extension of
an ASL measurement, the relative change in CMRO2 was estimated. To assess
the validity of this method, the effect of presenting hyperoxia on cerebral
vasculature and on local magnetic properties was considered. The effect of
increased oxygen in the oral cavity on field homogeneity was assessed as a
possible confound to BOLD measurements. Although there was a small shift
in voxel position, as long as the region of interest is not neighbouring the frontal
sinus, there should not be a significant effect on the GE EPI signal. This opens
the possibility for using hyperoxia as a tool for investigating the venous role
in the BOLD signal. An experiment to implement the new approach resulted
in measured changes in CMRO2 which agreed with other methods, but with
less assumptions than those methods.
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Chapter 7
Conclusions
This thesis has explored the haemodynamic behaviour underlying the BOLD
signal, with the goal of working towards a more quantitative measurement
which more closely represents the underlying neuronal activity. This chapter
provides a summary of the work presented.
The field strength dependence of BOLD temporal characteristics has been in-
vestigated using a short (5 s) visual stimulus. The objective of this work was
to use the relative change in sensitivity of the BOLD signal with field strength
to contributions from small and large blood vessels to investigate their tem-
poral characteristics. The main finding from this experiment is that increased
field strength lead to a faster onset of the BOLD response to the visual stim-
ulus. This is consistent with an earlier response from the small blood vessel
BOLD signal component, compared to that from larger blood vessels, which
are typically more distant from the region of neuronal activity. Future work
will focus on using this data to test and improve existing models [114, 97, 106].
The dependence of transverse relaxation on level of hypercapnia (a global
cerebral vasodilator) has been investigated at 3 Tesla and 7 Tesla, finding a
tight linear relationship. An approximately linear increase in the change in
transverse relaxation due to hypercapnia with field strength was found, a re-
sult which can be used to improve calibrated BOLD calculations. In another
experiment, the BOLD response to hypercapnia was measured in the left and
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right precentral gyri, finding a significant difference between these two regions.
This suggests a vascular asymmetry, which will affect the interpretation of the
BOLD response to a motor task in these regions. A future objective will be
to investigate the source of this vascular asymmetry, which could provide a
valuable contribution towards the understanding of brain development.
A new approach to BOLD calibration has been proposed, where a task is
performed both at normoxia and hyperoxia. The main advantage of this ap-
proach over previous methods is that this approach does not assume a poorly
characterised relationship between CBF and CBV. The effect of hyperoxia on
haemodynamic and magnetic properties affecting the BOLD signal has been
considered, in order to assess the viability of this approach. In particular, an
experiment was performed to assess the effect on the EPI data of changes in
field homogeneity due to changes in oxygen content in the nasal cavity and
frontal sinuses. This experiment found that only the regions immediately ad-
jacent to the nasal cavity and frontal sinuses (the orbitofrontal cortex, for
example) will experience a significant change in EPI signal, whereas the effect
will be negligible for the primary motor and visual cortices. The new BOLD
calibration approach was implemented to assess the oxygen metabolism and
venous blood oxygenation changes due to a motor task, finding values for oxy-
gen metabolism which are consistent with the literature. Future work will
focus on applications of this new approach and on a comparison with existing
BOLD calibration techniques [69, 172].
Although fMRI (BOLD in particular) techniques have become widely used in
the fields of psychology and neuroscience, the indirect nature of such tech-
niques to the underlying neuronal activity restricts the conclusions that can
be formed and currently limits the clinical applications of these techniques. It
is hoped that the work presented here may contribute towards forming a more
quantitative BOLD approach, which has a closer relationship to the underly-
ing neuronal activity, whilst preserving the advantages of the BOLD technique,
such as high SNR and spatial resolution.
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